



Rui A. Lima, Graça Minas and Susana Catarino
www.mdpi.com/journal/micromachines
Edited by
Printed Edition of the Special Issue Published in Micromachines
Micro/Nano Devices for Blood Analysis

Micro/Nano Devices for Blood Analysis
Special Issue Editors
Rui A. Lima 
Graça Minas
Susana Catarino













St. Alban-Anlage 66 
4052 Basel, Switzerland
This is a reprint of articles from the Special Issue published online in the open access journal
Micromachines (ISSN 2072-666X) from 2018 to 2019 (available at: https://www.mdpi.com/journal/
micromachines/special issues/micro nano devices for blood analysis).
For citation purposes, cite each article independently as indicated on the article page online and as
indicated below:





Cover image courtesy of Rui A. Lima, Graça Minas and Susana Catarino.
2019 by the authors. Articles in this book are Open Access and distributed under the Creative 
Commons Attribution (CC BY) license, which allows users to download, copy and build upon 
published articles, as long as the author and publisher are properly credited, which ensures maximum 
dissemination and a wider impact of our publications.
The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons 
license CC BY-NC-ND.
Contents
About the Special Issue Editors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
Susana O. Catarino, Graça Minas and Rui Lima
Editorial for the Special Issue on Micro/Nano Devices for Blood Analysis
Reprinted from: Micromachines 2019, 10, 708, doi:10.3390/mi10100708 . . . . . . . . . . . . . . . . 1
Susana O. Catarino, Raquel O. Rodrigues, Diana Pinho, João M. Miranda, Graça Minas and
Rui Lima
Blood Cells Separation and Sorting Techniques of Passive Microfluidic Devices: From
Fabrication to Applications
Reprinted from: Micromachines 2019, 10, 593, doi:10.3390/mi10090593 . . . . . . . . . . . . . . . . 5
Misa Kawaguchi, Tomohiro Fukui, Kenichi Funamoto, Miho Tanaka, Mitsuru Tanaka,
Shigeru Murata, Suguru Miyauchi and Toshiyuki Hayase
Viscosity Estimation of a Suspension with Rigid Spheres in Circular Microchannels Using
Particle Tracking Velocimetry
Reprinted from: Micromachines 2019, 10, 675, doi:10.3390/mi10100675 . . . . . . . . . . . . . . . . 25
Naoki Takeishi, Hiroaki Ito, Makoto Kaneko and Shigeo Wada
Deformation of a Red Blood Cell in a Narrow Rectangular Microchannel
Reprinted from: Micromachines 2019, 10, 199, doi:10.3390/mi10030199 . . . . . . . . . . . . . . . . 38
Vera Faustino, Raquel O. Rodrigues, Diana Pinho, Elı́sio Costa, Alice Santos-Silva, Vasco
Miranda, Joana S. Amaral and Rui Lima
A Microfluidic Deformability Assessment of Pathological Red Blood Cells Flowing in a
Hyperbolic Converging Microchannel
Reprinted from: Micromachines 2019, 10, 645, doi:10.3390/mi10100645 . . . . . . . . . . . . . . . . 53
Liliana Vilas Boas, Vera Faustino, Rui Lima, João Mário Miranda, Graça Minas, Carla Sofia
Veiga Fernandes and Susana Oliveira Catarino
Assessment of the Deformability and Velocity of Healthy and Artificially Impaired Red Blood
Cells in Narrow Polydimethylsiloxane (PDMS) Microchannels
Reprinted from: Micromachines 2018, 9, 384, doi:10.3390/mi9080384 . . . . . . . . . . . . . . . . . 68
Yang Jun Kang and Byung Jun Kim
Multiple and Periodic Measurement of RBC Aggregation and ESR in Parallel Microfluidic
Channels under On-Off Blood Flow Control
Reprinted from: Micromachines 2018, 9, 318, doi:10.3390/mi9070318 . . . . . . . . . . . . . . . . . 84
J. Ponmozhi, J. M. R. Moreira, F. J. Mergulhão, J. B. L. M. Campos and J. M. Miranda
Fabrication and Hydrodynamic Characterization of a Microfluidic Device for Cell Adhesion
Tests in Polymeric Surfaces
Reprinted from: Micromachines 2019, 10, 303, doi:10.3390/mi10050303 . . . . . . . . . . . . . . . . 101
Shukei Sugita, Risa Munechika and Masanori Nakamura
Multinucleation of Incubated Cells and Their Morphological Differences Compared to
Mononuclear Cells
Reprinted from: Micromachines 2019, 10, 156, doi:10.3390/mi10020156 . . . . . . . . . . . . . . . . 117
v
Masanori Nakamura, Daichi Ono and Shukei Sugita
Mechanophenotyping of B16 Melanoma Cell Variants for the Assessment of the Efficacy of
(-)-Epigallocatechin Gallate Treatment Using a Tapered Microfluidic Device
Reprinted from: Micromachines 2019, 10, 207, doi:10.3390/mi10030207 . . . . . . . . . . . . . . . . 127
Zhigang Gao, Zongzheng Chen, Jiu Deng, Xiaorui Li, Yueyang Qu, Lingling Xu, Yong Luo,
Yao Lu, Tingjiao Liu, Weijie Zhao and Bingcheng Lin
Measurement of Carcinoembryonic Antigen in Clinical Serum Samples Using a Centrifugal
Microfluidic Device
Reprinted from: Micromachines 2018, 9, 470, doi:10.3390/mi9090470 . . . . . . . . . . . . . . . . . 141
Yuan Fang, Ningmei Yu, Yuquan Jiang and Chaoliang Dang
High-Precision Lens-Less Flow Cytometer on a Chip
Reprinted from: Micromachines 2018, 9, 227, doi:10.3390/mi9050227 . . . . . . . . . . . . . . . . . 151
vi
About the Special Issue Editors
Rui A. Lima is Associate Professor at the Department of Mechanical Engineering, University of 
Minho (UMinho), and Researcher at the Mechanical Engineering and Resource Sustainability Center 
(MEtRICs, UMinho) and Transport Phenomena Research Center (CEFT), FEUP, University of Porto. 
His research is mostly centered on the area of microfluidics, nanofluidics, and blood flow in 
biomedical microdevices. Currently, he lectures as part of several Master courses in Mechanical and 
Industrial Engineering. In the past, he has delivered lectures as part of several Master courses in 
Biomedical Technology, including Cardiovascular Biomechanics and Micro/Nanotechnologies and 
Biomedical Applications at the Bragança Polytechnic Institute (IPB). Currently, he also supervises 
several PhD and Master students in the field of Mechanical and Biomedical Engineering.
Graça Minas is Associate Professor and Deputy Director at the Department of Industrial Electronics, 
as well as Researcher at the CMEMS-UMinho (Center for Microelectromechanical Systems), 
University of Minho, Portugal. Her research is mostly centered on the area of biomedical 
microdevices, specifically, in lab-on-a-chip integration of electronic circuits, optical filters, solid-state 
integrated sensors, biosensors, and actuators in those LOC devices. She is also developing organ-on-
a-chip systems that aim to mimic human responses to various chemicals in vitro. She has published 
more than 130 articles and 7 patents. She supervised 2 postdoctoral fellows, 11 PhD theses (7 
finished), 40 Master theses, and numerous research fellows (in the scope of project grants). 
Furthermore, she has participated in 18 national and European projects and has been Principal 
Investigator in 8 of them (6 completed).
Susana Catarino received her PhD degree in Biomedical Engineering in 2014 from the University of 
Minho, Portugal. She is currently Researcher at the Center for Microelectromechanical Systems 
(CMEMS-UMinho) at the same University. From October 2016, she was also Visiting Assistant 
Professor at the same institution, lecturing at the Dept. of Industrial Electronics in the areas of 
Modeling and Simulation for Microtechnologies, Electronics, Microsensors, and Microactuators. She 
has published more than 40 articles in international journals, conferences, and book chapters, and 1 
patent. She currently supervises 2 PhD thesis, 10 Master theses (7 completed), and 1 research fellow. 
She has also participated in 6 funded projects, in which she was Principal Investigator in 2 of these. 
Her research interests include diagnosis and lab-on-a-chip devices, optical and acoustic sensors and 





Editorial for the Special Issue on Micro/Nano Devices
for Blood Analysis
Susana O. Catarino 1,*, Graça Minas 1,* and Rui Lima 2,3,*
1 Center for MicroElectromechanical Systems (CMEMS-UMinho), University of Minho, Campus de Azurém,
4800-058 Guimarães, Portugal
2 CEFT, Faculdade de Engenharia da Universidade do Porto (FEUP), Rua Roberto Frias,
4200-465 Porto, Portugal
3 MEtRICs, Mechanical Engineering Department, University of Minho, Campus de Azurém,
4800-058 Guimarães, Portugal
* Correspondence: scatarino@dei.uminho.pt (S.O.C.); gminas@dei.uminho.pt (G.M.); rl@dem.uminho.pt (R.L.)
Received: 14 October 2019; Accepted: 15 October 2019; Published: 18 October 2019
The development of microdevices for blood analysis is an interdisciplinary subject that demands
an integration of several research fields such as biotechnology, medicine, chemistry, informatics, optics,
electronics, mechanics, and micro/nanotechnologies.
Over the last few decades, there has been a notably fast development in the miniaturization of
mechanical microdevices, later known as microelectromechanical systems (MEMS), which combine
electrical and mechanical components at a microscale level. The integration of microflow and optical
components in MEMS microdevices, as well as the development of micropumps and microvalves,
have promoted the interest of several research fields dealing with fluid flow and transport phenomena
happening at microscale devices.
Microfluidic systems have many advantages over macroscale by offering the ability to work
with small sample volumes, providing good manipulation and control of samples, decreasing
reaction times and allowing parallel operations in one single step. Despite the enormous scientific
achievements that microfluidics have had in the last decades in the field of biomedical applications,
this technology is still considered in an early stage, with some pullbacks, such as the difficulty to
achieve a cost-effective large-scale production, and a lack of complete understanding of the physics of
fluids at the microscale level over the biological species. Consequently, enormous efforts have been
performed in microfabrication and microfluidics research to enhance the potential of microdevices to
develop portable and point-of-care diagnostic devices, particularly for blood analysis.
In this special issue, Catarino et al. [1] present one review paper on an overview of the techniques
used for sorting and separation of red blood cells (RBCs) and the respective micro- and nanofabrication
techniques, as well as examples of lab-on-a-chip devices with high potential for the integration of
separation and detection tools in a single microfluidic platform [1].
Additionally, the special issue also contains 10 research papers covering different subjects related
to microfluidic structures and cells characterization. Particularly, Kawaguchi et al. [2] have proposed
a method to assess the changes in the rheological properties of a suspension containing fluorescent
particles. On one side, the authors used a microchannel with a circular cross section and measured
the distribution of suspended microparticles in the radial direction from the recorded images. On the
other side, the authors evaluated the non-Newtonian rheological properties of the suspension using
the velocity distribution obtained by the particle tracking velocimetry (PTV) and a power-law fluid
model [2].
Three of the research papers focus are focused on assessing the deformability of RBCs in
microchannels [3–5]. Takeishi et al. [3] numerically investigated the dynamics of RBCs flowing
at different velocities in a narrow rectangular microchannel, for different capillary (Ca) numbers.
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The authors found that RBCs confined in the microchannel assumed a nearly unchanged biconcave
shape at low Ca numbers, which became an asymmetrical slipper shape at moderate Ca numbers, and
a symmetrical parachute shape at high Ca values, showing that the measurement of the configurations
of the flowing cells can be a valuable tool to quantify the cell state [3].
Faustino et al. [4] have presented a passive microfluidic tool that provides the assessment of
motions and deformations of RBCs of end-stage kidney disease (ESKD) patients (comparing patients
with and without diabetes type II). The experimental flow studies were performed within a hyperbolic
converging microchannel where single-cell deformability was assessed under a controlled homogeneous
extensional flow field, using a high-speed video microscopy system. The velocities and deformability
ratios were calculated for 27 individuals, 20 of them having ESKD, and the results showed that the
proposed device was able to detect changes in the deformability ratio of the RBCs, allowing for
distinguishing the samples from the healthy controls and the patients. The RBCs deformability of
ESKD patients with and without diabetes was lower than of the healthy controls, with this difference
being more evident for the group of ESKD patients with diabetes [4].
Vilas Boas et al. [5] reported an experimental study of the deformability and velocity assessment of
healthy and artificially impaired red blood cells (RBCs), in narrow (8 μm width) polydimethylsiloxane
(PDMS) microchannels, with the purpose of potentially mimicking malaria effects. The authors
modified the RBCs by adding different concentrations of glucose, glutaraldehyde, or diamide in
order to increase the cells’ rigidity, and obtained a velocity/deformability relation in the microchannel
contraction, which shows great potential to relate the RBCs’ behavior with the various stages of malaria,
helping to establish the development of new diagnostic systems towards point-of-care devices [5].
Kang and Kim [6] studied the RBCs aggregation and sedimentation rate in a microfluidic device,
fabricated by xurography. In this study, multiple and periodic measurements were obtained by pulling
blood from a pipette tip into parallel microfluidic channels, and quantifying the image intensity.
The authors have considered two indices (aggregation index and erythrocyte-sedimentation-rate
aggregation index) and have evaluated the effect of hematocrit and dextran solution on these values,
showing that the erythrocyte-sedimentation-rate aggregation index varies linearly within a specific
concentration of dextran solution [6].
Ponmozhi et al. [7] developed and characterized a low-cost microfluidic device for adhesion tests
in polymeric surfaces, which can be fabricated in a laboratory with low resources. The fabrication
method consisted of a modification of the existing PDMS soft lithography method and, therefore,
is compatible with sealing methods and equipment of most microfluidic laboratories. The molds were
produced by xurography, and the fabrication method was tested by evaluating the bacterial adhesion in
five different materials, with different surface hydrophobicity and charges. The authors also performed
a computation fluid dynamics analysis of the flow in the microfluidic device [7].
Four research papers studied clinical applications of microfluidic devices, in particular for
quantification of tumor markers, as well as the characterization of the morphological properties of other
cell cultures and counting cells. In particular, Sugita et al. [8] developed a method to efficiently obtain
in vitro multinucleated cells and characterized their morphological properties. The authors seeded a
Xenopus tadpole epithelium tissue-derived cell line (XTC-YF) in different hydrophobicity dishes and
with or without supplements, and verified that 88% of the cells cultured on a less hydrophilic dish in
medium supplemented with Y-27632 became multinucleate 48 h after seeding [8].
Since metastatic cancer cells are known to have a smaller cell stiffness than healthy cells,
Nakamura et al. [9] developed a simple microfluidic system to assess metastatic capacity of the
cancer cells from a mechanical point of view, by evaluating the viscoelastic properties of cancer
cells on a tapered microchannel. Two metastasis B16 melanoma variants (B16-F1 and B16-F10) were
examined and the shape recovery process of the cell from a compressed state was evaluated with
the Kelvin–Voigt model. The shape recovery time constant became larger as cancer cells had higher
metastatic potential [9].
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Gao et al. [10] developed a high-throughput centrifugal microfluidic device for detecting
carcinoembryonic antigen (CEA) in serum, which is a broad-spectrum tumor marker used in clinical
applications, without the need for cumbersome washing steps normally used in immunoreactions.
This centrifugal microdevice contains 14 identical pencil-like units, and the CEA molecules were
separated from the bulk serum for subsequent immunofluorescence detection using density gradient
centrifugation in each unit simultaneously. The proposed device can achieve a high-throughput
detection [10].
Finally, Fang et al. [11] presented a low cost and small size flow cytometer on a microfluidic chip,
integrating an inline lens-free holographic microscope. The authors proposed an S-type microchannel
with a pulse injection flow, and obtained a less than 2% cell counting error. This on-chip flow cytometer
can continuously count cells and continuously collect a large number of cell images for subsequent cell
analysis, and is in full compliance with the current development trend of point-of-care testing [11].
We hope this issue can provide an opportunity to the engineering and biomedical community,
and those who are interested in the general field of MEMS and micro/nanofluidics, to access novel
knowledge and information, especially in its applications to biomedical areas. Particularly, we hope
this issue can contribute as a display of the latest achievements, breakthroughs, challenges and future
trends in microdevices for diagnostics and blood analysis, micro- and nanofluidics, technologies
for flows visualization, MEMS, biochips and lab-on-a-chip devices and their application to research
and industry.
Finally, we would like to congratulate, acknowledge and thank all the authors for submitting their
original manuscripts to this special issue, as well as all the reviewers for the time and help to improve
the quality of the submitted papers.
Conflicts of Interest: The authors declare no conflicts of interest.
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Abstract: Since the first microfluidic device was developed more than three decades ago, microfluidics
is seen as a technology that exhibits unique features to provide a significant change in the way that
modern biology is performed. Blood and blood cells are recognized as important biomarkers of many
diseases. Taken advantage of microfluidics assets, changes on blood cell physicochemical properties
can be used for fast and accurate clinical diagnosis. In this review, an overview of the microfabrication
techniques is given, especially for biomedical applications, as well as a synopsis of some design
considerations regarding microfluidic devices. The blood cells separation and sorting techniques
were also reviewed, highlighting the main achievements and breakthroughs in the last decades.
Keywords: microfluidics; red blood cells (RBCs); microfabrication; polymers; separation and
sorting techniques
1. Introduction
Since the development of the first microfluidic device, microfluidics heralded the promise to
change life science and industry [1]. Despite the enormous scientific achievements that microfluidics
have had in the last decades in the field of biomedical applications, this technology is still considered
in its “adolescence” [2]. Among the pullbacks, are the difficulty to achieve a cost-effective large-scale
production that allows its commercialization for clinical application, the so-called lab-on-a-chip, and the
complete understanding of the physics of fluids at the microscale level over the biological species,
such as blood and blood cells.
Blood and blood cells are important for scientific and clinical purposes because they can be used
as indicators of many pathological conditions, including arterial hypertension, ischemia, inflammation,
and diabetes [3,4]. Based on the fact that abnormal blood cells typically have distinctive biological
and physicochemical properties (e.g., size, deformability and chemical composition), with different
hydrodynamic properties when compared to healthy ones, these features can be used for rapid,
low-cost cell separation and diagnosis.
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In parallel, recent developments in microfabrication with polymers and elastomers made possible
to fabricate low-cost transparent micrometre-sized channels and, as a result, several studies have been
proposed using microfluidics to measure the motion and dynamic behaviour of cells flowing through
microfluidic devices [5–12]. Taken into consideration that since its origins, microfluidics has flourished
and paved its path in parallel with the development of new fabrication technologies, the present review
aims to give an overview perspective of this technology for blood cells separation and sorting from
the fabrication to application, and thus, revising the main achievements and breakthroughs in the
last decades.
This review is organized as follows: Section 2 presents a description of different techniques for the
fabrication of microfluidic devices, as well as a comparison between them; Section 3 approaches design
considerations regarding microfluidic devices for biomedical applications; Section 4 describes and
compares the main passive methods for cells sorting and separation; and Section 5 briefly discusses
future challenges and perspectives regarding microfluidic devices and their applications.
2. Fabrication of Polymeric Microfluidic Devices
The beginning of microfluidics and its early systems, in the late 1970s (Figure 1), were derived from
microelectronics and microelectromechanical systems (MEMS) technology and techniques, such as
photolithography and etching, which were highly developed at the time [2,13].
Figure 1. Timeline of the main microfluidics achievements from the first microfluidic device until
the present.
Initially, silicon and glass were the select material to produce those microfluidic devices.
Although, silicon had a big impact in microelectronics, initiating the Silicon Valley revolution,
the material has some disadvantages for microfluidics, such as its opacity in the Ultra-Violet/Visible
(UV/Vis) region of the electromagnetic spectrum and relative high cost [13,14]. Glass, on the other
hand, is transparent, but due to its amorphous structure is difficult to etch compared with pure SiO2.
For the pattern of small size structures, sandblast and wet etching are the most used techniques.
Nevertheless, sandblast is typically limited for patterns below 100 m and leads to rough surfaces,
while wet etching allows smooth sidewalls but has low aspect ratio [15]. Therefore, among the glass
micromachining limitations are the low etching aspect ratio and rate, limited mask selectivity and
surface roughness [15]. Other disadvantages are that both materials required that each device is
made in cleanroom facilities and its sealing made with high voltages and temperatures, which makes
the microfabrication laborious and expensive [13]. In contrast to glass and silicon, polymers and
elastomers, are less expensive and the channels can be obtained by molding or embossing that
makes the fabrication faster and less expensive [14]. Among the most popular polymers used
to fabricate microfluidic devices are poly(methyl methacrylate) (PMMA), cyclic olefin copolymer
(COC), poly(styrene) (PS), poly(carbonate) (PC), poly(ethyleneterephthalate glycol) (PETG) and
poly(dimethylsiloxane) (PDMS) [14]. Derived from this effort to find alternative materials, PDMS,
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a transparent elastomeric polymer pioneered by George Whitesides and his group at Harvard in the
1990s, quickly become the most popular material used in microfluidic devices [2]. The use of this new
material made possible the massification of soft-lithography technique, with rapid prototyping and
replica molding (Figure 2).
Figure 2 shows the main steps involved in the design and fabrication of microfluidic devices using
the soft-lithography technique. The detailed description of these steps is well described elsewhere [13].
Figure 2. Soft lithography technique introduced by Whitesides and co-workers in 1998. (a) Rapid
prototyping using photolithography and (b) replica molding with poly(dimethylsiloxane) (PDMS).
Reproduced with permission from [13].
This innovation allowed the growth of microfluidics field due to the many advantages of this
material: (i) high fidelity to replicate by molding features at the micro-scale level; (ii) its optically
transparent down to 280 nm; (iii) low temperature and time to cure; (iv) biocompatibility and nontoxicity
to cells; (v) possibility to change surface chemistry accordingly to the application needs; (vi) gas
permeability, allowing culture of cells; (vii) reversal and self-bonding, among others [13,16,17].
In general, soft-lithography follows four major steps: (i) pattern design, drawn in computer-aided
design (CAD) software programs for the fabrication of photomasks on transparency films (Figure 2a);
(ii) fabrication of the mask and master, photomasks on transparency films are designed in high-resolution
printers followed by photolithography technique (Figure 2a); (iii) fabrication of the PDMS stamp,
fabricated by casting PDMS (pre-polymer mixed with cure agent) against a master whose surface
has been patterned (Figure 2b) and (iv) fabrication of micro- and nanostructures with the stamp by
printing, molding and embossing [18].
Although the several advantages of the soft-lithography method with PDMS, the standard
prototyping method (i.e., photolithography) requires the access to cleanroom facilities and high-trained
people. Additionally, the replica molding with PDMS is achieved by casting the masters one by
one, which make the large-scale production slow. Nevertheless, this process is an ideal and fast
solution to test prototypes. Another important aspect is that despite the common statement that
BioMEMS is straightforward and inexpensive, the fabrication of microfluidic devices is, in general,
complex and costly. For instance, it is estimated that the user fee in the United States for a fully
staffed cleanroom, in a major research university, is in the order of $100/h per student [19]. This must
include the typical time for training that can take several weeks for the basic operation of equipment
and familiarization of techniques, such as spin coater, masker aligner and developing station [19].
An alternative is the contract of manufacturers that can provide custom master molds for a relatively
low fee. However, this process can take several weeks from manufacturing to shipping [20]. To suppress
the high cost and constrains of photolithography, alternatives have been developed in the last decade
7
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for the low-cost of microstructures without the need of cleanroom facilities. An example of this effort
was published by Pinto et al., 2014 [21], describing the fabrication and optimization of microstructures
in SU-8 (commonly used as epoxy-based negative photoresist), without the need of cleanroom facilities.
The proposed fabrication technique uses an alternative photomask printed in transparent photographic
sheet using standard tools and equipment employed in the printed circuit board (PCB) industry.
Even though the outstanding achievement of the proposed technique, the SU-8 shows a resolution
limitation of 10 m and the need to control the room temperature and humidity to optimize the
fabrication procedure.
In parallel, alternative non-lithographic techniques have also emerged from these requirements of
specific facilities and equipment that has inhibited many scientific groups to pursue new microfluidic
innovations, namely print and peel techniques, e.g., xurography, micromilling or direct laser plotting
(Figure 3), which are well reviewed elsewhere [22].
Briefly, xurography allows the generation of master molds (or masks) using a cutting plotter
machine and adhesive vinyl film. Recently, Pinto et al. (2014) [23] have shown that xurography can
be used as a rapid technique with good resolution to produce microfluidic structures down to 500 m.
By using this technique Bento et al. [24] were able to successfully produce microchannels contractions
with dimensions down to 350 m and as a result they have investigated how Taylor bubbles disturb the
blood flow at the scale of blood cells.
Micromilling, is another low-cost fabrication technique that creates microscale structures by
removing bulk material with cutting tools [25]. This technique was shown by Lopes and co-workers to
have the ability to produce reusable microfluidic devices with widths down to 30 m [26].
Direct laser plotting is a microfabrication technique similar to micromilling that uses laser beams
to create microchannels. This technique can typically generate microchannels widths up to 100 m.
Although it has been shown the possibility to down to 20 m by using short laser pulses [22].
Figure 3. Low-cost print-and-peel microfabrication techniques. (I) Xurography: (a) cutting plotter
machine; (b) features being cut by the cutting plotter; (c) PDMS being added to a petri dish containing
the vinyl mask; (d), (e) and (f) Cross sections of microchannels with 500, 300 and 200 m of width,
respectively. (II) Micromilling; (a) milling machine; (b) operating milling tool and (c) microchannels.
Reproduced with permission from [22]. (III) Direct laser plotting main steps. Reproduced with
permission from [27].
3D-printing fabrication techniques have also gained a growing interest to fabricate microfluidic
devices, offering the possibility to generate devices with complex architectures from a broader
range of materials and avoiding multi-step processing [28]. The main 3D-printing techniques are
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stereolithography (SLA), fused deposition modelling (FDM), selective laser sintering (SLS) and direct ink
writing (inkjet) [28–30], allowing a broad range of applications. Among the advantages, the simplicity,
fast and efficient prototyping with no need of photomask and cleanroom facilities, are some of the
most important.
FDM, is the most simple and low-cost 3D-printing method, working by extruding a thermoplastic
polymer through a hot nozzle to print layers of the object. The technique can be used to produce
directly the microfluidic devices or the 3D mask that combined with PDMS replication molding allows
the fabrication of 3D-biomodels, such as macro and micro-scale vascular system models [30,31].
An overview of the main advantages and disadvantages of the most representative fabrication
techniques used to develop microfluidic devices in polymer substrates is given in Table 1.
Table 1. Main advantages, disadvantages, resolution range and aspect ratio of microfabrication
techniques used to develop microfluidic devices using polymer substrates. Adapted from [14].
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With the recent development of nanotechnology for several applications and fields, nanofabrication
techniques for microfluidic devices have also been developed. In general, these new techniques are
based in advanced nanoscale photolithographic methods, such as extreme ultraviolet, electron beam and
nanoimprint lithography, or non-lithographic methods, such as anodic aluminium oxidation. All these
new nanofabrication approaches are well described elsewhere [17]. With the ability to generate features
with just a few nanometres, the main application of these nanofabrication techniques are lab-on-a-chip
microdevices, with high potentiality to medicine, biology and chemical applications [47–49].
3. Design of Microfluidic Devices for Biomedical Applications
Biomedical science found a fruitful field in microfluidics to replace routine analysis and diagnosis
tests, as well as to conduct fundamental biological studies in cells and diseases. Among the biomedical
applications, microfluidics research has allowed the emerging of a wide range of promising applications
from microscale genomic and proteomic analysis kits, biosensors, point-of-care diagnostic devices,
drug screening and delivery platforms, implantable devices, novel biomaterials to tissue engineering
and single cell studies [50].
Depending on the final application of the microfluidic device, different micro- or nanofabrication
techniques are available and can be used. In general, most of the research groups try to pursue a
time-cost effectiveness to fabricate their own microdevices. Based on this standpoint, Figure 4 gives an
overview of the fabrication techniques listed in Table 1, from a time and cost perspective.
The material selection also has an important role in the application. For biomedical applications
the selection of the material must consider important parameters, namely biocompatibility, bio-culture,
permeability and porosity, protein crystallization, reusability and disposable device use. Some of these
characteristics are listed in Table 2, for the most common materials used for biomedical applications.
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Figure 4. Fabrication techniques from a time and cost perspective. Adapted from [14]. * Despite
standard soft-lithography technique is considered expensive, new alternatives without the need of
cleanroom facilities significantly drop the cost, being considered as low-cost, as the work published by
Pinto et al., 2014 [21].
Table 2. Significant characteristics of the most common materials used for biomedical applications.
Adapted from [51].
Characteristics Silicon Glass Thermoplastics Elastomers (PDMS)
Protein crystallization Poor Poor Good Moderate
Droplet formation Excellent Excellent Good Moderate
Porosity Poor Poor Moderate Moderate
Permeability Poor Poor Moderate Good
Bio-culture Moderate Moderate Moderate Good
Reusability Yes Yes Yes No
Disposable device use Expensive Expensive Good Good
Another important aspect for the fabrication of microfluidic devices is the interfacing and/or
integration of modules for the applications that the device is being designed. Among them, integration
of microheaters, valves, sensors, electroosmotic fluid pumps, readout electronics, among others, can be
accomplished to complete microfluidic devices with remarkable capabilities [52].
4. Microfluidic Cell Separation and Sorting Techniques
Despite all the research and development of microfluidic systems, several challenges remain
related to the miniaturization of the lab-on-a-chip devices. At the microscale level, the mixture,
pumping, separation and control of fluids are limited, on the one hand, by the minimum sample
volumes and flow rates required by the biological analysis and, on the other hand, by the microscale
dimensions of the systems. The dominant physical and chemical effects at the microscale level are
different from the ones at the macroscale, leading to an increased complexity of the flow and mass
transport phenomena. In order to overcome those limitations, significant research efforts have been
performed for improving the design of micropumps, valves, mixers and separation devices that can be
incorporated on lab-on-a-chip devices [53–55], while addressing the non-Newtonian behaviour of the
majority of physiological fluids [56,57].
Microfluidic systems can integrate different kinds of sorting methods based on the physical
parameters of cells, providing a perfect interface for the manipulation of single cells and access forces
in a variety of ways and allowing a fully autonomous measurement of physical parameters [58].
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Particularly, cell separation techniques have been developed for cell concentration purposes (removal
of plasma and increase of the cell concentration, mainly haematocrit increase); plasma enrichment
(removal of cells from plasma and cells dilution); blood fractioning (separation of blood into different
components); cell sorting (separation of cells by type); and cell removal (specific cell sorting that
removes only some specific cells), that can work as cell isolation or removal of pathogenics [59].
The manipulating of forces for the separation techniques can be active, passive or both (label-free
cell sorting mechanism), as shown in Figure 5. Apart from these, there are other methods such as
paper-based [60,61] and CD based [62,63] methods to separate mainly the plasma from blood [64].
Active technologies, based on microelectromechanical systems, improve the control of fluids using
mobile parts or external mechanical forces, and can be based on dielectrophoresis, magnetophoresis,
acoustophoresis and optical tweezers mechanisms [58,64]. Passive technologies for controlling fluids
do not include external forces or mobile parts, and their control is promoted by diffusion as a function
of the channel geometry [64–70], or intrinsic hydrodynamic forces, such as punch flow fraction,
deterministic lateral displacement, inertial forces and intrinsic physical property of the cells [69–74],
including sieving, which uses the size of micropores, microweirs, membranes and the gap between
micropillars arrays for the separation of cells [26,69–78]. The passive microfluidic technologies bring
more interest in the lab-on-a-chip and microfluidics research field due to its precise manipulation,
low cost fabrication, simple structure, simple integration and lower maintenance in lab-on-a-chip
devices and high throughput [79–82].
Therefore, this paper presents, in addition to an overview over the microfabrication techniques
using polymers as substrates, a review and discussion of different passive techniques and microfluidic
devices for separation of cells, categorized according to the separation phenomena: hydrodynamic
phenomena (as punch flow, inertial forces or deterministic lateral displacement); hemodynamic
phenomena (based on the intrinsic physical properties of the cells); and filters and physical filtration
(based on micropores, microweirs, membranes and the gap between micropillars), as shown in Figure 5.
Figure 5. Classification of the main active and passive separation techniques used in microfluidic systems.
4.1. Hydrodynamic Separation and Sorting Techniques
The hydrodynamic separation techniques are adequate for low Reynolds number flows (Re < 1)
in the microfluidic devices. In a purely hydrodynamic flow separation technique, the laminar flow
conditions exist, i.e., viscous forces are strong enough to have any disturbances in the pumped flow
through the microchannel. In this process, the aligned cells are separated through multiple side
branching outlets (Figure 6b), so that particles of different sizes will follow different paths, achieving
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size-based separation [83]. The hydrodynamic focusing is able to achieve narrow streams through
sheath flows unlike the inertial focusing that occurs in a single flow stream.
Particles or cells exposed to a shear flow experience a lift force perpendicular to the flow direction
and a force from the wall. The equilibrium of these two forces is responsible for the cells or particles
migration and depends on several factors, such as channel geometry, flow rate, rheological properties
of the carrier fluid and mechanical properties of the elements, as in Figure 6a. By manipulating the flow,
for example, controlling the flow rate through one or more inlets, it is possible to achieve size-based
cell separation and sorting [84].
The inertial separation methods generate the deflection of larger particles away from the flow,
while smaller ones are carried on or near the original flow streamline. These mechanisms occur in
curved and focused flow segments, and result from the combination of asymmetrical sheath flows and
specific channel geometries, which are able to create a soft inertial force on the fluid. By using channels
with curvature (as in Figure 6e), an additional drag force arising from secondary flows (called Dean
vortices) enhances the speed of particle migration to more stable equilibrium positions, achieving a
faster focusing of cells and particles than in straight channels, with high-throughput and continuous
blood separation [64,70]. The inertial migration phenomenon has been widely recognised by the
counteraction of two inertial effects, i.e., the shear gradient lift and the wall lift forces [85]. Many of the
microfluidic devices have combined this separation inertial focusing strategy with other microfluidic
methodologies to enhance blood cells separation, as different examples are presented in Figure 6.
Figure 6. Hydrodynamic methods of separation: (a) the implied forces in a Poiseuille flow for cell
separation. Reproduced with permission from [86] (b) the principle of hydrodynamic filtration in a
microchannel with many outlets. Reproduced with permission from [81,84]. (c) trajectories analysis of
rigid and deformable cells through a contraction for cell separation in two outlets. Reproduced with
permission from [87]. (d) principle of deterministic lateral displacement. Reproduced with permission
from [86]. (e) separation using inertial flow forces and at high flow rates creating vortices downstream
a contraction. Reproduced with permission from [64,88]. (f) extensional forces for cell separation and
mechanical analysis. Reproduced with permission from [89].
13
Micromachines 2019, 10, 593
Wang et al. [90], reported an inertial microfluidic device for continuous extraction of large particles
or cells with high size-selectivity (under 2 μm) and high efficiency (above 90%). The authors developed
a simple geometry with four key parts: a main microchannel, with a high-aspect-ratio geometry,
to assure the inertial particle flow; two chambers for the formation of microvortexes, symmetrically
positioned; two side outlets, positioned at the chambers’ corners, for the creation of sheath flow and
removal of large particles; and, finally, an outlet for the small particles.
One of the hydrodynamic separation methods is based on the principle known as deterministic
lateral displacement (DLD). This method employs arrays of pillars placed within a microchannel
(array of obstacles). The laminar flow together with interactions in the array, forces the particles or
cells to flow with specific trajectories through the device. The distance among the pillars is tailored
according to the size of the cells or the particles to be sorted. The array pattern determines the
displacement of cells or particles [84], i.e., the gap between posts and their offset determines the
critical particle size for the fractionation. If the particles and/or cells are smaller than the critical
size, they tend to flow through the array gaps without net displacement from the original central
streamline. If the particles are bigger than the critical size, they will displace laterally, traveling at an
angle predetermined by the posts offset distance (as shown in Figure 6d) [84]. Liu et al. [91] developed
a rapid and label-free microfluidic structure for isolation of cancer cells from peripheral whole blood,
using deterministic lateral displacement arrays (based on the size-dependent hydrodynamic forces),
and achieved cells separation efficiency between 80% and 99% with a 2 mL/min throughput [91].
A high-throughput cytometry microsystem was reported by Rosenbluth et al. [92], to distinguish and
quantify blood cell properties and help to prevent different hematologic problems (as sepsis, occlusion
or leukastasis). The proposed microsystem presents a trifurcation into two bypass channels, and a
network of bifurcations that split into 64 parallel capillary-like microchannels.
4.2. Hemodynamic Phenomena on Cell Separation Techniques
Microfluidic biomimetic cell separation techniques are based on mimicking the hemodynamic
phenomena and the intrinsic properties of plasma and blood cells when flowing in microvessels.
Different hemodynamic phenomena have been observed in vivo and replicated in microfluidic systems,
including: plasma layer; Fåharaeus–Lindqvist effect (decrease of the apparent viscosity of blood in
small vessels), which causes the tendency of the RBCs to migrate toward the centre of the microchannel,
creating the cell-free layer (CFL) [11,93] (Figure 7b); leukocyte margination (migration of leukocytes,
that are less deformable than RBCs, to the wall of the microchannel due to collisions between leucocytes
and erythrocytes) [86]; plasma skimming (uneven distribution of red blood cells and plasma between
the small side branch and the main channel); and the Zweifach–Fung bifurcation effect (in asymmetric
bifurcations in which the vessel with the smaller flow rate gets a higher concentration of plasma),
as represented in Figure 7c [64,93]. A number of microdevices have been developed to take advantage
of these effects. For instance, in blood vessels with luminal diameter less than 300 μm, RBCs tend
to migrate radially to the axial centre line of the vessel (Fåharaeus–Lindqvist effect), as shown in
Figure 7a. Figure 7 summarizes the main hemodynamic phenomena of cell separation in microdevices.
In microcirculation, the Zweifach–Fung bifurcation law is a relevant effect describing the cells tendency
to travel to the daughter channel with a higher flow rate [86,88,94].
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Figure 7. Blood separation microdevices based on hemodynamic flow separation techniques:
(a) the Fåharaeus–Lindqvist effect in a microchannels with dimensions < 300 μm. Reproduced
with permission from [23]. (b) cell-free layer as an advantage for cell and plasma separation and plasma
skimming effect, WBCs margination. Adapted from [86,95,96]. (c) the Bifurcation law manipulated to
remove cell-free plasma from blood and to mimic the microvasculature networks. Reproduced with
permission from [86,97].
Jaggi et al. [94] developed a poly(methyl methacrylate) (PMMA) microdevice for blood plasma
separation at high flow rates, based on the bifurcation law. The authors obtained, for Hct 4.5% and
whole blood Hct of 45%, at a 5 mL/min−1 flow rate, separation efficiencies of 92% and 30%, respectively.
The plasma yield obtained was 4% for the 45% Hct. The authors reported shear stress values much
lower than the shear stress at which hemolysis occurs [94]. Lopes et al. [26] developed a microfluidic
device able to perform separation of RBCs from plasma due to the cell-free layer (CFL) created upstream
a contraction in a microchannel. The authors produced the device using a micromilling technique, and
concluded that the geometric contraction produced by that technique was able to enhance the CFL,
resulting in a low cost and efficient way to separate blood cells from plasma [26]. Faivre et al. [98]
developed a microchannel with a constriction-expansion region for studying the Fahraeus effect,
showing the increase of the cell-free region downstream of the constriction region. The authors
collected almost pure plasma with Hct 16% at a flow rate of 200 μL·h−1, with a 24% yield (the separation
efficiency was not mentioned explicitly). Lima et al. [99] successfully studied the behavior of RBCs
in a 75 μm circular polydimethylsiloxane (PDMS) microchannel. The authors tracked individual
RBCs (for 3% and 23% hematocrit) and observed that the trajectories of the solutions with higher RBC
concentrations exhibit higher fluctuations in the direction normal to the flow. Additionally, the authors
concluded that the RBCs flowing in a higher concentration environment tend to undergo multi-body
collisions, increasing the amplitude of the RBCs’ lateral motion. Yang et al. [13] described a PDMS
microfluidic device based on the Zweifach–Fung bifurcation law. The separation efficiency was defined
in terms of hematocrit and quantified using an image processing program. The authors obtained,
with the microdevice continuously running during 30 min without clogging, a separation efficiency of
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100% for an inlet Hct of 45%, using defibrinated sheep blood, at a 10 μL·h−1 flow rate, with a yield
or plasma volume percentage obtained of 15–25% [65]. During the last decade, Ishikawa et al., [67],
Leble et al., [9] and Pinto et al., [23] have performed in vitro blood flow studies in simple microchannels
with symmetric bifurcations and confluences and more recently Bento et al. [100,101] have performed
similar studies in more complex geometries such as in microchannel networks. In those works, it was
observed a clear cell-depleted layer at the region of the confluence apex that can be used to perform
blood plasma separation.
4.3. Microfluidic Filters-Physical Filtration Techniques
Combined with the mentioned separation techniques, microfluidic filters are usually introduced
to increment the efficiency of the microfluidic devices [82,102]. Microscale filters, such as micropillar
arrays, microweir structures or microporous membranes, are able to separate cells and particles based
on their size and/or deformability. Although these filters allow the precise adjustment of the filter
pore size to the required needs, they need to overcome different challenges, such as clogging of the
microchannels, fouling and heterogeneity of the cell sizes [84]. Additionally, the design of the filters
and barriers needs to take into consideration the different physical properties of the cells, including
density, shape and deformability. Physical filtration microstructures, besides being a simple and
non-destructive separation method, also allow the integration with other separation strategies. A major
problem of the latter separation methodology is the high tendency to have clogging, jamming and
possible blockage of the microdevice [103]. One way to minimize such a problem is by using cross-flow
filters [83,104–106], since in cross-flow filtration, the fluid flows tangentially rather than through the
filter as it does in membrane filtration (see Figure 8). This technique allows the particles to stay in
a suspended state, avoiding their deposition, and can be used for separation of particles and cells.
Crowley et al., [107] fabricated a passive crossflow filtration microdevice, operating entirely on capillary
action, for the isolation of plasma from whole blood. Another method is by using micro-pillars that are
suitably placed within the microchannel in a way that cells larger than the critical diameter follow
a deterministic path while smaller cells maintain an average downward flow direction around the
pillars, leading to the formation of multiple streams based size [86]. Chen et al., [105] developed a set
of microfluidic chips based on the crossflow filtration principle, in which parallel micropillar-array and
parallel microweirs were used to separate cells via their different sizes. Under the optimal conditions,
more than 95% of the RBCs in a sample can be removed from the initial whole blood, while 27.4%
of the white blood cells (WBCs) can be obtained. Plasma, WBCs and RBCs can be simultaneously
separated and collected at different outlet ports with multilevel filtration barriers [105]. This principle
is presented in Figure 8.
Zhang et al., [108] combined the use of hydrodynamic forces with passive filters comprised
of artificial microbarriers of varying dimensions (that range in size from 15 to 7 μm, following the
direction of fluid flow) in a chip to promote the flow and the separation of cells. By combining
hydrodynamic forces with passive filters, the authors reported the separation of cancer cells based
on their deformability. Additionally, by arranging the microbarriers in a rectangular, matrix-like
structure, and by placing wide channels between post arrays, the authors ensured that the most flexible
cells were able to seek alternate routes in the event of a blockage, as well as to regulate and equalize
hydrodynamic pressure throughout the chip. The microscale geometry of the flow channels and post
arrays ensured that the fluid flow is laminar, resulting in continuous cell movement and deformation
in the device [108].
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Figure 8. Schematic illustration for weir, pillar and cross-flow microfluidic filters. Images adapted
from [81,84,109].
4.4. Comparison between the Separation Methods
Table 3 presents a comparison between the different categories of microfluidic cell separation,
in terms of separation criteria, efficiency and throughput.


















92% separation efficiency with
diluted blood (Hct 4.5%) and
37% with whole blood (Hct
45%) [94]
More than 95% of the RBCs
and 27% of the WBCs removed
from whole blood [105];
65–100% [102];





1.2 mL/h (1010 cells/min)
[111]
3–4 μL/min [112];
5 mL/min [94] 2 × l03 cells/s [112,113]
Potential effects on cells Shear stress Shear stress Clogging, fouling, shear stress
Required
instrumentation Fluidic pumps Fluidic pumps Fluidic pumps
Processing layout Continuous flow Continuous flow Batch; Continuous flow
The referred passive separation methods are able to separate cells in a simple and non-destructive
way and, furthermore, they allow easy integration of other processes in a single microdevice [114].
Ideally, a lab-on-a-chip platform should be small, simple and portable, by combining simple fluid
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driving mechanisms, reaction chambers and integrated detection systems for easy readout, making it
able to be used by an end user or as a research tool, as a support for other laboratory technology [115].
Several authors have been approaching attempts for integration of passive separation of target
cells and analysis, particularly of RBCs deformability assessment in a single microfluidic chip,
which is still a challenge. Shevkoplyas et al. [116] developed a passive microfluidic device with
a microvascular network perfusion system for cells separation and for measuring of the RBCs
deformability. Faustino et al. [117] developed a microfluidic device in PDMS, with pillars and
geometric variations, for the passive separation of RBCs, as well as to deform the cells and assess
their deformability, by analyzing the acquired images. However, the proposed device is not fully
integrated yet, since it still requires an external microscope for images evaluation and an external
pumping system [117]. The described examples open new opportunities for research and show that
lab-on-a-chip devices have high potential for integration of separation and detection tools in a single
microfluidic platform.
There are still a lot of challenges to overcome regarding the integration of passive separation
techniques in autonomous, functional and portable microdevices. Particularly, clogging, hematocrit,
the amount of the sample and preparation time, mechanical stress (under relatively high pressure in
microfluidic structures, several biological entities are at risk of rupturing, such as RBCs, or starting an
adverse activation, such as platelets), contamination and biocompatibility are still challenging for the
design and implementation of blood separation devices [64]. However, they also open new avenues for
the miniaturization of analysis systems, requiring multidisciplinary synergies to assure the integration
of microfluidics, actuation, detection, and readout systems in a single chip.
5. Perspectives
The research in the lab-on-a-chip area opens new possibilities for the miniaturization of analysis
systems, requiring multidisciplinary synergies to assure the integration of microfluidics, actuation,
detection, and readout systems in a single chip. All the developed efforts in this field are focused
on the development of low-cost, portable, autonomous, multifunctional and commercial devices,
with high sensitivity.
This paper presented an overview of the techniques used for separation of RBCs and the respective
micro- and nanofabrication techniques, as well as examples of lab-on-a-chip devices with high potential
for the integration of separation and detection tools in a single microfluidic platform. However, the use
of these methods for separation of RBCs and detection of their properties has still a lot of challenges to
overcome. Particularly, most separation methods, despite being able to separate particles, still need
further development to be able to separate large cells, as RBCs, in microdevices, and require additional
external equipment, which limits the methods’ portability.
As the lab-on-a-chip devices become multifunctional tools for separation and analysis of cells,
without altering their state, efforts are converging into new analytical chemistry, diagnostic and
treatment applications [118,119]. Further advances include lab-on-a-cell platforms [120,121] for
isolation and individual characterization of cells and organ-on-a-chip devices for, among other
applications, oxygenation studies [122,123], improvement of the clinical translation of nanomaterials
for cancer theranostics, drug screening and personalized medicine [124,125].
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Abstract: Suspension flows are ubiquitous in industry and nature. Therefore, it is important to
understand the rheological properties of a suspension. The key to understanding the mechanism
of suspension rheology is considering changes in its microstructure. It is difficult to evaluate the
influence of change in the microstructure on the rheological properties affected by the macroscopic
flow field for non-colloidal particles. In this study, we propose a new method to evaluate the
changes in both the microstructure and rheological properties of a suspension using particle tracking
velocimetry (PTV) and a power-law fluid model. Dilute suspension (0.38%) flows with fluorescent
particles in a microchannel with a circular cross section were measured under low Reynolds number
conditions (Re ≈ 10−4). Furthermore, the distribution of suspended particles in the radial direction
was obtained from the measured images. Based on the power-law index and dependence of relative
viscosity on the shear rate, we observed that the non-Newtonian properties of the suspension showed
shear-thinning. This method will be useful in revealing the relationship between microstructural
changes in a suspension and its rheology.
Keywords: suspension; rheology; power-law fluid; circular microchannel; pressure-driven flow;
particle tracking velocimetry; microstructure
1. Introduction
The rheological properties of a suspension (solid particles dispersed in a fluid) vary depending
on the particle volume fraction, particle shape, interactions between particles, spatial arrangement
of particles, and nature of the solvent [1]. Non-Newtonian phenomenon is commonly accompanied
by shear-thinning [2] or shear-thickening [3] behavior, or yield stress [4] resulting from the complex
influence of many factors. Suspension flows are ubiquitous in industry and nature. In the industrial field,
the rheology of suspension directly influences product quality such as food and paint [5]. Furthermore,
suspensions are also important for industrial processes such as filtration [6] and ceramic processing [7,8],
since they are the precursors to the manufacturing of numerous products. In nature, examples of
suspensions include mud, which is essentially a dispersion of rigid particles, and blood, which is
a suspension of red blood cells dispersed in plasma [9,10]. Therefore, understanding rheological
properties of suspensions is expected to lead to control of suspension rheology and elucidation
of hemorheology.
When the size of particles increases with respect to the channel size, wall effects and interactions
between particles are observed. Sangani et al. [11] reported that the presence of walls increases the
Micromachines 2019, 10, 675; doi:10.3390/mi10100675 www.mdpi.com/journal/micromachines25
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particle stresslet. Fukui et al. [12] found that particles rotate to achieve a kinetic balance with the
surrounding hydrodynamic forces, which results in a decrease in fluid resistance. Moreover, some
researchers reported that viscosity significantly decreased for strongly confined conditions [13–16].
The above phenomena are reflected in the strong correlation between suspension viscosity and
microstructure defined by spatial particle arrangements.
Many researchers have addressed the connection between the microstructure and rheology
of a suspension [1,17,18]. A numerical approach is useful in assessing the relationship between
microstructure and rheology. It is easy to obtain information on the microstructure of a suspension
because particle distribution can be captured accurately at all times. Fukui et al. [19] conducted a
two-way coupling simulation and reported that non-Newtonian properties change because of particle
migration. However, the experimental evaluation of the microstructure is difficult. Light scattering
techniques are often used to obtain the structure factor of suspensions, and, although these techniques
are useful for colloidal suspensions, their application to non-colloidal suspensions becomes difficult
because the size of the particles is large compared with the wavelength of light [20]. Talini et al. [21]
proposed a nuclear magnetic resonance (NMR) technique for non-colloidal suspensions, which is
capable of measuring structures up to 1 mm. However, this technique could only be applied to static
conditions because particles must stay in their positions during the scanning. Thus, for non-colloidal
suspensions, it is difficult to evaluate the influence of the change of the microstructure on the rheological
properties affected by the macroscopic flow field.
Various methods for measuring viscosity in complex fluids using microfluidic devices have been
proposed [22], and several studies have evaluated the velocity field of complex fluids using particle
imaging velocimetry (PIV) [23–25]. Degré et al. [24] evaluated the viscosity of polymer solutions by
PIV. Jesinghausen et al. [26] report that the viscosity evaluated using PIV was 10%–20% lower than the
value measured by a viscometer. These studies were conducted using rectangular channels. However,
from an engineering and hemorheological point of view, it is important to consider the relationship
between particle distribution and rheology in circular channels of pipe flow.
The purpose of this study is to propose a new method for evaluating both the microscopic structure
and viscosity of non-colloidal hard sphere suspension flows. In this paper, a microchannel with a
circular cross section was fabricated, and the suspension flow with fluorescent particles was measured
using a microscope. The velocity distribution was obtained using a particle tracking velocimetry
(PTV), and the particle radial distributions were also determined. The non-Newtonian properties of a
suspension were examined using the power-law fluid model.
2. Materials and Methods
2.1. Suspension
Dilute suspensions of rigid spherical particles in a Newtonian fluid were used. Fluorescent
polymer microspheres with a diameter dp = 25 μm (35-5, Thermo Fisher Scientific, Waltham, MA, USA)
were suspended in a mixture of water and glycerol (075-00616, Wako, Osaka, Japan) to attain neutral
buoyancy. The density of the mixture was equivalent to that of the particle density (1.05 g/cm3). A small
amount (<0.5%) of surfactant Tween 20 (17-1316-01, GE Healthcare, Chicago, IL, USA) was added
to fully disperse the dry powder of fluorescent particles. The volume fraction (φ) of the suspended
particles measured by using a chip (C-Chip, NanoEntech, Seoul, Korea) was 0.38%. The suspension
viscosity was 1.73 mPa·s, which was measured using an oscillation-type viscometer (VM-10A, CBC Co.,
Ltd., Tokyo, Japan) at room temperature (27 ◦C).
2.2. Microchannel
Circular cross section polydimethylsiloxane (PDMS) microchannels (Figure 1) were fabricated
using a fishing gut [27]. Most PDMS microfluidic channels are fabricated using photolithographic
techniques and their cross section is typically rectangular [28]. Recently, some methods [29,30] have
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been developed to form more complex microchannels. Because pipe flow is important for many
applications, such as industrial or blood flow, circular cross section PDMS microchannels are often
used [31–33]. The fabrication of a circular PDMS microchannel using a fishing gut is explained below.
Figure 1. Circular polydimethylsiloxane (PDMS) microchannel in the PDMS mold. Needles were
inserted on both sides of the microchannel and connected by tubes.
(1) Holes were drilled in a case (Styrol square case type 3, As One, Osaka, Japan) and a fishing gut
with a diameter D = 520 μm (Type 10, Matsuura Industry, Osaka, Japan) was passed through
the holes.
(2) PDMS (Silgard 184 Silicone Elastomer Kit, Dow Corning, Midland, MI, USA) was synthesized by
mixing the elastomer base with its curing agent in a weight ratio of 10:2. The ratio of the curing
agent was increased to twice the recommended value to suppress the effects of PDMS elasticity.
Next, PDMS was poured into the case and cured in an oven (75 ◦C) overnight.
(3) Lastly, the gut was pulled out gently and the PDMS mold with the microchannel was taken out
from the case. For the measurement, needles (NN-2516R, TERUMO, Tokyo, Japan) were inserted
on both sides of the microchannel and connected by tubes.
2.3. Experimental Setup
Figure 2 shows a schematic of the experimental apparatus. A suspension was injected into
the microchannel by a syringe pump (KDS210, KD Scientific, Holliston, MA, USA) in a steady
state. Fluorescent images of the flow field and phase contrast images were obtained for calibration.
The Reynolds number was altered by presetting the flow rate to approximately 5–20 μL/min, which
corresponds to the Re range from 0.125 to 0.5. In this study, confinement C [11] is defined as
C = dp/D = 0.05, which is the ratio of the particle size to tube size. The particle Reynolds number
(Rep) [34] is defined as Rep = Re × C2 and it corresponds to Rep in the range of 2.9 × 10−4–1.2 × 10−3.
The measurement area was set parallel to the flow direction passing through the tube axis.
The particle distribution in the radial direction and flow velocity were measured. To eliminate the
influence of the attachment of the connector on the tube, the flow field was measured at a location 20D
away from the inlet. Measurement conditions were fixed as recorded in Table 1. Different frame rates
were set for each condition so that the particles travel similar distances (about 0.3D on the centerline)
at each shutter interval. Furthermore, the flow fields were measured three times for each condition
using a disk scanning microscope system (IX83-DSU, Olympus, Tokyo, Japan) at 10×magnification.
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Figure 2. Schematic view of experimental apparatus. The measurement area was set parallel to the
flow direction passing through the tube axis to measure both particle distribution in the radial direction
and flow velocity.
Table 1. Measurement conditions.
Re (-) Rep (-) Time (s) Frame Rate (fps)
0.125 2.9 × 10−4 200 5
0.25 5.8 × 10−4 100 10
0.5 1.2 × 10−3 50 20
2.4. Image Processing
Figure 3 shows the sample of images used for analysis. The procedure for obtaining particle
concentration profiles and axial velocity profiles using image processing software (ImageJ/Fiji, National
Institutes of Health (NIH), Bethesda, MD, USA) [35,36] is as follows.
Figure 3. Representative images of particles in a microchannel. (a) Fluorescent image after background
subtraction and (b) a sample of extracted particles in a binary image. Particles are encircled in red in
Figure 3b for clarity.
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1. Fluorescent particle images were converted to binary images using the “subtract background”
command given as a preparation, and the binarization was conducted based on the threshold
determined using the Otsu method [37].
2. Particle size for analysis was set to 200 pixel2, which corresponds to the particle diameter of ~
22 μm, and the coordinates of the particle center point were extracted using macros. Figure 3b
shows a sample of extracted particles obtained from a binary image. The particles are encircled in
red in Figure 3b for clarity. In this step, “watershed segmentation” was used for identifying each
particle, and the function of automatically separated or cut apart particles were recognized as a
single cluster due to overlapping.
3. The measurement region was equally divided in the radial direction, and the number of particles
in each section was counted from their radial positions. The existence probability of particles in
the radial direction σwas then obtained with respect to the number of particles in the entire image.
4. Steps 1–3 were repeated for all images, and these data were analyzed for a time-averaged particle
concentration profile.
5. PTV was also employed, and time-averaged velocity profiles were obtained. The non-Newtonian
properties of the suspension were evaluated by comparing the time-averaged measured velocity
profiles with those from a power-law fluid. Details have been provided in Section 2.5.
Sizes of the particles in the images were certainly different from each other, as shown in Figure 3.
This could be attributed to the particle distance with respect to the focus plane of the microscope.
Since the apparently large particles might be out of the focal area, the translational velocity of the
particles could be decreased when compared to the theoretical value. On the other hand, the apparent
particle size variation was also caused by the difference in the refractive index between the fluid
and the microchannel. The refractive index of PDMS is 1.41 while that of water is 1.33, or 1.47 for
glycerol. The refractive index of a water/glycerol mixture of 61% glycerol matches that of PDMS [30,38].
However, in order to satisfy the neutrally buoyant condition according to priority, a water/glycerol
mixture with approximately 20% glycerol was used in this study. Therefore, the refractive index of the
fluid may not be well-matched with that of the microchannel. Nevertheless, the error of the flow rate
was, at most, 5%, as described later, and these effects might be negligible in this study.
2.5. Non-Newtonian Properties
A power-law model is a simple model used to represent viscosity as a function of the shear rate.
The non-Newtonian properties of the suspension were assessed by comparing the measured velocity
profiles acquired by PTV with those from a power-law fluid. The velocity profiles of power-law













where u(r) is the axial velocity, n is the power-law fluid index, u0 is the characteristic velocity, R is the
radius of the microchannel, and r is the radial position in a range satisfying the condition – R < r < R.
If n = 1, the fluid is Newtonian. Otherwise, it is classified as a non-Newtonian fluid, which exhibits
shear-thinning (thixotropy) for n < 1 and shear-thickening (dilatancy) for n > 1.





|um|r| − u|r|| → min., (2)
where um(r) is the measured axial velocity and u(r) is the axial velocity estimated using the power-law
fluid equation (Equation (1)) at the corresponding radial position. The cost function was defined as a
sum of the absolute differences for all particles.
29
Micromachines 2019, 10, 675
2.6. Relative Viscosity
The relative viscosity was assessed using the viscosity equation for power-law fluids. The effective
viscosity ηeff is defined in the following equation.
ηeff = η0
.∣∣∣γ∣∣∣n−1, (3)
where η0 is the viscosity of a suspension, and
.
γ is the shear rate. Note that when
.
γ = 1, the relative
viscosity equals 1, regardless of the power-law fluid index n.
The viscous resistance is equivalent to the pressure drop in a fully developed laminar tube flow.
For dilute suspensions, the drag force acting on the particles can be neglected when the suspension
flows steadily [12], and the flow energy dissipates on the walls. Thus, the pressure drop is equal to
the spatially integrated wall shear stress value. The wall shear stress can be calculated from the shear
rate on the walls using Newton’s law, and, therefore, the relative viscosity ηeff/η0 can be approximated
using the shear rate on the wall. The shear rate on the wall is analytically expressed in Equation (4),
















3. Results and Discussion
Figure 4 shows the particle concentration profiles in the radial direction for different particle
Reynolds number conditions. In this study, the number of divisions in the radial direction was set
to 20, which is approximately equivalent to the ratio of the channel diameter to the particle size
(=1/C). Therefore, the value of the probability density function becomes σ = 1/20 = 0.05 (shown with
a solid black line) when the spatial arrangement of suspended particles is uniform. Figure 4 shows
that the particles were distributed around σ = 0.05 with minor deviation, regardless of the particle
Reynolds number.
Figure 4. Concentration profiles. The data plotted are the mean ± 1 SD. The solid black line represents
uniform distribution, and the black dash–dot line at r/R = 0.0 indicates the center of the microchannel.
Choi et al. [40] investigated the distributions of neutrally buoyant spherical particles suspended
in a micro-scale pipe flow using a digital holography technique, which showed a qualitatively similar
distribution when compared to our experimental results.
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where L is the distance from the inlet of a microchannel. Choi et al. [40] observed that the particle
distribution changes due to an inertial effect under the following condition.
L3 ≥ 3. (6)
In this study, the reduced tube length L3 was in the order of 10−4–10−3, and, hence, slight changes
in radial particle distribution can be observed due to weak inertial effects. Fukui et al. [42] in their
numerical study demonstrated that the dispersion of the particles was relatively uniform under low
particle Reynolds number conditions. In this study, a mixture of water and glycerol was selected
as a solvent for neutrally buoyant conditions. A similar distribution has been confirmed for low
concentration suspensions under neutrally buoyant conditions by Yan and Koplik [43].
Figure 5 shows the axial velocity profiles for each particle Reynolds number condition.
The measured flow rate decreased by, at most, 5% when compared with the presetting flow rate value.
When the measured velocity profiles were compared with those from the power-law fluid model,
the velocity profile (Equation (1)) with an equivalent measured flow rate was applied. Moreover,
the fully developed boundary layer can be observed because the length of the measurement area from
the inlet of the tube was sufficiently long when compared with the inlet length.
Figure 5. Normalized axial velocity profiles. The red plots and error bars are the mean ± 1 SD, and the
black solid line is the velocity profile of Newtonian fluid (n = 1) for comparison. (a) Rep = 2.9 × 10−4,
(b) Rep = 5.8 × 10−4, and (c) Rep = 1.2 × 10−3.
From Figure 5, it can be seen that the velocity profiles were slightly blunted with an increasing
particle Reynolds number. Hampton et al. [44] experimentally observed blunted velocity profiles.
Jabeen et al. [45] reported a similar trend by numerical approach. Moreover, it has also been observed
that velocity profiles become more blunted at high concentration conditions [43,46]. In this study,
the suspension was dilute. Therefore, the velocity profiles were observed to be slightly blunted.
Figure 6 shows the relationship between the power-law index n and particle Reynolds number.
The power-law fluid index decreases with an increasing particle Reynolds number. Although the
experimental conditions were limited, this tendency was consistent with that of the previous study [42]
by numerical simulation. Non-Newtonian properties of the suspension showed shear-thinning because
the power-law index n is smaller than 1. Moreover, it is considered that the shear-thinning is more
enhanced with an increasing particle Reynolds number.
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Figure 6. Relationship between power-law index n and particle Reynolds number Rep. The plots are
the mean ± 1 SD.
Figure 7 shows the relationship between relative viscosity ηeff/η0 and shear rate
.
γ. In this study,
because non-Newtonian properties were evaluated by the power-law fluid, the relative viscosity
equals 1 when
.
γ = 1 analytically (Equation (3)). This is also plotted in Figure 7 as an analytical value.
From Figure 7, it was found that the relative viscosity ηeff/η0 decreased with an increasing shear rate
.
γ.
Figure 7. Relationship between relative viscosity ηeff/η0 and the shear rate
.
γ. The plots are the mean ±
1 SD. The relative viscosity was estimated using Equation (4).
The viscosity of the suspension was determined from the velocity distribution using the power-law
fluid model. Degré et al. [24] measured the viscosity of polymer solutions using PIV. Jesinghause
et al. [26] applied a similar method for suspension flow in a rectangular channel. In this study,
the viscosity of the suspension flow in a circular channel was evaluated by PTV. The benefit of using
PTV lies in its application to the dilute suspensions or to a suspension with larger particles. In this
study, we focus on the relationship between the microstructure and the consequential rheological
properties of a suspension. Especially, we also focus on change in microstructure due to inertia. In order
to investigate the inertial effects of suspended particles, experimental works should be conducted for a
wide range of particle Reynolds number conditions. Particle Reynolds number can be changed by
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two parameters, i.e., flow velocity or particle size. If larger particles are used, the number of particles
are decreased for the same particle concentration condition. When the number of particles contained
in an interrogation window is not enough, accuracy of the PIV analysis becomes poor. Therefore,
in this sense, PTV may be preferable to PIV. Moreover, one of the advantages of our method is that it
is capable of evaluating rheological properties while considering the microstructure changes of the
suspension, which is difficult with a classical rheometer. It has been reported in previous research that
wall shear stress decreases locally in micro-vessels due to the motion of blood cell and hydrodynamic
interactions [47,48]. Furthermore, in numerical simulations, the relative viscosity could be below
1 locally for dense (highly concentrated) suspensions with rigid particles [16]. These findings are
important for considering blood flow in bioengineering. Endothelial cells covering the inner surface of
blood vessels sense the wall shear stress (WSS) and respond to it mechanically. For example, when
the WSS increases, endothelial cells produce vasodilators, such as nitric oxide (NO) [49]. It is also
suggested that endothelial cells can sense changes in WSS not only temporally but also spatially [50].
Therefore, it is important to understand the local WSS distribution and the local viscosity changes.
On the other hand, this proposed method is limited in the case of non-transparent fluid or highly
concentrated suspension.
Figure 8 shows the spatially averaged axial distances between particles referring to the
radial direction. Note that the particle–particle distance was normalized by the channel diameter.
The difference in the distance referring to the radial direction was not significant. In addition, these
distributions are independent of the particle Reynolds number. Doyeux et al. [13] mentioned that
the intrinsic viscosity can be expressed as a function of the particle–wall distance. In order to
consider suspension rheology in terms of the microstructure, the radial particle distributions have
been investigated in many studies. On the other hand, according to Fukui et al. [12], when the
rotational velocity decreases due to the particle–particle interactions, the macroscopic viscosity of the
suspension increases. Therefore, it is important to consider particle–particle distance not only in the
radial direction but also in the axial direction in order to evaluate the microstructure and consequential
rheological properties.
Figure 8. Spatially averaged axial distances between particles referring to the radial direction. The data
plotted are the mean ± 1 SD. The value of distance was normalized by the diameter of the microchannel.
Microstructure is key to understanding the mechanism of suspension rheology [1,17,18]. Red blood
cells move to the axis of the blood vessel due to their deformability, which is known as axial
accumulation [51]. On the other hand, for rigid particles, when the bulk or particle Reynolds number
increase, particles begin migrating due to inertia toward the radial equilibrium positions at 0.6R.
When particle migration occurs, the distribution of particles in the cross section becomes annulus,
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which is known as the “tubular pinch effect” or the “Segré–Silberberg effect” [41,52]. Analysis by
numerical approaches suggest that the non-Newtonian properties are altered due to these microstructure
changes [42,45]. According to previous research, the equilibrium position is around 0.6R, and the
equilibrium position shifts toward the wall with an increasing Reynolds number [53,54], while it
shifts toward the tube axis with increasing confinement [54]. In the future works, we will elucidate
the influence of these equilibrium positions, i.e., the difference in microstructure, on the suspension
rheology in detail.
In previous studies, velocimetry-based viscometers rely on measuring the velocity profile at
a given pressure drop. The shear rate can be calculated from the gradient of the velocity profiles
(Equation (4)), and shear stress was calculated from the pressure drop. A curve of shear stress versus
the shear rate can be obtained directly. Thus, the previous method allows for direct quantification of
the rheology of complex fluids [22]. On the contrary, in the proposed method, the relative viscosity is
examined using the power-law fluid model in consideration of the microstructure. However, only a
qualitative evaluation of non-Newtonian properties of a suspension is implemented in this paper.
Therefore, quantitative validation of our method is required. This includes measuring the relative
viscosity using a Couette rheometer or introducing a pressure sensor to the experimental system as
seen in previous research [24,26]. Such quantitative examinations will be necessary in future works.
4. Conclusions
Suspension flows containing fluorescent particles in a microchannel with a circular cross section
were measured. We proposed a new method for evaluating the changes of the microstructure and
rheological properties of a suspension using PTV and a power-law fluid model. The distribution
of suspended particles in the radial direction was obtained from measured images. In addition,
non-Newtonian properties of the suspension were evaluated using the velocity distribution obtained
by PTV and the power-law fluid model. This method is useful for revealing the relationship between
microstructural changes of a suspension and rheology.
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Abstract: The deformability of a red blood cell (RBC) is one of the most important biological
parameters affecting blood flow, both in large arteries and in the microcirculation, and hence it can
be used to quantify the cell state. Despite numerous studies on the mechanical properties of RBCs,
including cell rigidity, much is still unknown about the relationship between deformability and
the configuration of flowing cells, especially in a confined rectangular channel. Recent computer
simulation techniques have successfully been used to investigate the detailed behavior of RBCs
in a channel, but the dynamics of a translating RBC in a narrow rectangular microchannel have
not yet been fully understood. In this study, we numerically investigated the behavior of RBCs
flowing at different velocities in a narrow rectangular microchannel that mimicked a microfluidic
device. The problem is characterized by the capillary number Ca, which is the ratio between the
fluid viscous force and the membrane elastic force. We found that confined RBCs in a narrow
rectangular microchannel maintained a nearly unchanged biconcave shape at low Ca, then assumed
an asymmetrical slipper shape at moderate Ca, and finally attained a symmetrical parachute shape
at high Ca. Once a RBC deformed into one of these shapes, it was maintained as the final stable
configurations. Since the slipper shape was only found at moderate Ca, measuring configurations of
flowing cells will be helpful to quantify the cell state.
Keywords: red blood cells; Lattice–Boltzmann method; finite element method; immersed boundary
method; narrow rectangular microchannel; computational biomechanics
1. Introduction
It is well known that many blood-related diseases are associated with alterations in the geometry
and membrane properties of red blood cells (RBCs) that result in reduced functionality [1]. For instance,
RBCs in patients with diabetes mellitus exhibit impaired cell deformability [2], as do those in patients
with sepsis [3]. As another example, malaria-infected RBCs demonstrate membrane stiffening as well as
shape distortion [4–6]. Hence, cell deformability may be an important indicator of cell state, and might
be used to diagnoses relevant blood diseases. To date, various experimental techniques have been
proposed to evaluate RBC deformability, e.g., optical tweezers and atomic force microscopy, but they
usually suffer from low throughput. Recently, several microfluidic techniques that are capable of
high-throughput measurement have been developed [7–11]. For instance, Ito et al. (2017) successfully
developed a novel high-throughput assay to quantify the mechanical response of RBCs after spatial
constriction, and found a characteristic mechanical response to long-term deformation that may have
been related to chemical energy content [9].
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Along with these experimental studies, recent computer simulation techniques have successfully
been used to investigate aspects of cell dynamics such as stresses, velocities, and deformations,
and have been shown to reproduce single-cell dynamics [12–14]. Mokbel et al. (2017) quantitatively
related cell deformation to mechanical parameters in an experiment involving microfluidic flow
through a square channel [13]. To elucidate patient-specific blood rheology, RBCs in diabetes
mellitus and sickle-cell anemia were modeled in terms of cell rigidity and membrane viscosity,
and their hydrodynamic interactions were quantified [15,16]. Since such numerical models allow us
to investigate cell behavior in large parameter spaces, the coupling of experimental and numerical
approaches may constitute a usefull bioengineering strategy to quantify the cell state.
Despite the studies referred to above, much is still unknown about the behavior of flowing
RBCs, especially in a confined microchannel or between two closely spaced parallel plates
(i.e., Hele-Shaw cell). Since the deformation of a RBC in a narrow rectangular microchannel
is limited to an almost two-dimensional space, it is relatively easy to quantify the deformed
configuration [17,18]. Although a number of studies using microfluidic devices have reported
cellular-scale dynamics [19–24] as well as numerical studies [20,25–28], the dynamics of a translating
RBC in a narrow rectangular microchannel have not yet been fully investigated. Recent our developed
on-chip feedback manipulation system allowed us to investigate the two-dimensionally projected
shape profile of RBCs, and showed RBC heterogeneity in a narrow rectangular microchannel [17,18].
However, a precise deformation especially in thickness direction of RBCs cannot be captured by means
of the experimental observation.
One of the pioneering theoretical works about the behavior of the cell membrane in a confined
channel was reported by Secomb & Skalak (1982) [29]. More recently, Tahiri et al. (2013) systematically
investigated the shape transition of confined RBCs modeled as vesicles, and showed a phase diagram
of the mode of RBCs [28]. Since these works were limited to the two-dimensional behavior of RBCs,
it is unknown whether their insights are applicable to estimating the three-dimensional deformation
of a RBC in a narrow rectangular microchannel. Fedosov et al. (2014) systematically investigated the
behavior of a single RBC in cylindrical microchannels for a wide range of channel confinements
(2a/D, being the radius of the RBC a and the channel diameter D) using a three-dimensional
dissipative particle dynamics model [30]. However, their microchannels (2a/D < 0.8) had relatively
large cross-sectional area comparing to a narrow rectangular microchannel represented in [17,18,31].
Zhu et al. (2016) numerically investigated the behavior of a droplet in a Hele-Shaw cell, and identified
characteristic flow structures that were induced by the translating droplet [31]. Since forces acting on
an interface depend on the constitutive law, it is expected that the hydrodynamic interaction between
the fluid and cell membrane will differ from that observed in the droplet model.
The objective in this study, therefore, is to clarify the detailed behavior of translating RBCs in a
narrow rectangular microchannel. The RBCs was modeled as a biconcave capsules, whose membranes
followed the Skalak constitutive law [32]. We quantified the stable configuration of deformed RBCs in
a narrow rectangular microchannel, mimicking a microfluidic device [17], for different values of the
capillary number Ca, which is the ratio between the fluid viscous force and the membrane elastic force.
We also investigated the effect on this configuration of altering parameters such as bending rigidity
and viscosity ratio. To accelerate numerical simulations, we resorted to computing with a graphics
processing unit (GPU), using the Lattice–Boltzmann method (LBM) for the inner and outer fluids and the
finite element method to follow the deformation of the RBC membrane. These models were previously
successfully applied to the analysis of cellular hydrodynamic interactions in channel flows [12,33–35].
2. Materials and Methods
2.1. Flow and RBC Model
We considered a cellular flow consisting of an external/internal fluid and a RBC membrane
with radius a in a rectangular box representing a microfluidic device with 10 μm × 3.5 μm along
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the wall-normal and span-wise directions (Figure A1a). Representative images of a flowing RBC
in a microfluidic device (Figure A1b,c) are shown in Figure A1d. The stream-wise distance for the
computational domain was set to be 50 μm (Figure 1). Each RBC was modeled as a biconcave
capsule, or a Newtonian fluid enclosed by a thin elastic membrane, with a major diameter 8 μm (=2a)
and maximum thickness 2 μm (= a/2 = tR). The flow was driven by a pressure gradient. Periodic
boundary conditions were imposed on the inlet and outlet. To reproduce in vivo human RBC condition
experimentally, the cytoplasmic viscosity was taken to be μ1 = 6.0 × 10−3 Pa·s, which is five times
higher than the external fluid viscosity, μ0 = 1.2 × 10−3 Pa·s. Hence, the viscosity ratio λ (=μ1/μ0) was
set to be 5. The computational domain and the initial state or steady deformed state of the RBC are





where Gs is the surface shear elastic modulus, and γ̇ (=U∞m /H) is the shear rate defined by the mean
velocity of the external fluid without cell U∞m and channel height H (=10 μm). Since the inertial effect
can be negligible in the microfluidic device, we set Re as small enough to assume the Stokes flow.
To reduce the computational costs, we set Re = ρU∞H/μ0 = 0.2, where ρ is the external fluid density
and U∞ is the maximum velocity of the external fluid with no cell. This value accurately represents
the capsule dynamics solved by the boundary integral method in Stokes flow [12,33].
Figure 1. Computational domain to reproduce a translating red blood cell (RBC) in the narrow
rectangular microchannel. The domain mimicked a microfluidic device as shown in Figure A1.
The domain cross-section was 10 μm × 3.5 μm along the wall-normal and span-wise directions,
respectively, and the stream-wise distance was set to be 50 μm. Flow direction is from left to right.
The membrane was modeled as an isotropic and hyperelastic material that followed the Skalak
constitutive (SK) law [32]. The strain energy w and principal tensions in the membrane T1 and T2



















, (likewise for T2), (3)
where C is a coefficient representing the area incompressibility, I1(=λ21 + λ
2
2 − 2) and I2 (= λ21λ22 −
1 = J2s − 1) are the first and second invariants of the strain tensor, λ1, λ2 are the two principal in-plane
stretch ratios, and Js = λ1λ2 is the Jacobian, which expresses the ratio of the deformed to reference
surface areas. If I2 equals zero (i.e., Js = 1), the membrane satisfies perfect incompressibility. In this
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study, the surface shear elastic modulus and area incompressibility coefficient of RBCs were determined
to be Gs = 4.0 μN/m and C = 102, respectively [6,33]. The bending resistance kb was also considered [36],
with a bending modulus kb = 1.2 × 10−19 J, according to the order of the value of kb [37].
2.2. Numerical Simulation
We used the LBM [38] coupled with the finite element method (FEM) [39]. The membrane
mechanics were solved by the FEM, and are given by
∫
S
û · qdS =
∫
S
ε̂ : TdS, (4)
where T is the Cauchy stress tensor, q is the load on the membrane, û is the virtual displacement,
and ε̂ = (∇sû + ∇sûT)/2 is the virtual strain tensor. The fluid mechanics were solved by the
LBM [38] as,




fi (x, t)− f eqi (x, t)
]
+ FiΔt, (5)
where fi is the particle distribution function for ideal particles with velocity ci at position x, Δt is the
time step size, f eqi is the equilibrium distribution, τ is the nondimensional relaxation time, and Fi is
the external force term. Subscript i represents the distribution direction of an ideal particle (i = 0–18).
The D3Q19 LBM was used. FEM and LBM were coupled by the immersed boundary method [40].
All procedures were fully implemented on a GPU to accelerate the numerical simulation [41].
Our coupling method has been successfully applied to numerical analyses of cellular flow [33–35] and
cell adhesion [12]. The solid and fluid mesh sizes were set to be 125 nm (an unstructured mesh with
20,480 elements was used for the RBC membrane). This resolution has been shown to successfully
represent single-cell dynamics in a channel [12]. The results of cell deformation did not change with













Δx = 125 nm
Δx = 62.5 nm
(b)
Figure 2. (a) Typical snapshots of a deformed RBC subjected to Ca = 0.15 at the initial state (left) and
steady state (right). Two views, from the span-wise and stream-wise directions, are shown above and
below, respectively. The markers represent node points. (b) Superposition of the fully deformed RBC
projected on the x-z plane at Ca = 0.15 . The two lines obtained with Δx = 125 nm (black) and 62.5 nm
(red), respectively. The membrane position is normalized by the reference radius a.
3. Results
3.1. Deformation of a Translating RBC in a Narrow Rectangular Microchannel
We performed numerical simulations to reproduce a translating RBC in a narrow rectangular
microchannel, as shown in Figure A1d, and found that the RBC demonstrated an asymmetrical shape,
the so-called slipper shape [42], which was also observed in the experiment as shown in Figure A2
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(see also Videos S1 and S2). A typical asymmetrical shape of a deformed RBC subjected to Ca = 0.15 is
shown in Figure 2a, where the markers represent membrane node points. The result clearly shows that
the membrane does not rotate; in other words, the RBC stably translates without a tank-treading motion.
The outlines of the deformed RBC at different fluid mesh resolutions are shown in Figure 2b, projected
on the z-x plane. The result remains the same with twice the fluid mesh resolution (Δx = 62.5 nm).
Therefore, the present resolution (Δx = 125 nm) successfully reproduces the fluid dynamics between
the membrane and wall, and will be used in this study.
Figure 3a shows snapshots of a stable RBC configuration for different Ca at fully developed
flow. The RBC demonstrated an almost unchanged (symmetrical) biconcave shape at small Ca = 10−3,
then shifted to an asymmetrical slipper shape as Ca increased (see also Video S3 for Ca = 0.1), and finally
attained a symmetrical parachute shape at Ca ≥ 0.35 (see also Video S4 for Ca = 0.5). To quantify
the symmetry of the stable configuration of the deformed RBC, we propose a symmetry index IDsym,
which is defined by the volume ratio of two volumes that are divided by a plane parallel to the flow
direction at the midline of the channel, as shown in Figure 3b. Using volume 1 (Vol1) and volume 2





A complete symmetrical shape is expressed as IDsym = 1. We show the results of IDsym as a
function of Ca in Figure 3c. An asymmetrical parachute shape abruptly appeared for Ca ≥ 0.01,
but it gradually recovered and finally reached IDsym = 1 for Ca ≥ 0.35. These results suggest that there
exists the following specific range of Ca that allows a RBC to deform into an asymmetrical slipper





























Figure 3. (a) Snapshots of a fully deformed RBC for different Ca. (b) Typical snapshots of a RBC
at Ca = 0.01, where the blue plane denotes the center of the x-z-plane parallel to the flow direction,
dividing the cell into the volume 1 (Vol1) and volume 2 (Vol2). (c) The symmetry index IDsym as a
function of Ca. The insets represent snapshots of deformed RBCs at specific Ca.
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Figure 4a shows one example of the temporal history of the RBC centroid velocity Vc at Ca = 0.01,
where Vc is normalized by the characteristic (maximum) fluid velocity without cell U∞. The centroid











∇ · (v ⊗ r) dV = 1V
∫
S














n · rdS, (8)
where v(xm) is the interfacial velocity of the membrane at the membrane node point xm, r is the
membrane position relative to the center of the RBC, n is the surface normal vector, V the volume of
the RBC, and S is the surface area of the membrane. The velocity slightly (∼3%) decreased when the
RBC shape changed from a symmetrical to asymmetrical shapes at Ca = 0.01 (Figure 4a). Because the
membrane of a slipper-shaped RBC is dragged by the fluid near the wall, Vc is slower than that of a
symmetrically shaped RBC. Once the membrane deformed into an asymmetrical shape, that shape
persisted. In this study, we defined the “steady state” as the condition wherein the centroid velocity
reached a plateau (this time is hereafter referred to as γ̇t = 0), and used data after γ̇t = 0 to reduce the
influence of the initial conditions. A time average was performed for the period γ̇t ≥ 100 after γ̇t = 0.
Figure 4b shows the time average of centroid velocity Vc and total fluid velocity Vtotal for different Ca,
where those values are normalized by characteristic velocity U∞. The tendency that Vc/U∞ slightly
decreases as Ca increases (Figure 4b) agrees with previous numerical results of a spherical capsule in
a square channel [43] and constricted channel [44]. Note that the dimensional cell velocity basically
increases as Ca increases, for instance, Vc ∼ 0.12 μm/s for the lowest Ca (=10−4) and Vc ∼ 1200 μm/s






























Figure 4. (a) Time history of the RBC centroid velocity (Vc) at Ca = 0.01, where Vc = 24.7 μm/s at
γ̇t = 200 corresponding to t = 12 s. The images represent snapshots of the deformed RBC at γ̇t = 70
(t = 4.2 s) and 200 (t = 12 s), respectively. The blue line denotes the center axis of the channel. (b) Time
average of the RBC centroid velocity Vc and total fluid velocity Vtotal as a function of Ca. The velocity
Vi is normalized by the characteristic fluid velocity without cell U∞, where Vi represents Vc and Vtotal
by the index i = “c” or “total”.
The deformation of each axis in a steady-state membrane is quantified by the deformation index
Li/L
re f
i , which is the ratio between each axis length of a deformed RBC Li and each reference axis
length Lre fi (i.e., without flow), where subscript i represents the maximum, middle and minimum
axes (i.e., i = “max”, “mid”, and “min”). The results of Li/L
re f
i are shown in Figure 5a. We found that
only the minimum axis (i.e., thickness) increases as Ca increases, while the maximum and middle
axes decrease.
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Figure 5. (a) Time average of the deformation index Li/L
re f
i as a function of Ca, where the maximum,
middle, and minimum axis lengths (Lmax, Lmin, and Lmid, respectively) are normalized by each reference
length Lre fi (i.e., no flow condition), where the reference major and minor axis lengths are d0 and t0
(thickness), respectively. (b) Averaged first and second invariants Ii (i = 1 and 2) as a function of Ca.
(c) Averaged maximum and isotropic tensions; Tmax and Tiso, respectively. These values are normalized
by the shear elastic modulus Gs. (d) The average of these tensions, Ti, as a function of the deformation
index Lmin/t0, which is the ratio between the minimum axis length of the deformed RBC (thickness)
and the reference thickness.
To quantify the strain of an isotropic elastic membrane, the first and second invariants of the
strain tensor Ii (i = 1 and 2) are calculated, and are given in Figure 5b. These are averaged by the total








Ii(xg, t)dSdt (i = 1 and 2), (9)
where T is the period of analysis duration, and xg is the centroid of the triangle element of the
membrane. According to Figure 5b, the second invariant I2 is almost zero for Ca ≤ 0.1, and only
slightly increases for Ca > 0.1. Therefore, the membrane incompressibility is well maintained
even after the membrane demonstrates the slipper/parachute shape. The first invariant I1, on
the other hand, starts to increase from Ca ≥ 0.01 and grows rapidly compared to I2. Therefore,
the symmetrical parachute-like deformation results from greater membrane extension than the
asymmetrical slipper-like deformation.
We also investigated the maximum in-plane principal tension Tmax (T1 ≥ T2) and the isotropic
tension Tiso(=T1 + T2)/2 in the deformed RBC, and show the results in Figure 5c. We calculated the
average value of those tensions as Tmax and Tiso by using Equation (9). As expected, both tensions
start to increase simultaneously when I1 increases (i.e., Ca = 0.01). The isotropic tension Tiso is always
lower than the maximum principal tension Tmax. To demonstrate the relationship between tension and
44
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deformation, Ti is described as a function of the deformation index Lmin/t0 in Figure 5d. The result
clearly shows the strain-hardening behavior of the RBC due to the nonlinearity of the SK law.
3.2. Effects of Perturbations on Stable Membrane Configuration
To clarify the reproducibility of the stable configuration of a deformed RBC in the narrow
rectangular microchannel, we investigated the effects of potential perturbations, e.g., the initial centroid
position x0, bending rigidity kb, and viscosity ratio λ. Figure 6 shows the centroid velocity Vc of a
RBC subjected to low Ca (= 5 × 10−3) and maximum Ca (= 0.5) for different initial centroid positions
along the span-wise direction of the channel. When the centroid of the RBC was initially placed two
fluid meshes away from the midline of the channel (i.e., x0 = −2Δx), the RBC started to flow with an
asymmetrical slipper shape, but gradually migrated to the channel axis due to the lift forces induced
by the wall and shear gradient, and finally attained a symmetrical shape for both Ca values with the
same velocity as that obtained with x0 = 0 (Figure 4; see also Videos S5 and S6). Therefore, the stable
configuration of the deformed RBC is insensitive to the initial position. Note that although the RBC
subjected to low Ca (= 5.0 × 10−3) did not perfectly orient parallel to the flow direction (Figure 6a) and
suffered from decreasing the cell velocity, the symmetry index IDsym remained the same (Figure 7a).
We also tested different values for bending rigidity kb, where the value of kb was set to a quarter
of the original bending resistance (kb = 3.0 × 10−20), and twice the original bending resistance
(kb = 2.4 × 10−19). As shown in Figure 7a, the symmetry index IDsym remained same regardless
of the value of kb. Therefore, bending rigidity does not affect the stable configuration of the translating
RBC in the narrow rectangular microchannel, at least within the parameter space that we investigated,































Figure 6. Time history of the RBC centroid velocity (Vc) at (a) low Ca = 5 × 10−3, and (b) high Ca = 0.5
for different initial positions along the span-wise direction x0, where one RBC is initially placed at the
midline of the channel (x0 = 0, dashed line) and the other RBC is placed two fluid meshes away from
the midline (x0 = −2Δx, red line). The images represent snapshots of the RBC with x0 = −2Δx at the
indicated times (see also Videos S5 and S6). Note that Vc = 12.7 μm/s for Ca = 5 × 10−3 at γ̇t = 500
(t = 60 s), and Vc = 1180 μm/s for Ca = 0.5 at γ̇t = 500 (t = 0.6 s).
However, DIsym was affected by the viscosity ratio λ. When λ decreased to unity (i.e., λ = 1),
the membrane tended to assume a symmetrical shape even at relatively low Ca = 0.01. The most
asymmetrical shape was found at at λ = 5, and the minimum DIsym|λ=1 shifted to larger Ca ≈ 0.1
(Figure 7a). The value of DIsym at λ = 1 started to recover beginning at Ca = 0.1, and finally almost
reached 1 at Ca = 0.3. To see the effect of λ, we compared the centroid velocity Vc and membrane
tension Ti between different λ (= 1 and 5). Vc at λ = 1 tended to be larger, and was approximately
4% greater than that obtained with λ = 5 (Figure 7b). The results of Ti, on the other hand, tended to
decrease as λ decreased (Figure 7c).
Figure 7d shows the membrane tensions as a function of the deformation index Lmin/t0.
When Lmin/t0 was invariant, the tensions acting on the membrane Ti tended to be lower as λ decreased.
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This tendency was inconsistent with the previous numerical results of the RBC in simple shear
flow [45]. Compared with the previous results in [45], the similarities or discrepancies in the values
of Ti (Figure 7c,d) for different λ would arise from different flow modes and confined geometries.
Even though tensions acting on the membrane and deformation depend on λ, the RBC in the narrow
rectangular microchannel underwent the same history of deformation as a function of Ca; the almost
original biconcave shape at low Ca, and an asymmetrical slipper shape at low/moderate Ca, and finally
a symmetrical parachute shape at high Ca. These results suggest that the stable configuration of the
translating RBC in the narrow rectangular microchannel was reproducible independently of any
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(d)
Figure 7. (a) The symmetry index IDsym as a function of Ca for different values of bending modulus
kb = 3.0 × 10−20 J (square), 1.2 × 10−19 J (triangle), and 2.4 × 10−19 J (inverted triangle). The results
obtained with a viscosity ratio of unity (i.e., λ = 1) are also displayed (diamond). The circular dot
represents the result of x0 = −2Δx at low Ca (= 5 × 10−3) and high Ca (= 0.5) and λ = 5. These results
were obtained with kb = 1.2 × 10−19 J. (b) Time average of the RBC centroid velocity (Vc) as a function
of Ca for different viscosity ratios (λ = 1 and 5). (c) Averaged maximum and isotropic tensions, Tmax
and Tiso, respectively. (d) Averaged tension Ti as a function of the deformation index Lmin/t0.
4. Discussion
The asymmetric slipper shape of RBCs has been found in capillaries [42], and the motion has been
systematically investigated both in experiments [19–23] and in numerical simulations [20,26,28,30].
An experiment using microfluidic devices showed that RBCs undergo a transition from a symmetrical
parachute shape to an asymmetrical slipper shape as cell velocity increased [23]. Other experimental
results showed that viscous shear stresses controlled this transition, and confinement was not necessary
for the slipper shape [19]. The results reported in [19] are consistent with the numerical results obtained
using a two-dimensional (2D) droplet model [26]. The numerical studies reported in [26] clearly
showed that the shape transition in an unbounded Piseuille flow occurred when a dimensionless
46
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vesicle deflation number, representing shape stability, fell below a certain value. Other numerical
results reported in [28] demonstrated that 2D droplets also assumed the slipper shape, not only in an
unbounded Piseuille flow but also in a confined channel. These numerical studies also clarified the
effect of the viscosity ratio λ on stable configuration, showing specifically that a droplet with λ = 1
transitioned from a parachute shape to a slipper shape as the flow strength decreased [26], while a
droplet with λ ≈ 5 made this same transition as the flow strength increased [28]; these findings were
consistent with the experimental results reported in [23]. Since the above numerical analyses were
performed using a 2D droplet model, it is uncertain whether their results are applicable to the dynamics
of a translating three-dimensional (3D) RBC in a confined rectangular channel when taking membrane
elasticity into account. Fedosov et al. (2014) systematically investigated the behavior of single RBC in
cylindrical microchannels for a wide range of channel confinements (2a/D, being a channel diameter D)
using a 3D dissipative particle dynamics model [30], but the cross-sectional area of the microchannels
were relatively large (2a/D < 0.8) comparing to a narrow rectangular microchannel represented
in [17], where the channel confinement is characterized as 2a/H = 0.8 and 2a/W ∼ 2.29 using the
wall-normal length H and span-wise length W (Figure A1a–c). We thus numerically investigated
the behavior of translating RBCs in a narrow rectangular microchannel that mimicked a microfluidic
device (Figure A1) [17] with different Ca. Our numerical results demonstrated that the confined RBCs
maintained a nearly unchanged, biconcave shape at low Ca, then shifted to an asymmetrical slipper
shape at low/moderate Ca, and finally attained a symmetrical parachute shape at high Ca. Such
asymmetrical slipper shape was also observed in the experiment (Figure A2). The finding that RBCs
tended to show a symmetrical shape with increasing Ca contradicted previous experimental results [23]
as well as numerical results obtained using a 2D-droplet model with λ ≈ 5 [28]. This discrepancy
may have been caused by the effects of three-dimensional flow structures in a confined channel and
by the membrane constitutive law. Our numerical results of the transition from slipper to parachute
shapes qualitatively agree with those obtained in cylindrical microchannels for 2a/D < 0.8 [30].
To the best of our knowledge, such shape transition in a narrow rectangular microchannel that was
presented here is the first of its kind. We also showed that the stable configuration of the translating
RBC in the narrow rectangular microchannel was reproducible independently of any perturbations
that we investigated such as the initial centroid position, bending rigidity, and viscosity ratio. If the
fully deformed configuration or the transition mode is related to membrane shear elasticity, which is
characterized by Ca, these insights will help us identify the cell state. Since different motions of
individual RBCs may affect the bulk suspension rheology [46], identifying a stable mode of RBCs in a
channel will be also helpful to evaluate the blood rheology.
In our experiment using microfluidic devices, we observed a slipper-shaped RBC whose velocity
was almost 1.2 mm/s (Figure A2), while the numerical results showed that a velocity this high resulted
in a RBC with a symmetrical parachute shape (Figure 3c). This discrepancy may have been due
to the duration of the observation. Since experimental observation periods are limited to 0.1 s or
less, the slipper-shaped RBC in the microfluidic device may have been in the transition. According
to our numerical results shown in Figure 6, the transition from slipper shape to parachute shape
takes at least γ̇t ∼ 300, corresponding to ∼0.3 s for Ca = 0.5 (Vc ∼ 1.2 mm/s). Another possible
reason may have been due to RBC heterogeneity as reported in our previous experiments [17,18].
The experimental observations of an asymmetrical slipper shape in a microfluidic device are required
for precise statistical analysis, which will be addressed in future study.
We are not sure what perturbations are needed to destroy the stable symmetrical shape. Thermal
energy is unlikely to be affecting the state: indeed, although the RBC membrane usually demonstrates
Brownian motion in the free state, the Peclet number (Pe = γ̇a/Dp, being a radius of the RBC a and a
diffusion coefficient Dp) is estimated as approximately O(Pe) = 101, even at Ca = 10−4, by using the
Stokes–Einstein equation, and thus the Brownian diffusion (thermal fluctuations) should have little
effect. Although the membrane bending rigidity did not affect the stable membrane configuration at
least for 3 × 10−20 J ≤ Ca ≤ 2.4 × 10−19 J, further investigation will be required for larger parameter
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spaces. In this study, we defined the initial shape of RBCs as a biconcave disc. Since some recent
numerical studies have debated the stress-free shape of RBCs [47–49], it will be interesting to study
how the reference shape (biconcave, oblate spheroid, and sphere) affects the stable configuration of
translating RBCs in a narrow rectangular microchannel.
5. Conclusions
We numerically investigated the dynamics of translating RBCs in a narrow rectangular microchannel
for different capillary numbers (Ca). Our numerical results demonstrated that a confined RBC in a narrow
rectangular microchannel maintained a nearly unchanged, biconcave shape at low Ca, then assumed an
asymmetrical slipper shape at moderate Ca, and finally attained a symmetrical parachute shape at high
Ca. Once the RBC deformed into either of the latter two shapes, they sustained that shape as their final
stable configurations. The membrane deformation as a function of Ca remained the same even when the
viscosity ratio λ decreased from physiological relevant value (λ = 5) to unity. The final stable configuration
was insensitive to bending resistance and initial position. If these shapes are found in diseased RBCs
translating at specific velocities, the shapes will be an important indicator of cell state.
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Ca = 5 × 10−3 and Ca = 0.5, respectively. These numerical results were obtained with λ = 5 and kb = 1.2 × 10−19 J.
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Appendix A. Sample Preparation and Observation
Adult blood was drawn from healthy donors based on the informed consent. All the experiments
and experimental protocols in microchannels were approved by the Ethical Committee of Osaka
University and performed according to the appropriate guidelines and regulations. Immediately
after the blood was drawn, it was maintained in an intact condition by dispersal at a concentration of
1% (v/v) in standard saline.
A microfluidic channel was constructed between a glass slide and poly (dimethylsiloxane)
(PDMS) that was designed and printed from a master mold made of SU-8 photoresist using
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standard photolithography. The cross-section of the rectangular microchannel was 10 μm × 3.5 μm
(Figure A1a,b). The experimental system was composed of a high-speed camera (IDP-Express R2000,
Photron) and microscope (IX71, Olympus) equipped with an × 40 (N.A. = 0.6) or × 50 (N.A. = 0.42)
objective lenses. Images were captured at 1000 frames/s with exposure time of 1 ms. The spatial
resolutions of captured images were 0.24 μm/pixel (Figure A1d) and 0.26 μm/pixel (Figure A2) for
× 40 and × 50 objective lenses, respectively. Flow of the solution inside the microchannel was basically
driven by a constant pressure difference between the inlet and outlet of the channel, maintained by
atmospheric pressure and gravitational force.
Figure A1. Detailed channel geometry. Magnified view of the channels with the cross-sections of
(a) 10 μm × 3.5 μm and (b) 3.5 μm × 10 μm, which were used in Figure A2 and Figure A1, respectively.
(c) Schematic view of the whole channel, whose stream-wise length was 8000 μm. (d) Representative
images of a flowing RBC in a microfluidic device. Flow direction is from left to right.
Figure A2 shows representative snapshot images of a RBC flowing at a velocity of 1200 μm/s;
imaging was performed at 1000 frames/s, perpendicular to the span-wise direction of the microchannel.
The RBC deformed into an asymmetrical shape, the so-called slipper shape [42]. Interestingly, this
configuration was also found in a numerical simulation with Ca = 0.01, where the RBC centroid velocity
was Vc ∼ 25 μm/s (Figure A2). Although we reported RBC heterogeneity in [17], the asymmetrical
shape of RBCs by means of the experimental observations is required for a precise statistical analysis,
which is however future study.
Figure A2. Representative images of the flowing RBC at frame numbers 0 (top), 20, 40 60, and 80
(bottom), respectively, where the speed of the cell is 1200 μm/s (see also Video S1). A representative
numerical result of a stable slipper-shaped RBC subjected to Ca = 0.01 (calculated centroid velocity
Vc ∼ 25 μm/s) is also displayed (see also Video S2).
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Abstract: The loss of the red blood cells (RBCs) deformability is related with many human diseases,
such as malaria, hereditary spherocytosis, sickle cell disease, or renal diseases. Hence, during the
last years, a variety of technologies have been proposed to gain insights into the factors affecting the
RBCs deformability and their possible direct association with several blood pathologies. In this work,
we present a simple microfluidic tool that provides the assessment of motions and deformations of
RBCs of end-stage kidney disease (ESKD) patients, under a well-controlled microenvironment. All of
the flow studies were performed within a hyperbolic converging microchannels where single-cell
deformability was assessed under a controlled homogeneous extensional flow field. By using a
passive microfluidic device, RBCs passing through a hyperbolic-shaped contraction were measured
by a high-speed video microscopy system, and the velocities and deformability ratios (DR) calculated.
Blood samples from 27 individuals, including seven healthy controls and 20 having ESKD with or
without diabetes, were analysed. The obtained data indicates that the proposed device is able to
detect changes in DR of the RBCs, allowing for distinguishing the samples from the healthy controls
and the patients. Overall, the deformability of ESKD patients with and without diabetes type II
is lower in comparison with the RBCs from the healthy controls, with this difference being more
evident for the group of ESKD patients with diabetes. RBCs from ESKD patients without diabetes
elongate on average 8% less, within the hyperbolic contraction, as compared to healthy controls;
whereas, RBCs from ESKD patients with diabetes elongate on average 14% less than the healthy
controls. The proposed strategy can be easily transformed into a simple and inexpensive diagnostic
microfluidic system to assess blood cells deformability due to the huge progress in image processing
and high-speed microvisualization technology.
Keywords: microfluidic devices; cell deformability; chronic renal disease; diabetes; red blood cells
(RBCs); hyperbolic microchannel; blood on chips
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1. Introduction
Blood is a complex and an extremely information-rich fluid that can be used to diagnose different
kinds of blood diseases with multiple biophysical techniques and tools [1,2]. Under normal healthy
conditions, the red blood cells (RBCs) comprise about 42% in adult females and 47% in adult males
of the total blood volume [3]. As RBCs are the most abundant cells in blood, their deformable
properties strongly influence the blood rheological properties, particularly in microvessels with
complex geometries and diameters of less than 300 μm [4]. Several research works have found that
complex microgeometries, such as contractions [5,6] and bifurcations [2,7–9], promote the presence of
strong shear and extensional flows that elongate the RBCs without reaching the rupture.
Ever since the RBCs deformability became a potential biomarker for blood diseases, such as
malaria [10,11], sickle cell disease [1,12], and diabetes [13–15], several techniques have been developed
to measure the biomechanical properties of the RBCs. Additionally, there have been several reviews
that discuss different kind of experimental methods to measure the RBC deformability [1,2,16–18].
The available methods can be divided in two main kinds, i.e., the high-throughput methods that
measure high concentrations or diluted suspensions of RBCs, and the single-cell techniques. The
most popular high-throughput methods, which include the conventional rotational viscometer [19–21],
ektacytometer [9,14] and micro-pore filtration assay [9], have been used to measure the blood viscosity
and other rheological properties, but they are generally expensive, labor intensive, and do not provide
a direct and detailed source of information on the mechanical properties of the RBCs. A recent study
that was performed by Sosa et al. [9] has shown that the results from the micro-pore filtration and
ektacytometry were often in disagreement, and that neither of them represent the actual blood flow
conditions occurring in microvascular networks. Other methods, known as single-cell techniques,
which include the micropipette aspiration and optical tweezers, are also extremely popular for
measuring the mechanical properties of the RBC membrane [1,13]. However, these techniques also
have several drawbacks, such as a low-throughput, labor intensive, and static process. Additionally,
it is argued that these methods do not represent the actual RBC deformability that happens during
microcirculation [2].
The progress in microfabrication made fabricating microfluidic devices with the ability to
directly visualize, measure, and control the motion and deformation of RBCs flowing through
constricted [19,22–24] and bifurcated microchannels [7,9,24] possible. The distinctive advantage of
the microfluidic devices, such as the need of small sample’s volumes and their ability to reproduce
more realistic conditions of the microcirculation, have promoted a vast amount of studies on the cell
motion and deformability, mainly under the shear flow effect [3,6,16,20,25–27]. Some examples are
the deformability measurements that were performed under transient high shear stress in sudden
constriction channels, [16,28] and in microchannels with dimensions that were comparable to cell
size [2,16]. Besides the shear flow effect, the extensional flow and the combination of both can be
often found in the microcirculation system, such as in microstenosis and microvascular networks.
Hence, during the last decade, several extensional blood flow studies have been performed in cross
slot devices [29,30] and in microfluidic devices with hyperbolic channels [31–36]. Recent studies that
were performed in cross slot devices [37] and sudden constriction channels [26] have shown that cells
entrance location and angular orientation strongly affect the cells deformability. On the other hand,
extensional flows, where cells are deformed at almost constant strain rates, has been demonstrated to be
a microfluidic methodology that is capable of efficiently and accurately probing singe-cell deformability
with high throughputs [16,29].
Additionally, the ability of hyperbolic-shaped contraction channels to generate constant strain-rates
makes them a promising strategy for measuring RBCs deformability under a well-controlled
microenvironment. Taking these advantage into account, the present study investigates the ability
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of hyperbolic microfluidic channels to measure the deformation and cell motion of RBCs that were
obtained from healthy and diseased individuals (having end-stage kidney disease (ESKD), with or
without diabetes type II) and exploits the relevance of this flow technique to be used as a viable tool
suitable for detecting and diagnosing RBC related diseases.
Chronic kidney disease (CKD) is a pathological condition that results from a gradual, permanent
loss of kidney function over time, usually, months to years, which can lead to an end-stage kidney
disease (ESKD) [38]. This condition is associated with a decreased quality of life [39], increased
hospitalization [39,40], cardiovascular complications, such asangina, left ventricular hypertrophy
(LVH), and chronic heart failure, and increased mortality [41,42].
The remainder of this paper is organized, as follows: Section 2 comprises several subsections
to explain the experimental framework around blood samples, setups used to acquire the data,
and methods used to analyze it. Sections 3 and 4 presents and results and discussion, respectively.
2. Materials and Methods
2.1. Patients
In this study, a total of 20 ESKD patients under online hemodiafiltration (OL-HDF) that voluntary
accepted to participate in the study, have been tested. From those, eight additionally showed diabetic
nephropathy. Patients were excluded if they: (1) did not accept to participate in the study; (2) were
under 18 years old; (3) were cognitively impaired; (4) had a severe speech or hearing impairment;
(5) were in the dialysis program for less than three months; and, (6) presented malignancy, autoimmune,
inflammatory, or infectious diseases.
The control group included seven healthy volunteers presenting normal haematological and
biochemical values, with no history of renal or inflammatory diseases, and, as far as possible, age- and
gender-matched with ESKD patients. The controls did not receive any medication known to interfere
with the studied variables. Blood samples (using EDTA as anticoagulant) were drawn from the fasting
controls or before the second dialysis session of the week in ESKD patients.
All of the blood samples were obtained from dialysis patients at the hemodialysis clinic of
Gondomar, in Porto, Portugal. Informed consent was obtained from all the participants and this study
was approved by the clinic’s ethics review board.
2.2. Microfluidic Device, Experimental Setup and Parameters
The polydimethylsiloxane (PDMS) microfluidic devices that were evaluated in this work were
fabricated by using a conventional soft-lithographic technique [22]. To perform the deformability
assessment, hyperbolic converging microchannels were fabricated with 382 μm of length (Lc), as well
as maximum width of 400 μm (W1) and minimum width of 20 μm (W2) at the wide and narrow sizes,
respectively (cf. Figure 1). This particular geometry corresponds to a hyperbolic contraction with a
Hencky strain (εH) of ~3. Note that the εH can be defined as ln (W1/W2) [32]. The advantages of the use
of this hyperbolic geometry for RBCs screening have already been ascribed in previous studies [43,44].
The hyperbolic contraction geometry was chosen, mainly due to the strong extensional flow that was
generated in the middle of the microchannel, which is dominant over the shear flow. The cells by
passing through the hyperbolic contraction are submitted to a strong extensional flow, where the
velocity almost linearly increases, but the strain rate stays approximately constant. Note that the depth
was about 50 μm along the full length of the device.
Figure 1b also shows the main advantage of using hyperbolic converging microchannels. At the
entrance of these kinds of geometries, the RBCs tend to exhibit a linear increase of their velocities
and consequently the strain rates within the hyperbolic contractions are close to a constant. This
flow phenomenon imposes a homogenous mechanical fluid behaviour to the RBCs and avoids some
possible motions (tumbling, twisting, and rolling rotations), often observed in abrupt contractions [26].
Hence, by using hyperbolic converging microchannels, most of the RBCs tend to elongate when they
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flow through the contraction. It is worth mentioning that RBCs motions, such as tumbling, twisting,
and rolling rotations, were never observed during our experiments.
Figure 1. Microfluidic device fabricated in polydimethylsiloxane (PDMS) with a hyperbolic-shaped
contraction to assess the of the red blood cells (RBCs) deformability: (a) main dimensions; (b) flow
phenomena happening in this kind of geometry. Adapted with permission from [45].
The visualization and measurements of the motion of the RBCs were performed by means
of a high-speed video microscopy system that includes an inverted microscope (IX71, Olympus,
Tokyo, Japan) combined with a high-speed camera (Fastcam SA3, Photron, San Diego, CA, USA).
The microfluidic device was placed on the microscope stage and the flow rate of the working fluids
was kept constant at 3 μL/min. by using a syringe pump (PHD Ultra, Harvard Apparatus, Holliston,
MA, USA) with a 1 mL disposable syringe (Terumo) (Figure 2). For all of the flow measurements, the
average shear rate at the hyperbolic contraction region was about 1750 s−1. The average or pseudo
shear rate was calculated by γ = UDh , where U is the mean velocity of the blood cells that were obtained
at the contraction region, and Dh is the hydraulic diameter at the end of the contraction region.
Figure 2. Experimental set-up used to perform the motion and measurements of the RBCs deformability.
The images of the RBCs flowing through the hyperbolic contraction were captured by the
high-speed camera with a frame rate of 3000 frames/s and a shutter speed ratio of 1/75,000 s. These
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parameters were selected in order to obtain well defined RBCs and avoid possible image distortions
that are caused by the high flow velocities at the contraction region. Table 1 shows the most of the
relevant experimental parameters that were used to perform the RBCs deformability measurements.
Table 1. Main experimental parameters used to perform the RBCs deformability measurements.
Main Experimental Parameters
Maximum width of the microchannel 400 μm
Minimum width of the microchannel 20 μm
Total length of the contraction region 382 μm
Depth of the microchannel 50 μm
Flow rate (syringe of 1 mL) 3 μL/min
Average shear rate 1750 s−1
Shear viscosity of the Dextran 40 4.5 × 10−3 Pa·s
Density of the Dextran 40 1046 kg/m3
Haematocrit of the working fluid 1%
Temperature of the working fluid 22 ◦C
Magnification (M) 40×
Numerical Aperture (NA) 0.75
Frame rate 3000 frames/s
Exposure time 1/75,000 s
2.3. Working Fluids
To perform the RBCs deformability studies, Dextran 40 (Sigma-Aldrich, Saint Louis, MO, USA)
at 10% (w/v) solution containing 1% of haematocrit (Hct 1%, v/v) of RBCs was used as the working
fluid. Briefly, venous blood samples from both patients and healthy donors were collected into
10 mL BD-Vacutainers (BD, Franklin Lakes, NJ, USA) tubes containing ethylenediaminetetraacetic
acid (EDTA) to prevent coagulation. The RBCs and buffy coat were separated from the plasma after
centrifugation (2500 rpm for 10 min., at 4 ◦C). The RBCs were then washed with physiological salt
solution (PSS) and then centrifuged, with this procedure repeated twice. The RBCs were suspended in
Dextran 40 to make several samples with low hematocrit levels of ~1% by volume (cf. Figure 3) to
obtain the measurements of individual RBC flowing through hyperbolic contraction. Dextran 40 was
used as substitute of the blood plasma, since it prevents not only the sedimentation of the RBCs during
the experimental assays, but also the cell clogging phenomenon. All of the analyses were performed
within a maximum period of 12 h, with blood samples being hermetically stored at 4 ◦C until being
used in the flow experiments.
Image analysis was essential to obtain sharper, brighter, and clearer images of the RBCs flowing
through the contraction, and to consequently obtain reliable velocity and deformability measurements,
at the regions of interest (ROI) in both contraction and expansion regions, where the RBCs deform
and recover to their normal circular shape, respectively (see Figure 3a and supplementary video).
The first step of this process involves the capture of videos with a resolution of 1024 × 576 pixels at
frame intervals of 330 μs at the end of the contraction region. Figure 4a shows a typical obtained image.
In order to reduce static artifacts in the images, a background image (Figure 4b) was created from
the original stack images, by averaging each pixel over the sequence of static images while using an
ImageJ function, called Z project, and then subtracted from the stack images. This process eliminates
all the static objects including the microchannel walls and some possible attached cells, which resulted
in having at the end, only the RBCs of interest (Figure 4c). Brightness/Contrast adjustment was also
applied to enhance the image quality. Finally, the greyscale images were converted to binary images
adjusting the threshold level (Figure 4d). At this stage, an Otsu threshold method was applied and
when required, the level was manually refined. This segmentation process generates objects of interest
(RBCs) as black ellipsoidal objects against a white background. At the end, the flowing RBCs in the
binary images were measured frame by frame manually, by using Wand tool function in ImageJ. The
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main output results of these measurements were the major and minor axis lengths of the RBCs and the
x-y coordinates of their centroid.
Figure 3. Schematic diagram from blood collection up to the flow microfluidic tests with RBCs. Samples
with low hematocrit levels of ~1% were crucial in order to visualize individual RBC flowing through
hyperbolic contraction. The ROI regions represent the regions of interest used to analyze the RBCs
deformation index.
Figure 4. Images analysis sequence: (a) original image at the regions of interest (ROI) regions in which
moving RBCs as well as microchannel boundaries are visible, (b) background image containing only
static objects, (c) original image after background subtraction showing only moving RBCs, and (d) final
binary image to perform measurements of the RBCs major and minor axis lengths.
The deformation ratio (DR) of all the measured RBCs was calculated and saved with the cell’s
positions, given by their x-y coordinates, using the set of data obtained for the cells at the regions of
interest (ROI) at both constriction and expansion locations of the microchannel. In this study, DR was
defined by the equation that is shown in Figure 5, where Lmajor and Lminor refer to the major and minor
axis lengths of the RBC, respectively.
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Figure 5. Definition of the deformation ratio, DR = Lmajor/Lminor, where Lmajor and Lminor are the major
and minor axis lengths of the ellipse best fitted to the cell.
Although different automatic methods to track RBCs in microfluidic devices have been reported in
the literature [45–49], further improvements still need to be achieved to perform reliable deformability
measurements. Hence, in the present study, hundreds of RBCs were manually tracked by using
the ImageJ plug-in, MTrackJ. By selecting this method, it is possible to easily track the cells by a
centroid based strategy and obtain their centroid position (x-y coordinates), by carefully tracking
individual RBCs and consequently determine their orientations and velocities within the hyperbolic
contraction and downstream of the contraction region. In this study, measurements were only
performed for the in focus cells flowing from the side, as it is possible to observe in the examples at the
supplementary video. In this video, it is also possible to observe a RBC that flows from the top (the
biconcave disc shape cell). However, the cells flowing with this orientation were not considered in our
deformability measurements.
2.4. Statistical Analysis
The statistical analysis was performed by using one-way ANOVA (Microsoft Office Excel, version
Office 365 ProPlus). Before performing the ANOVA analysis, the requirements regarding normal
distribution were tested by means of the Shapiro–Wilk’s test. In this test, the null hypothesis that
the population is normally distributed was accepted since p > 0.05. Overall, for the constriction
region, we have measured the deformability of 1769 RBCs corresponding to 12 ESKD patients and
a total of 736 measured RBCs, eight ESKDD patients and a total of 444 measured RBCs, and seven
healthy controls and a total of 589 measured RBCs. All of the statistical tests were performed at a 95%
confidence level; differences with p < 0.05 were considered to be statistically significant, and were
represented as asterisks (*).
3. Results and Discussion
The determination of the RBC velocities plays an essential role in confirming whether the cells
are deformed under similar flow conditions. Hence, before the deformability assessment of each
sample, velocity measurements were performed and compared. After analyzing the average velocities
of each sample at the contraction region, it was decided to compare the RBC deformability for all of
the samples having similar flow conditions, i.e., both shear and extensional flows. Figure 6 shows
representative RBC trajectories that were manually tracked within the hyperbolic contraction and
downstream of the contraction region.
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Figure 6. Trajectories of two RBCs flowing within the hyperbolic contraction and downstream of
the contraction region (Upper part); detail of a representative trajectory of a RBC flowing near the
microchannel wall at different times intervals (Bottom part).
Figure 7 shows the measurements of the velocity and DR of representative RBCs flowing through
the hyperbolic-shaped contraction (ROI region) for both healthy donors and ESKD patients (see also
supplementary video). The majority of the RBC velocities tend to slightly increase as they move
through the exit of the contraction, and then they suffer a dramatic reduction of their velocities when
flowing from the narrow to the wide region of the microchannel (cf. Figure 7a). Overall, the velocities
of the RBCs of both control and ESKD patients present a similar qualitative flow behavior at the tested
region of the device, which results in a good agreement in the deformability results obtained in all the
samples (cf. Figure 7b). However, it should be noted that, quantitatively, the DR results indicate that
the deformability of the ESKD RBCs under extensional flow tend to be smaller when compared to the
control RBCs (cf. Figure 7b). These latter results are further confirmed with the measurements that
were performed with several ESKD patients and healthy individual, as shown in Figure 8. Additionally,
during all the flow visualization measurements at constriction region, the RBCs did not show any
tumbling and rolling motion, which was mainly due to the uniform and strong extensional flow
generated along the hyperbolic-shaped contraction. Note that, under shear flow, it is extremely
common to observe RBCs flowing with complex dynamics, such as tumbling and rolling [26,46]. In the
present study, the RBCs only exhibited such kind of complex flow motions at the expansion region,
due to the dominant shear flow with respect to the extensional flow (cf. supplementary video). Hence,
by using the proposed method, when the RBCs enter into the contraction region, they change from a
circular to an elliptical shape, with a tendency to become increasingly elongated as they moved through
the hyperbolic contraction. This latter flow behavior is possible to observe in Figure 7b. Additionally,
in this figure, it can be observed that, at the downstream of the contraction region, the cells start to
recover their nearly circular shape, exhibiting a DR that is close to one.
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Figure 7. Measurements of RBCs from healthy donors and end-stage kidney disease (ESKD) patients,
flowing within the hyperbolic contraction and downstream of the contraction region: (a) velocity
measurements; (b) deformability measurements. The X axis represents the position of the cells centroid
flowing through the microchannel.
Figure 8 shows the box plot of the deformation ratio (DR) for three different groups, i.e., samples
of ESKD patients without diabetes type II (n = 12), samples of ESKD patients with diabetes (n = 8)
type II, and samples from healthy donors (n = 7). For each patient sample, more than 60 RBCs with
similar flow behavior were individually measured and analyzed at the hyperbolic constriction and
recovering channel of the proposed microfluidic device (Figure 8). Additionally, Table 2 shows the data
of the average DR and standard deviation (SD) of the RBCs deformation at both the contraction and
expansion region for all of the tested samples. Overall, the deformability of ESKD patients (with and
without diabetes) measured at the hyperbolic constriction is lower in comparison with the RBCs from
the normal healthy controls (p < 0.05), as shown in Figure 8b. This difference is more evident when
only the group of ESKD patients with diabetes is taken into consideration. For instance, RBCs from
ESKD patients without diabetes elongates, on average, 8% less within the hyperbolic contraction when
compared to healthy controls, whereas RBCs from ESKD patients with diabetes elongates on average
14% less than the healthy controls (cf. Figure 8b). On the other hand, all of the cells analyzed, both
healthy and diseased, have been shown to have a similar DR (nearly to 1, i.e., close to a spherical-shape)
at the expansion region of the microchannel (Figure 8c,d), where cells tend to recover to their normal
61
Micromachines 2019, 10, 645
circular shape due to the low shear rate and a negligible strain rate. Therefore, the results from the
present study demonstrate that the RBCs DR measured by using the proposed microfluidic device
can be considered as a sensitive mechanical biomarker, as it was able to detect changes in DR of
the RBCs from patients with different diseases in comparison with healthy ones. Moreover, this
study also corroborates other previous research works [13,14], where, by using different deformability
measurement techniques, it was shown that elongation of RBCs from patients with diabetes is lower in
comparison with the non-diabetic healthy controls.
Figure 8. Box plot representation of RBC’s deformation ratio (DR) measured by the proposed
microfluidic device: (a) DR of individual donors, including ESKD patients, ESKD patients with diabetes
and healthy donors (control) in the hyperbolic constriction, (b) Average DR of the groups of donors,
including ESKD patients, ESKD patients with diabetes and healthy donors (control) in the hyperbolic
constriction, (c) DR of individual donors, including ESKD patients, ESKD patients with diabetes and
healthy donors (control) at the expansion region, (d) Average DR of the groups of donors, including
ESKD patients, ESKD patients with diabetes and healthy donors (control at the expansion region.
The asterisks (*) indicates statistically significant differences (p < 0.05) determined by Student’s t test.
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Table 2. Average DR and standard deviation (SD) of the flowing RBCs at both contraction and expansion
region for each sample.
Blood Samples
Contraction Region DR Expansion Region DR
Average SD Average SD
ESKD1 3.03 0.34 1.12 0.08
ESKD2 2.79 0.36 1.10 0.09
ESKD3 2.86 0.26 1.13 0.06
ESKD4 3.11 0.25 1.14 0.08
ESKD5 3.03 0.39 1.12 0.06
ESKD6 3.15 0.37 1.15 0.07
ESKD7 2.89 0.31 1.15 0.08
ESKD8 2.93 0.26 1.16 0.05
ESKD9 2.94 0.35 1.13 0.10
ESKD10 3.02 0.24 1.10 0.05
ESKD11 2.96 0.32 1.14 0.06
ESKD12 3.17 0.35 1.13 0.08
ESKDD1 2.78 0.25 1.12 0.05
ESKDD2 2.60 0.27 1.13 0.07
ESKDD3 3.01 0.32 1.15 0.05
ESKDD4 3.02 0.32 1.13 0.08
ESKDD5 2.72 0.37 1.14 0.07
ESKDD6 2.74 0.28 1.16 0.08
ESKDD7 2.69 0.34 1.14 0.08
ESKDD8 2.81 0.43 1.11 0.06
C1 2.99 0.21 1.14 0.07
C2 3.12 0.23 1.13 0.06
C3 3.28 0.22 1.13 0.10
C4 3.23 0.27 1.12 0.06
C5 3.24 0.31 1.15 0.07
C6 3.07 0.30 1.14 0.07
C7 3.27 0.27 1.15 0.06
As previously mentioned, RBCs occupy almost half of the total blood volume and, under healthy
conditions, they are highly deformable in order to pass through capillaries with dimensions several
times lower than the RBCs size [16]. Hence, it is well known that the RBC deformability plays a crucial
role in the rheological properties of blood in microvessels, i.e., the decrease of the RBC deformability
might result in an increase of the blood viscosity and, consequently, in an increased tendency for
microvascular complications and associated diseases. The results that are presented in this study
indicate that the ESKD patients with and without diabetes have a tendency to decrease the RBCs
deformability and, as a result, night have a substantial impact in the whole blood viscosity of these
patient’s health. This can result in an elicit hemolysis in the capillaries and premature sequestration
of RBCs by the reticulo-endothelial system, and altering tissue oxygenation. However, a larger scale
study is required to confirm whether the decrease of the RBC deformability contributes to the increase
of the blood viscosity, or not.
4. Limitations and Future Directions
The primary goal of the present work was to investigate the ability of hyperbolic converging
microchannels to be used as an alternative clinical tool that is suitable to detect and diagnose RBC
related diseases. To accomplish it, high speed microfluidic studies were performed in a hyperbolic
contraction microchannel with a uniform depth of about 50 μm. The selection of this depth was
a compromise solution mainly due to the limitation of our high-speed video camera: although,
by decreasing the microchannel depth, the orientation of the cells tend to be more stable, the difficulty
to measure the RBCs deformability increases due to the extremely high velocities that were generated at
this region. The major advantage of this geometrical modification is the ability to use simple automatic
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methods, which results in a significant increase of the number of cell measurements performed under
similar flow conditions. Nevertheless, in this study, we opted for manual measurements to guarantee
that only adequate cells were included.
Additionally, we would like to refer that recently, Schonbrun et al. [50] have shown that by
using blue light the hemoglobin absorption makes cells extremely visible and easier to track in
microchannels for low shear rates. Although this optical option looks promising, further research
needs to be performed regarding the ability to measure blood cells at high shear rates. We consider that
a combination of both strategies could result in a promising methodology to preform DR measurement
of RBCs with high accuracy. The high-speed camera used due to its cost can be a limitation to consider
the technique as a common tool; however, during the last two decades, the cost of this technology
has been decreasing in an exponential way, thus we believe that it will be possible to have in a more
affordable way a high-speed system in the future. Another way can be the use of compact CCD cameras
due its capacity to achieve similar sensitivity and exposure, but in an affordable way.
5. Conclusions
RBCs deformability plays a crucial role in microcirculation and the loss of their deformability can
be related to many pathologies. The present study investigated the ability of hyperbolic microfluidic
channels to measure the deformation and RBC motion from the blood samples of patients with ESKD
(with and without diabetes type II) compared to healthy individuals (used as control) and exploit the
relevance of this method to be used as viable clinical tool suitable to detect and diagnose RBC related
disease. This study has shown the potential of the proposed device to detect changes in DR of the RBCs
from patients with different complications. Overall, the elongation of RBCs from the ESKD patients,
with and without diabetes, was lower in comparison with the RBCs from the healthy controls, being
the difference more evident for the group of ESKD patients with diabetes. Another important finding
was related to the comparison of the cells at the expansion region, where the RBCs have recovered their
normal circular shape. At this region, the cells were deformed under low shear rate and negligible
strain rate. Under those conditions, we have not found any difference between the ESKD patients and
the healthy controls. This latter result indicates that the RBCs need to be submitted to high mechanical
stresses to deform the cells and, consequently, to detect different state of blood diseases.
Additionally, the results that are presented in this study indicate that the ESKD patients with and
without diabetes have a tendency to decrease the RBCs deformability, which might have a substantial
impact in the whole blood viscosity of these patients. However, a larger scale study would be necessary
to confirm whether the decrease of the RBC deformability contributes to the increase of the blood
viscosity, or not. Although the proposed microfluidic tool requires further improvements, the results
that were obtained from the present study suggest that this technique is able to assure a simple and
efficient cell deformability assessment at both physiological and pathological situations.
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Figure S1: Images from a video where it is possible to observe that the RBCs rotation only happens at the expansion
region of the microchannel, and Video S1: Visualization of RBCs flowing within the hyperbolic contraction and
downstream of the contraction region.
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Abstract: Malaria is one of the leading causes of death in underdeveloped regions. Thus, the development
of rapid, efficient, and competitive diagnostic techniques is essential. This work reports a study
of the deformability and velocity assessment of healthy and artificially impaired red blood cells
(RBCs), with the purpose of potentially mimicking malaria effects, in narrow polydimethylsiloxane
microchannels. To obtain impaired RBCs, their properties were modified by adding, to the RBCs,
different concentrations of glucose, glutaraldehyde, or diamide, in order to increase the cells’ rigidity.
The effects of the RBCs’ artificial stiffening were evaluated by combining image analysis techniques
with microchannels with a contraction width of 8 μm, making it possible to measure the cells’
deformability and velocity of both healthy and modified RBCs. The results showed that healthy
RBCs naturally deform when they cross the contractions and rapidly recover their original shape.
In contrast, for the modified samples with high concentration of chemicals, the same did not occur.
Additionally, for all the tested modification methods, the results have shown a decrease in the RBCs’
deformability and velocity as the cells’ rigidity increases, when compared to the behavior of healthy
RBCs samples. These results show the ability of the image analysis tools combined with microchannel
contractions to obtain crucial information on the pathological blood phenomena in microcirculation.
Particularly, it was possible to measure the deformability of the RBCs and their velocity, resulting in a
velocity/deformability relation in the microchannel. This correlation shows great potential to relate
the RBCs’ behavior with the various stages of malaria, helping to establish the development of new
diagnostic systems towards point-of-care devices.
Keywords: biomicrofluidics; red blood cells; deformability; velocity
1. Introduction
Malaria is a parasitic disease with more than half the world population at risk and around
500 thousand deaths per year, with 80% of infections occurring in children under 5 years old [1].
This disease is mainly widespread in underdeveloped regions, with lack of proper infrastructure
and living conditions, worsening the chances of infection for the population. The control, effective
treatment, and elimination of malaria require an early and accurate diagnosis. Currently, the malaria
diagnosis is based on blood smear microscopy or rapid diagnostic tests (RDTs) [2,3], which have
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limitations in the detection limit (only detect above 50 parasites/μL of blood). Additionally, microscopy
has limitations in the required time to perform the assays and in the need for specialized technicians
and/or laboratories, compromising the reduction of global incidence. To fulfill these needs, innovative
diagnosis based on molecular assays have been developed, with detection limits below 2 parasites/μL,
particularly using loop-mediated isothermal amplification [4] or more advanced portable devices
such as QuantuMDx/Q-POC [5]. However, these techniques require disposable reagents, technicians,
more than 30 min to get the test results, and imply aseptic conditions (hard to maintain in endemic
regions). Therefore, there is a huge need for fast, reagent-free, and low-cost malaria diagnostic systems,
without requiring special training and independent of the genetic variability of the parasite, and overall
the final ideal device should comprise all these concerns.
The malaria parasite lifecycle passes from the mosquito vector to the human host by entering the
liver cells where it matures, to further being released into the blood stream, invading the red blood
cells (RBCs). At this stage, the infected RBCs (iRBCs) suffer biochemical, optical, and morphological
changes [6,7], making these cells more rigid and thicker, resulting in a decrease of the cells velocity
(when the cells are infected with Plasmodium falciparum parasite) [8]. Hemodynamic studies help
to obtain information regarding the evolution of the disease. Particularly, the RBCs’ deformability
and the RBCs’ velocity when crossing a geometric contraction can work as relevant markers for
malaria diagnostics applications, since they are directly related to the changes that the parasite causes
throughout the evolution of the disease [9]. The literature reports different methods for assessment
of the RBCs’ deformability, including filtration [10], ektacytometry [11,12], optical tweezers [13,14],
micropipette aspiration [15], and microfluidic geometrical constrictions [16–22]. Some numerical
and experimental studies in the literature already report the relation between RBCs’ deformability
and hemodynamics [23,24], or between deformability and the individual RBCs’ velocities in specific
geometrical conditions [9,25–28]. This work will be focused on a microfluidic system to measure the
RBCs’ deformability and velocity, as well as to establish a relation between these properties when the
cells cross geometric microcontractions, with the expectation to, in the future, compare this correlation
with the real malaria effects in RBCs. The microfluidic systems are a potential alternative to the current
diagnostic methods, since they are able to mimic the hemodynamic phenomena that happens in blood
vessels and have advantages in terms of sample preparation and analysis (low volume of samples,
easy handling, low-cost, and fast processing), eliminating the need for specialized personnel [22].
Additionally, microfluidic devices enhance the possibility of creating a fully automated and portable
diagnostic device for malaria, when assembled in a microfluidic platform that includes microfluidic
handling, control and readout electronics, and data acquisition.
In order to develop and evaluate those microfluidic methods for the deformability and velocity
assessment, it is essential to synthetically impair the RBCs for mimicking malaria behavior, for testing
the method’s efficiency and reproducibility, without the constant need for parasites or infected samples,
improving laboratorial safety, when testing, and decreasing the costs. For that purpose, glutaraldehyde,
diamide, and glucose will be used for increasing the rigidity of the RBCs and, their effect in narrow
constrictions will be compared [29–32]. When exposed to these chemicals, the RBCs will be rigidified
and their dynamic behavior in narrow constrictions, relative to deformability and velocity, will be
compared to healthy RBCs. The evaluation of the RBCs’ velocity and deformability will be performed
in a set of microchannels with abrupt constrictions, followed by abrupt expansions [25]. This approach
takes advantage of the potential of these sudden geometrical contractions to deform the cells due to
shear and extensional flows. The cells’ behavior will be captured by a setup comprising a high-speed
camera and a microscope, and the obtained images will be processed in two software tools (ImageJ and
PIVLab) for determining both the RBCs’ deformability and the RBCs’ velocities, as well as determining
the relationship between those properties.
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2. Materials and Methods
This section presents the materials and samples used to perform the experimental assays, as
well as the description of the microchannel fabrication method, experimental setup, and image
processing techniques. In brief, RBC samples with low concentration (low hematocrit) will be
exposed to glutaraldehyde, diamide, or glucose and will be tested in polydimethylsiloxane (PDMS)
microchannels that comprise 8 μm widths abrupt contractions. The ability of the RBCs to flow through
the microchannels contractions will be assessed.
2.1. Microchannels Fabrication
A polydimethylsiloxane (PDMS) microfluidic device was microfabricated by soft lithography
techniques, using SU-8 molds (SU-8 purchased from Microchem Corporation, Westborough, MA,
USA) [33,34]. PDMS (Sylgard 184 Silicone Elastomer kit obtained from Dow Corning, Midland, MI,
USA) was chosen due to its transparency that is required for microscope visualization, easy fabrication,
and low-cost for prototypes. The PDMS microchannels have a 25 μm height in order to reduce the
flow volume and the number of RBCs within the microchannels, also making it easier to observe the
RBCs. Each microchannel is composed by a linear transition zone followed by an abrupt contraction
(at a 90◦ angle) with 8 μm width and 780 μm length (seen in Figure 1), designed to force the RBCs to
deform and gain velocity when crossing it. The width of the contractions mimics capillary vessels with
the same average dimensions of the RBCs (around 8 μm).
Figure 1. (a) 2D masks for microchannel fabrication. The narrow contractions in the central region of
the microchannels have 8 μm width; (b) polydimethylsiloxane (PDMS) microchannels with a 12.8 mm
total length; (c) Detail of the entrance of the 8 μm width contraction of the PDMS microchannel;
(d) Detail of the outlet of the 8 μm width contraction of the PDMS microchannel. Magnification: 40×.
2.2. Samples
For the in vitro assays, samples containing human RBCs (hematocrit = 0.5%) in Dextran40
(Dx40) were used. Human RBCs have a biconcave shape and typical diameters in the 6–8 μm range,
being highly deformable.
The healthy human whole blood samples were taken from a female volunteer and provided
by Instituto Politécnico de Bragança (Bragança, Portugal). All procedures for the blood collection,
transport, and in vitro experiments were carried out in compliance with the EU directives 2004/23/CE,
2006/17/CE, and 2006/86/CE and approved by the Unidade Local de Saúde do Nordeste (Bragança,
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Portugal). In order to evaluate the RBCs’ deformability and velocity in the microchannels, the RBCs
were separated from the other blood constituents through centrifugation (15 min, 2000 rpm, at room
temperature). After that, RBCs were re-suspended and washed twice in a physiological solution
(PSS) (from B. Braun Medical, Melsungen, Germany) with a NaCl concentration of 0.9%. The Dx40
solution, where the RBCs were suspended, was used as a plasma-volume expander to prevent RBC
sedimentation and maintain the ideal osmotic physiological conditions for the RBCs. This solution
was synthetically produced by mixing 68 μL of CaCl2 with 201 μL of KC, 7.35 mL of NaCl, and 5 g of
Dx40 (for 1 M solution) (all reagents purchased from Sigma-Aldrich, St. Louis, MO, USA). The 0.5%
hematocrit, representing a 0.5% volume of RBCs in 5 mL of Dx40, was considered in order to assure
that the RBCs are isolated when crossing the microchannel contraction. Although the 0.5% hematocrit
is significantly lower than the physiological one, it was decided to study diluted samples, to improve
the visualizations and measurements of each individual RBC and, as a result, to avoid effects such as
interactions and aggregation of RBCs. Preliminary tests performed with hematocrit values ranging
from 0.5% up to 2% have shown that as the concentration of RBCs was increased, it was difficult to
individually follow the RBCs and, consequently, to measure the RBCs’ velocity and deformation index.
Hence, the current study was performed with a hematocrit of 0.5%.
The RBC samples were then modified with glucose (COPAN Diagnostics Inc., Murrieta, CA,
USA), glutaraldehyde (Sigma-Aldrich Corporation, St. Louis, MO, USA), and diamide (Sigma-Aldrich
Corporation, St. Louis, MO, USA) solutions, in order to rigidify the cells at different levels.
These chemicals were selected since they are commonly used to perform deformability studies,
are accessible, and have simple preparation protocols, as well as they allow one to rigidify the
cells at different levels, according to the added concentration. To modify the RBCs with glucose,
four different concentrations of glucose were considered: 2%, 5%, 10%, and 20% (v/v). First, glucose
(powder) was diluted in a phosphate buffered saline solution (PBS: pH 7.4). Then, the RBCs (already
separated from the other blood constituents and suspended in Dx40) were incubated for 20 min, at
room temperature, at each of the referred glucose concentrations. The cells were then washed in PSS
to remove the excess of glucose from the samples and re-suspended in Dx40. To modify the cells
with glutaraldehyde, at 0.00625%, 0.0125%, 0.025%, and 0.08% glutaraldehyde concentrations (v/v),
the RBCs (already separated from the other blood constituents and suspended in Dx40) were incubated
for 10 min at each of the referred concentrations, washed in PSS, re-suspended in Dx40, and used right
away. The RBCs were also modified with diamide, at 0.00625%, 0.0125%, 0.025%, 0.08%, 0.32%, and 1%
diamide concentrations (v/v), using the same protocol: Incubation for 10 min at each of the referred
concentrations, washing in PSS, and re-suspension in Dx40.
2.3. Experimental Setup
The cells’ deformability and velocity assays were performed with an experimental setup
comprising the microfluidic device placed on the stage of an inverted microscope (IX71; Olympus
Corporation, Tokyo, Japan). A flow rate of 5 μL/min was controlled using a syringe pump system
(KD Scientific Inc., Holliston, MA, USA). For selecting the ideal flow rate, preliminarily studies were
performed for four different flow rates (0.1, 1, 3, and 5 μL/min) and no significant differences were
observed in the cells’ deformability. Additionally, it was observed that the syringe pump system
presented more stability for the highest tested flow rate, i.e., the 5 μL/min. The images of the RBCs
were captured using a high-speed camera (Fastcam SA3, Photron, Motion Engineering Company,
Westfield, IN, USA) at a 2000 frames/s rate and exported to a computer to be analyzed. Each assay
was repeated 3 times.
2.4. Image Processing and Analysis Techniques
The images exported from the high-speed camera to the computer were analyzed using two
software tools: ImageJ [35] and PIVLab [36,37]. For each assay, a sequence of 10,000 frames was
considered. ImageJ was used to perform the pre-treatment of the acquired frames, in order to remove
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the noise and image artifacts, as well as convert them into binary images. Initially, the image sequence
was imported and the crop function was executed to define the region of interest (ROI) as a rectangle
with 308 μm × 332 μm dimension (Figure 2a). Then, by using the Z-Project function, the selected
frames were stacked to determine an average of the frames. This averaged frame was subtracted
from all the frames under analysis, eliminating all static objects, which resulted in frames comprising
only the visible RBCs, without any additional information. Finally, by using a threshold function,
the images were converted into binary images. The ImageJ software was also used to measure the cells
size in order to calculate the RBCs’ deformation index (DI). Using the ROI Manager and the Measure
functions, it was possible to follow both the healthy and the impaired RBCs (example in Figure 2b)
and calculate their DI along the microchannel, using the expression: DI = (X − Y)/(X + Y), where X
and Y represent the largest (X) and the smallest (Y) axis of the ellipse correspondent to the RBC under
analysis. Typically, the RBCs’ DI varies between 0 and 0.8, where 0 represents non-deformed cells
and 0.8 represents cells at maximum elongation. For each assay, a group of RBCs was followed at the
entrance and at the outlet of the contraction to measure their DI and determine an averaged value.
Figure 2c presents the area at the entrance and at the outlet of the microchannel contraction (the areas
inside the dashed lines in Figure 2c), where the deformability of the RBCs is measured. These areas
were chosen after performing preliminary observations of the RBC flows. For the entrance of the
contraction, a 121 μm × 237 μm region of interest was selected, since it is in this area that the RBCs
experience the highest extensional flow and consequently start to deform to enter the narrowing.
For the outlet, in the region immediately after exiting the contraction, the RBCs are at maximum
deformation, and outside that region, the cells start to recover their original shape. Then, for assuring a
standard area at the outlet for all assays, an 86 μm × 142 μm region of interest was selected. It should
be noted that the evaluation area at the outlet of the contraction is significantly smaller than at the
entrance. This difference is explained by the authors’ intention, in future devices and prototypes,
of integrating micro-sensors in the outlet of the contraction (occupying the smallest area possible)
and, therefore, in this work it was expected to obtain relevant data from a small area of evaluation in
the outlet.
In order to determine the average of the velocity values of the RBCs at the entrance and at the
outlet of each contraction, the sequence of frames was analyzed using the PIVLab image analysis
toolbox, integrated in MATLAB. First, the pre-treated images were imported into the software and
calibrated (relatively to their dimensions and time between frames), and a ROI mask was applied to
remove the areas where there are no RBCs. Following, the motion of the particles between the frames
was analyzed and the instantaneous velocities were calculated by the variation of the distance traveled
by the RBCs between each time step. Then, the average velocity vectors (Ux and Uy) were calculated
in the x and y directions and the velocity field of each sample (Uxy) was determined based on the
equation: |Uxy| = sqrt (Ux2 + Uy2). Finally, a filter was applied to smooth the images and remove
the high frequencies, which could indicate spikes of velocity without physical significance. Figure 2d
presents an example of the velocity field distribution at the entrance of the contraction. It is possible
to observe that the velocity of the RBCs is significantly higher in the zone of the narrowing entrance,
reasoning that the abrupt transition causes an increase of the velocity of the RBCs. Note that, due
to limitations of the available equipment, it was not possible to acquire frames with RBCs moving
at high velocity in the interior of the microchannel contraction. As a result, almost no cells were
registered in that region, explaining the 0 velocity in the interior of the contraction in the PIVLab
image (Figure 2d), this way the results section will approach and compare the DI and velocity of the
RBCs at the entrance and outlet of the contractions, neglecting the study of cells inside the contraction
regions. Note that both RBC deformability and velocity are measured in the same area (as defined in
Figure 2c, left and right) in order to establish a relation between the RBCs’ deformability and their
velocity. After obtaining the velocity distribution immediately before the entrance and after the outlet
of the contraction, a criterion for determining the RBCs’ velocity was defined (as presented in the
Results Section 3): From the region of interest (Figure 2c, left and right), where the velocities are higher,
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the 100 pixels with highest velocity (obtained in PIVLab) were selected and those velocities were
averaged, neglecting the surrounding areas with lowest velocities.
Additional details on the ImageJ and PIVLab procedures for the determination of RBC
deformability and velocity can be found in [25].
Figure 2. (a) Example of a cut-off of a transfer zone (308 μm × 332 μm) in the entrance of the
microchannel contraction, using the crop function of ImageJ; (b) Example of a tracked red blood
cell (RBC) at the outlet of the microchannel contraction, using ImageJ, where the dashed line
represents a region where the RBCs expand after the outlet (relaxation area); (c) Definition of the
areas (inside the dashed lines) for measuring the RBCs’ deformability and velocity at the entrance
(left—121 μm × 237 μm region) and at the outlet (right—86 μm × 142 μm region) of the microchannel
contraction (Magnification: 40×); (d) Example of the velocity distribution, obtained with PIVLab,
of healthy RBCs (non-modified) at the entrance of the microchannel contraction (the arrows indicate
the flow direction in each frame). Note that, due to limitations of the available equipment (frame rate
acquisition), it was not possible to acquire frames with RBCs moving at high velocity in the interior of
the microchannel contraction and, as a result, no cells were registered in that region, explaining the
0 velocity in the image.
3. Results and Discussion
This section presents the deformability and velocity results (obtained as in Section 2.4) of
the comparison between healthy and chemically modified RBCs with glucose, glutaraldehyde,
and diamide. All the presented results are an average of three assays. For each assay, a sequence
of 10,000 frames was considered and around 10 RBCs were followed to measure their DI. Figure 3
shows examples of RBCs from different assays at the entrance and at the outlet of the contraction
in the PDMS microchannel, for different percentages of glucose, considering a 5 μL/min flow rate,
and for a healthy RBC sample (for control—0% glucose). From Figure 3a, it is possible to detect a
difference between RBC deformability as the glucose percentage increases, i.e., the RBCs change from
a deformed/stretched shape to a non-deformed shape, as the cells have more difficulties to deform
and tend to keep their original shape.
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Figure 3. (a) Examples of healthy RBCs and RBCs modified with different glucose percentages at the
entrance and at the outlet of the microchannel contraction, extracted from three assays; (b) Healthy
RBCs (red arrow, left) deforming at the entrance of the contraction (green arrow, left), leaving the
contraction still deformed (green arrow, right), and recovering their original shape following the
outlet on an expansion area (red arrow, right); (c) 10% glucose-modified RBCs (red arrow, left) with
almost no deformation at the entrance of the contraction (green arrow, left) and leaving the contraction
(green arrow, right), recovering their original shape on an expansion area (red arrow, right). The black
arrows indicate the flow direction.
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These results suggest that the glucose concentration affects the RBCs’ deformability, in agreement
with several past studies regarding the influence of glucose over RBC deformability [31,32].
The increase of glucose (hyperglycemia) in RBCs causes damage in the RBCs’ membranes and increases
the blood viscosity, also increasing the cells’ aggregation, which leads to a significant decrease on the
RBCs’ DI. When the RBCs were modified with glutaraldehyde or diamide, the results were similar
to the ones observed for glucose (shown in Figure 3), and, therefore, only the glucose images are
presented. Following the outlet of the microchannel contraction, the RBCs start to recover their shape,
again decreasing their deformation index, as shown in Figure 3b,c, for an assay with healthy RBCs and
one assay with 10% glucose-modified RBCs.
Figure 4 presents the DI for healthy and modified RBCs (with glucose, glutaraldehyde,
and diamide), at the entrance and at the outlet of the microchannel 8 μm contraction, as well as
at the relaxation area (see Figure 2b), for the 5 μL/min flow rate.
The results show that, as the percentage of glucose, glutaraldehyde, or diamide increases, the cells
tend to become more rigid, decreasing their DI [29]. While the healthy cells deformed at the entrance of
the contraction to pass throughout the contraction and then recovered their initial shape after reaching
the microchannel expansion area, the modified RBCs did not deform and some aggregation of the
cells was observed, increasing the difficulty to cross the contraction. At the outlet of the contraction,
where the deformability was measured, the RBCs tend to start to recover their original shape, which is
verified in Figure 4: The RBCs at the outlet have lower DI than at the entrance of the contraction.
As the rigidity of the cells increases, the difference between the DI at entrance and at the outlet of the
contraction decreases. Since the evaluation regions at entrance and at the outlet have a different total
area (as defined in Figure 2c), it may also help to explain the hysteresis in the results between entrance
and outlet (the entrance evaluation area is larger than the outlet evaluation area).
Table 1 presents the differences between the averaged RBC deformability at the entrance of
the contraction and at the relaxation area, for all the tested conditions. This allows us to observe
the cells’ maximum deformability, passing from their deformed shape entering the contraction,
until their recovered shape after relaxation. The results show that, as the rigidity of the cells increases,
the difference in the deformability between the entrance and the relaxation area (ΔDI) decreases,









Figure 4. Deformation index (DI) and error bars for healthy and (a) glucose-, (b) glutaraldehyde-,
and (c) diamide-modified RBCs, at the entrance (blue series), at the outlet (orange series) and at the
relaxation area (green series) of the microchannel contraction and trend lines. In (b), the X represents
the clogging of the microchannel, with no deformability or velocity data. Each point of the plots is the
average of 30 RBCs (three assays for each condition and 10 RBCs followed in each assay).
Table 1. Difference of the deformation index (ΔDI) between red blood cell (RBC) deformability at
the entrance of the contraction (Figure 2c, left) and at the relaxation area (Figure 2b) for all the tested
conditions, obtained from the data presented in Figure 4.
Sample Concentration (%) ΔDI
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It was also observed that, for 0.08% (v/v) glutaraldehyde-modified RBCs, the rigidified cells
clogged the entrance of the contraction and no deformability or velocity data could be extracted (this is
represented by X in Figure 4b). Therefore, for a high concentration of glutaraldehyde, it was unable to
measure the transiting velocity of the cells. Figure 5 presents an example of clogging at the entrance of
the contraction, when the RBCs were modified with a 0.08% (v/v) concentration of glutaraldehyde.
 
Figure 5. Detail of clogging at the entrance of the 8 μm contraction when the RBCs were modified with
a 0.08% (v/v) concentration of glutaraldehyde.
Elevated blood glucose in the RBCs alters RBC membrane proteins through glycosylation and
oxidation. Glutaraldehyde penetrates into cell membranes and non-specifically cross-links the cytosol,
the cytoskeletal, and the transmembrane proteins, acting on all components of the cell and increasing
the effective viscosity of the cytoplasm and lipid membrane. Diamide is a spectrin-specific cross-linker,
oxidizing thiol groups while forming disulfide bonds within the structural region [30]. The obtained
results indicate that viscous effects in the cytoplasm and/or lipid membrane are a dominant factor
when dictating dynamic responses of RBCs in pressure-driven flows, explaining the higher effect of
the glutaraldehyde in damaging the RBCs and the microchannel clogging, when compared to diamide
and glucose [30].
Figure 6 presents the average cell velocity for healthy and modified RBCs (with glucose,
glutaraldehyde, and diamide), at the entrance and at the outlet of the microchannel 8 μm contraction,
for the 5 μL/min flow rate.
Overall, the results agree with those of deformability. When the average velocity at the
high velocity regions was evaluated, it was found that the impaired RBCs (by adding glucose,
glutaraldehyde, or diamide) presented lower velocities than healthy RBCs, indicating that the increase
of the RBCs’ rigidity causes the non-deformed cells to follow streamlines that on average have lower
velocity, while the stretched and healthy RBCs follow streamlines that on average have higher velocity.
Supplementary material videos show how the cells gain velocity when entering the contraction,
explaining the higher velocity immediately at the outlet of the contraction (when compared to the
velocity at the entrance), before starting to relax and recover their original shape. Similarly to the
deformability results, for 0.08% (v/v) glutaraldehyde-modified RBCs, the rigidified cells clogged at the
entrance of the contraction and, as a result, no velocity data could be extracted (this is represented by
X in Figure 6b).
Additionally, it would be interesting to quantitatively study the relation between deformation
index and velocity inside the microchannel contraction, besides the data presented at entrance and
outlet (Figures 4 and 6). However, due to technical limitations of the high speed acquisition system,
it was not possible to acquire an enough number of RBCs with high quality contrast to perform
the measurements of RBC deformability and velocity with the software tools referred in Section 2.
Despite that limitation, some RBCs could still be observed within the contraction. Examples of RBCs
(healthy, with 0.025% diamide, and with 10% glucose) flowing within the contraction are shown in
Figure 7.
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Figure 6. Velocity (mm/s) and error bars for healthy and (a) glucose-, (b) glutaraldehyde-, and (c)
diamide-modified RBCs, at the entrance (blue series) and at the outlet (orange series) of the
microchannel contraction and trend lines. In (b), the X represents the clogging of the microchannel,
with no deformability or velocity data.
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Figure 7. Examples of healthy RBCs, RBCs modified with 0.025% diamide, and RBCs modified with
10% glucose inside the 8 μm width microchannel contraction, at different areas (entrance and outlet of
the contraction).
A qualitative analysis of the presented results shows that healthy RBCs cross the microchannel
contraction in a more deformed shape than the 0.025% diamide and 10% glucose samples, and the
10% glucose samples are less deformable than the 0.025% diamide ones, which corroborates the
quantitative results (before the entrance and after the outlet) presented in Figure 6. Supplementary
material presents videos of healthy and modified RBCs flowing at the entrance and at the outlet of
the contraction, allowing a better observation of the RBCs’ behavior at the different regions of the
microchannel contraction.
Since one of the main objectives of this work was to establish a relation between the RBCs’
deformability and their velocity, Figure 8 presents the velocity vs DI calibration curves for glucose-,
glutaraldehyde-, and diamide-modified RBCs at the entrance and at the outlet of the microchannel
contraction. This figure purpose is to show the dispersion that occurs between the cells. Therefore,
instead of presenting all RBCs averaged together (as in Figures 4 and 6), it is intended to evaluate
how each small group of cells fits the deformability vs velocity curve, in order to understand their
individualized behavior. Therefore, from the performed assays, the RBCs were gathered in groups of
three cells measured under the same conditions and their average was calculated (each blue dot of the
plots). Consequently, each plot of Figure 8 gathers data from a high number of RBCs (three RBCs ×
number of dots in each plot, leading to a range of RBCs between 3 × 16 = 48 in Figure 8d and
3 × 28 = 84 in Figure 8e), measured in the areas defined in Figure 2.
Based on the results, it is observed that, overall and as expected, for all synthetically modified
RBCs, an increase of cell deformation index leads to an increase of the cells’ velocity, both at the entrance
and at the outlet of a microchannel contraction. When comparing the velocity with the deformability
correlation at entrance and at outlet, it is clear, for all the tested methods, that the results at the outlet
present a better fitting to the linear tendency curve than at the entrance (based on the R2 values).
Therefore, in the future, when advancing for a diagnostic tool, the analysis must be performed at the
outlet of the contraction (the place to integrate a sensor), where the RBCs’ behavior is more reliable.
Additionally, our results indicate that diamide is the most interesting approach for mimicking the
malaria effects on RBCs with the intention of exploring sensor applications, as the velocity vs DI results
show a better fitting to the linear tendency curve (R2 = 0.89) and, consequently, it is easier to control
the velocity vs deformability curve. These results are a promising step to help the development of
integrated sensors in microfluidic devices that allow the design of an autonomous malaria detection
system of high sensitivity, precise, low-cost, portable, and with low energy consumption.
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Figure 8. Velocity (mm/s) vs. deformability (a.u.) curve, measured at the entrance and at the outlet
of the 8 μm contraction, for the RBC samples modified with (a) at entrance; glucose, (b) at outlet;
glucose (c) at entrance; glutaraldehyde; (d) at outlet; glutaraldehyde, (e) at entrance; diamide, and (f)
at outlet; diamide.
4. Future Perspectives
Future works will include an increase in cell quantity in order to define the average property
of the entire cell population with higher accuracy, since the physical properties of individual RBCs
within the same RBC population can vary significantly [38]. Additionally, since the ultimate goal
is to develop a clinical tool, more blood samples from different donors will be assessed to increase
the RBCs’ variability and to include more independent data. It is also planned to improve our high
speed video microsystem, allowing the capture of good enough quality images to quantitatively
measure both velocity and deformability of the RBCs flowing across the microchannel contraction.
This improvement will allow to develop an improved association between RBC deformability and
transiting velocity through the narrow constrictions. Finally, after obtaining an improved correlation
with synthetically modified samples, it is intended to test real parasite-affected RBC samples [39] to
measure their deformability and velocity, compare disease and artificially impaired RBCs, establish
target values, and fully validate the proposed approach. This improved correlation will be used to
relate the RBCs’ behavior according to the various stages of malaria and to develop integrated sensors
in microfluidic devices for RBC velocity measurements.
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5. Conclusions
This work has investigated the deformability and the velocity of healthy and chemically
modified RBCs, attempting to mimic the effect of malaria in RBCs and to establish a relation
between RBCs’ velocity and deformability. The glucose, glutaraldehyde, and diamide effect in the
RBCs was compared using PDMS microchannels with 8 μm narrow contractions that forced the
RBCs to undergo deformation when they passed through them. It was concluded that, by adding
glucose, glutaraldehyde, or diamide, the RBC membrane tends to become stiffer, decreasing the cell’s
deformability and, consequently, decreasing the cell shape recovery capacity. Additionally, when the
RBCs’ rigidity increased, the RBCs’ velocity decreased.
When the relation between deformability and velocity was evaluated, it was concluded that,
for all synthetically modified RBCs, an increase of the cells’ deformation index led to an increase
of the cells’ velocity. It was also verified that diamide was the most interesting approach to impair
the cells and mimic the malaria effects on RBCs, as the velocity vs deformation index results have
showed the best fitting to the linear tendency curve and, consequently, it would be easier to control the
deformability and velocity of the cells based on this method.
Despite still being a challenge, this work will be a valuable contribution to help establishing
the development of simple, reagent-free, inexpensive, and accurate new malaria diagnostic systems
towards point-of-care devices.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-666X/9/8/384/s1,
Video S1: 10% glucose RBCs at the entrance of the contraction, Video S2: 10% glucose RBCs at the outlet of the
contraction, Video S3: Healthy RBCs at the entrance of the contraction, Video S4: Healthy RBCs at the outlet of
the contraction.
Author Contributions: Conceptualization, R.L. and S.O.C.; Methodology, R.L. and S.O.C.; Validation, R.L., J.M.M.,
C.S.V.F. and G.M.; Investigation, L.V.B. and V.F.; Data Analysis, L.V.B. and V.F.; Writing-Original Draft Preparation,
S.O.C.; Writing-Review & Editing, S.O.C., R.L., J.M.M., C.S.V.F. and G.M.; Supervision, C.S.V.F. and S.O.C.
Funding: This work results of the project NORTE-01-0145-FEDER-028178, MalariaChip, supported by
Programa Operacional Regional do Norte—Norte Portugal Regional Operational Programme (NORTE 2020),
under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund
(ERDF) and by Fundação para a Ciência e Tecnologia (FCT), IP. Work also supported by Fundação para a
Ciência e Tecnologia (FCT) with the reference project UID/EEA/04436/2013, by FEDER funds through the
COMPETE 2020—Programa Operacional Competitividade e Internacionalização (POCI) with the reference
project POCI-01-0145-FEDER-006941; and by project POCI-01-0145-FEDER-016861 (with associated reference
PTDC/QEQ-FTT/4287/2014). S.O. Catarino thanks the FCT for the SFRH/BPD/108889/2015 grant, supported
by national funds from Ministérios da Ciência, Tecnologia e Ensino Superior and by FSE through the
POCH—Programa Operacional Capital Humano.
Acknowledgments: The authors would like to thank Diana Pinho from the IP Bragança for providing the blood
samples and for the support in the experimental tests.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. WHO. Malaria World Report; World Health Organization: Geneva, Switzerland, 2016.
2. WHO. Malaria Rapid Diagnostic Test Performance: Results of WHO Product Testing of Malaria RDTs; World Health
Organization: Geneva, Switzerland, 2017.
3. Wongsrichanalai, C.; Barcus, M.J.; Muth, S.; Sutamihardja, A.; Wernsdorfer, W.H. A review of malaria
diagnostic tools: Microscopy and rapid diagnostic test (RDT). Am. J. Trop. Med. Hyg. 2007, 77, 119–127.
[PubMed]
4. Lucchi, N.; Ljolje, D.; Silva-Flannery, L.; Udhayakumar, V. Use of malachite green-loop mediated isothermal
amplification for detection of Plasmodium spp. parasites. PLoS ONE 2016, 11, e0151437. [CrossRef] [PubMed]
5. QuantuMDx. Available online: http://quantumdx.com/applications/malaria (accessed on 1 March 2018).
6. Saha, R.; Karmakar, S.; Roy, M. Computational investigation on the photoacoustics of malaria infected red
blood cells. PLoS ONE 2012, 7, e51774. [CrossRef] [PubMed]
81
Micromachines 2018, 9, 384
7. Diez-Silva, M.; Dao, M.; Han, J.; Lim, C.T.; Suresh, S. Shape and biomechanical characteristics of human red
blood cells in health and disease. MRS Bull. 2010, 35, 382–388. [CrossRef] [PubMed]
8. Handayani, S.; Chiu, D.T.; Tjitra, E.; Kuo, J.S.; Lampah, D.; Kenangalem, E.; Russell, B. High deformability of
Plasmodium vivax-infected red blood cells under microfluidic conditions. J. Infectious Dis. 2009, 199, 445–450.
[CrossRef] [PubMed]
9. Shelby, J.P.; White, J.; Ganesan, K.; Rathod, P.K.; Chiu, D.T. A microfluidic model for single-cell capillary
obstruction by Plasmodium falciparum-infected erythrocytes. Proc. Natl. Acad. Sci. USA 2003, 100, 14618–14622.
[CrossRef] [PubMed]
10. How, T.V.; Black, R.; Hughes, P. Hemodynamics of vascular prostheses. In Advances in Hemodynamics and
Hemorheology; How, T.V., Ed.; Elsevier: Amsterdam, The Netherlands, 1996; Volume 1, pp. 373–423.
11. Tomaiuolo, G. Biomechanical properties of red blood cells in health and disease towards microfluidics.
Biomicrofluidics 2014, 8, 051501. [CrossRef] [PubMed]
12. Johnson, R.M. Ektacytometry of red blood cells. Methods Enzymol. 1989, 173, 35–54. [PubMed]
13. Lim, C.; Dao, M.; Suresh, S.; Sow, C.; Chew, K. Large deformation of living cells using laser traps. Acta Mater.
2004, 52, 1837–1845. [CrossRef]
14. Grier, D.G. A revolution in optical manipulation. Nature 2003, 424, 810–816. [CrossRef] [PubMed]
15. Hochmuth, R. Micropipette aspiration of living cells. J. Biomech. 2000, 33, 15–22. [CrossRef]
16. Rodrigues, R.O.; Pinho, D.; Faustino, V.; Lima, R. A simple microfluidic device for the deformability
assessment of blood cells in a continuous flow. Biomed. Microdevices 2015, 17, 108. [CrossRef] [PubMed]
17. Zhao, R.; Antaki, J.F.; Naik, T.; Bachman, T.N.; Kameneva, M.V.; Wu, Z.J. Microscopic investigation of
erythrocyte deformation dynamics. Biorheology 2006, 43, 747–765. [PubMed]
18. Yaginuma, T.; Oliveira, M.S.N.; Lima, R.; Ishikawa, T.; Yamaguchi, T. Human red blood cell behavior
under homogeneous extensional flow in a hyperbolic shaped microchannel. Biomicrofluidics 2013, 7, 054110.
[CrossRef] [PubMed]
19. Faustino, V.; Pinho, D.; Yaginuma, T.; Calhelha, R.C.; Ferreira, I.C.; Lima, R. Extensional flow-based
microfluidic device: Deformability assessment of red blood cells in contact with tumor cells. BioChip J. 2014,
8, 42–47. [CrossRef]
20. Lee, S.S.; Yim, Y.; Ahn, K.H.; Lee, S.J. Extensional flow-based assessment of red blood cell deformability
using hyperbolic converging microchannel. Biomed. Microdevices 2009, 11, 1021–1027. [CrossRef] [PubMed]
21. Bento, D.; Rodrigues, R.O.; Faustino, V.; Pinho, D.; Fernandes, C.S.; Pereira, A.I.; Garcia, V.; Miranda, J.M.;
Lima, R. Deformation of red blood cells, air bubbles, and droplets in microfluidic devices: Flow visualizations
and measurements. Micromachines 2018, 9, 151. [CrossRef]
22. Hou, H.; Hou, H.W.; Bhagat, A.A.S.; Chong, A.G.L.; Mao, P.; Tan, K.S.W.; Han, J.; Lim, C.T. Deformability
based cell margination—A simple microfluidic design for malaria-infected erythrocyte separation. Lab Chip
2010, 10, 2605–2613. [CrossRef] [PubMed]
23. Passos, A.; Sherwood, J.; Agrawal, R.; Pavesio, C.; Balabani, S. The effect of RBC stiffness on
microhaemodynamics. In Proceedings of the 5th Micro and Nano Flows Conference, Milan, Italy, 11–14
September 2016.
24. Chien, S. Red blood cell deformability and its relevance to blood flow. Ann. Rev. Physiol. 1987, 49, 177–192.
[CrossRef] [PubMed]
25. Vilas Boas, L.; Lima, R.; Minas, G.; Fernandes, C.S.; Catarino, S.O. Imaging of healthy and malaria-mimicked
red blood cells in polydimethylsiloxane microchannels for determination of cells deformability and flow
velocity. In VipIMAGE—ECCOMAS 2017. Lecture Notes in Comp. Vision and Biomechanics; Tavares, J.,
Natal Jorge, R., Eds.; Springer: New York, NY, USA, 2018; pp. 915–922.
26. Kaneko, M.; Ishida, T.; Tsai, C.D.; Ito, H.; Chimura, M.; Taniguchi, T.; Ohtani, T.; Sakata, Y. On-Chip RBC
Deformability Checker Embedded with Vision Analyzer. In Proceedings of the 2015 IEEE International
Conference on Mechatronics and Automation, Takamatsu, Japan, 6–9 August 2017; pp. 2005–2010.
27. Tsai, C.D.; Tanaka, J.; Kaneko, M.; Horade, M.; Ito, H.; Taniguchi, T.; Ohtani, T.; Sakata, Y. An On-Chip RBC
Deformability Checker Significantly Improves Velocity-Deformation Correlation. Micromachines 2016, 7, 176.
[CrossRef]
28. Jeong, J.H.; Sugii, Y.; Minamiyama, M.; Okamoto, K. Measurement of RBC deformation and velocity in
capillaries in vivo. Microvasc. Res. 2006, 71, 212–217. [CrossRef] [PubMed]
82
Micromachines 2018, 9, 384
29. Rodrigues, R.O.; Faustino, V.; Pinto, E.; Pinho, D.; Lima, R. Red Blood Cells deformability index assessment
in a hyperbolic microchannel: The diamide and glutaraldehyde effect. Webmed Cent. Biomed. Eng. 2013, 4,
WMC004375.
30. Forsyth, A.M.; Wan, J.; Ristenpart, W.D.; Stone, H.A. The dynamic behavior of chemically “stiffened” red
blood cells in microchannel flows. Microvasc. Res. 2010, 80, 37–43. [CrossRef] [PubMed]
31. Babu, N.; Singh, M. Influence of hyperglycemia on aggregation, deformability and shape parameters of
erythrocytes. Clin. Hemorheol. Microcirc. 2004, 31, 273–280. [PubMed]
32. Shin, S.; Ku, Y.H.; Suh, J.S.; Singh, M. Rheological characteristics of erythrocytes incubated in glucose media.
Clin. Hemorheol. Microcirc. 2008, 38, 153–161. [PubMed]
33. Pinto, V.C.; Sousa, P.J.; Cardoso, V.F.; Minas, G. Optimized SU-8 Processing for Low-Cost Microstructures
Fabrication without Cleanroom Facilities. Micromachines 2014, 5, 738–755. [CrossRef]
34. Faustino, V.; Catarino, S.O.; Lima, R.; Minas, G. Biomedical microfluidic devices by using low-cost fabrication
techniques: A review. J. Biomech. 2016, 49, 2280–2292. [CrossRef] [PubMed]
35. Abramoff, M.; Magalhães, P.; Ram, S. Image processing with ImageJ. Biophotonics Int. 2004, 11, 36–42.
36. Thielicke, W.; Stamhuis, E.J. PIVlab—Towards User-friendly, Affordable and Accurate Digital Particle Image
Velocimetry in MATLAB. J. Open Res. Softw. 2014, 2, e30. [CrossRef]
37. Thielicke, W.; Stamhuis, E.J. PIVlab—Time-Resolved Digital Particle Image Velocimetry Tool for MATLAB.
Available online: https://figshare.com/articles/PIVlab_version_1_35/1092508 (accessed on July 2017).
38. Picot, J.; Ndour, P.A.; Lefevre, S.D.; El Nemer, W.; Tawfik, H.; Galimand, J.; Costa, L.D.; Ribeil, J.-A.;
Montalembert, M.d.; Brousse, V.; et al. A biomimetic microfluidic chip to study the circulation and mechanical
retention of red blood cells in the spleen. Am. J. Hematol. 2015, 90, 339–345. [CrossRef] [PubMed]
39. Barber, B.E.; Russell, B.; Grigg, M.J.; Zhang, R.; William, T.; Amir, A.; Lau, Y.L.; Chatfield, M.D.;
Dondorp, A.M.; Anstey, N.M.; et al. Reduced red blood cell deformability in Plasmodium knowlesi malaria.
Blood Adv. 2018, 2, 433–443. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Multiple and Periodic Measurement of RBC
Aggregation and ESR in Parallel Microfluidic
Channels under On-Off Blood Flow Control
Yang Jun Kang 1,* and Byung Jun Kim 2
1 Department of Mechanical Engineering, Chosun University, 309 Pilmun-daero, Dong-gu,
Gwangju 61452, Korea
2 Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST),
Gwangju 61005, Korea; gene392@gist.ac.kr
* Correspondence: yjkang2011@chosun.ac.kr; Fax: +82-62-234-7055
Received: 16 May 2018; Accepted: 21 June 2018; Published: 24 June 2018
Abstract: Red blood cell (RBC) aggregation causes to alter hemodynamic behaviors at low flow-rate
regions of post-capillary venules. Additionally, it is significantly elevated in inflammatory or
pathophysiological conditions. In this study, multiple and periodic measurements of RBC aggregation
and erythrocyte sedimentation rate (ESR) are suggested by sucking blood from a pipette tip into
parallel microfluidic channels, and quantifying image intensity, especially through single experiment.
Here, a microfluidic device was prepared from a master mold using the xurography technique rather
than micro-electro-mechanical-system fabrication techniques. In order to consider variations of RBC
aggregation in microfluidic channels due to continuous ESR in the conical pipette tip, two indices
(aggregation index (AI) and erythrocyte-sedimentation-rate aggregation index (EAI)) are evaluated by
using temporal variations of microscopic, image-based intensity. The proposed method is employed
to evaluate the effect of hematocrit and dextran solution on RBC aggregation under continuous ESR
in the conical pipette tip. As a result, EAI displays a significantly linear relationship with modified
conventional ESR measurement obtained by quantifying time constants. In addition, EAI varies
linearly within a specific concentration of dextran solution. In conclusion, the proposed method
is able to measure RBC aggregation under continuous ESR in the conical pipette tip. Furthermore,
the method provides multiple data of RBC aggregation and ESR through a single experiment. A future
study will involve employing the proposed method to evaluate biophysical properties of blood
samples collected from cardiovascular diseases.
Keywords: red blood cell (RBC) aggregation; multiple microfluidic channels; master molder using
xurography technique; RBC aggregation index; modified conventional erythrocyte sedimentation
rate (ESR) method; regression analysis
1. Introduction
Normal red blood cell (RBC) in autologous plasma suspension tends to aggregate and form
rouleaux (i.e., stacks-of-coins) under extremely low shear-rate conditions [1,2]. This reversible process
is strongly dependent on several factors such as surface properties (membrane deformability and
negative surface charge), plasma proteins (fibrinogen and globulins), shear stress, and hematocrit [3].
Additionally, RBC aggregation is considered a key determinant of blood viscosity, because it contributes
to increasing blood viscosity at low shear rates. Thus, it causes to alter hemodynamic behaviors at
low flow-rate regions of post-capillary venules [4,5]. Furthermore, RBC aggregation is significantly
elevated in inflammatory or pathophysiological conditions [6,7]. As an indicator of RBC aggregation,
erythrocyte sedimentation rate (ESR) is quantified by measuring setting distance of RBCs in a vertical
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tube (inner diameter = 2.55 mm, length = 300 mm, and blood volume = 5 mL) for 1 h. In other
words, ESR is measured as the height of an RBC-depleted region (or plasma region) of a blood
sample in a vertical tube with a specific elapse of time (t) (t = 1 h). The ESR is widely used in clinical
medicine, because it is a simple and inexpensive method [6–12]. However, the method involves
several disadvantages such as large volume consumption (~2 mL) and long measurement time (~1 h).
Conversely, after blood flow in a microfluidic channel is agitated with external sources such as pressure
source [13], syringe pump [2,14], and pinch valve [3], RBC aggregation is immediately quantified by
constructing variations of image intensity [3,13–15], laser back-scattering [16], ultrasound signal [17],
or electrical impedance [18] with an elapse of time (i.e., syllectogram). Previously, our group suggests
the simple measurement method of ESR in the microfluidic device [15]. In other words, after setting
a disposable syringe into a syringe pump, the syringe pump is reversely aligned with respect to
gravitational direction. Then, blood is supplied from the top position of the syringe into a microfluidic
device. Hematocrit of blood supplied into a microfluidic channel decreases over time due to continuous
ESR in the disposable syringe. This variation in hematocrit is used to measure ESR by quantifying
image intensity of blood within a region-of-interest (ROI) of a microfluidic channel [15]. The method
is devised to monitor RBC-depleted region in a disposable syringe. However, it does not provide
sufficient information on RBC aggregation of blood in a microfluidic channel. According to a previous
study [17], RBC aggregation with microscopic, image-based intensity gave comparable value to RBC
aggregation, compared with the ultrasonic method and conventional ESR methods. Recently, a simple
method is devised to measure RBC aggregation under continuous ESR in a conical pipette tip [19].
According to the previous study [20], blood storage time at 25 ◦C should be limited to four hours for
RBCs aggregation. Above four hours, RBC aggregation was varied with an elapse of time. In other
words, when RBCs aggregation was varied over time, the repetitive test increased the scattering of
the aggregation index significantly. Thus, multiple measurements of RBC aggregation were required
to avoid large scattering due to repetitive tests being conducted for a long period of time. Thus, it is
effective to obtain several data points without repetitive tests. Specifically, RBC aggregation should be
quantified as mean ± standard deviation in single experiment with respect to an elapse of time. Thus,
it does not require repetitive tests, which cause rheological properties to vary continuously.
In this study, multiple measurements of RBC aggregation under continuous ESR are proposed
by sucking blood from a pipette tip into parallel microfluidic channels and quantifying image
intensity, especially throughout a single experiment. Furthermore, two indices (aggregation index
(AI), and erythrocyte-sedimentation-rate aggregation index (EAI) [19]) are evaluated to consider
variations in RBC aggregation due to continuous ESR in a conical pipette tip. The proposed
method is demonstrated by using a microfluidic device that is composed of an inlet port, an outlet
port, and identical-parallel-microfluidic channels. The microfluidic device is prepared from master
mold using xurography technique rather than MEMS (micro-electro-mechanical-system) fabrication
techniques. A pipette tip is fitted into the inlet port, and the outlet port is then connected to a disposable
syringe with a polyethylene tube. A disposable syringe is installed into a syringe pump. The syringe
pump is set to a constant flow rate and operates in the withdrawal mode. A pinch valve is installed
between the outlet port and a disposable syringe to control blood delivery from the pipette tip to a
microfluidic device. The blood flow stops or runs in parallel microfluidic channels when the pinch
valve is periodically clamped or released. The image intensity of blood in each microfluidic channel is
quantified to obtain several data points of RBC aggregation over an interval of time. Thus, the proposed
method measures several data points of RBC aggregation under continuous ESR in a single experiment
without requiring additional repetitive tests.
The feasibility of the proposed method is evaluated by conducting experimental tests with two
RBC aggregation indices such as EAI and AI. The EAI is applied to quantify RBC aggregation under
continuous ESR in conical pipette tip. Furthermore, AI as a conventional aggregation index is used to
compare EAI. In order to evaluate the performance of the proposed method, AI and EAI are quantified
for several blood samples (hematocrit = 20%, 30%, 40%, and 50%) that are prepared by adding normal
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RBCs into autologous plasma. In order to elevate RBC aggregation, blood samples are prepared using
normal RBCs with three different concentrations of dextran solution (Cdextran = 5 mg/mL, 15 mg/mL,
and 20 mg/mL). Subsequently, the proposed method is employed to quantify the effect of dextran
solution on the RBC aggregation under continuous ESR in the pipette tip.
2. Materials and Methods
2.1. Blood Sample Preparation
Blood samples were prepared by adding human RBCs to autologous plasma to evaluate RBC
aggregation and ESR. Concentrated RBCs and plasma were provided by the Gwangju-Chonnam Blood
Bank (Gwangju, Korea). In blood bank, RBCs were collected by removing plasma from whole blood.
Then, the RBCs were stored in anticoagulant citrate phosphate dextrose adenine solution (CPDA-1).
After concentrated RBCs packed within blood bag (~320 mL) were provided by blood bank, they were
immediately stored at 4 ◦C. To collect pure RBCs from the concentrated RBCs, blood sample was
prepared by adding concentrated RBCs (~8 mL) into 1× phosphate-buffered saline (PBS) solution (~8 mL).
By operating centrifugal separator, pure RBCs were collected by removing buffy layer and PBS from the
blood sample. This washing procedure was repeated three times. When blood storage time at 25 ◦C was
over four hours, RBC aggregation was varied with an elapse of time [20]. Thus, after blood samples were
prepared, they were stored at 4 ◦C before blood test. All experiments were finished within four hours.
According to the previous studies [21,22], blood biophysical properties including blood viscosity, and RBC
aggregation remained constant for up to 7 days of storage time. In other words, when storage time of RBCs
was over 7 days, the RBCs were removed. Hematocrits of normal blood (Hct = 20%, 30%, 40%, and 50%)
were adjusted by adding normal RBCs to autologous plasma. In order to elevate RBC aggregation in blood
samples, three different concentrations of dextran solution (Cdextran) (Cdextran = 5 mg/mL, 15 mg/mL,
and 20 mg/mL) were prepared by adding dextran (Leuconostoc spp., MW = 450–650 kDa, Sigma-Aldrich,
St. Louis, MO, USA) to a 1× PBS solution. Hematocrit of blood samples was adjusted to 30% by adding
normal RBCs into a specific dextran solution. A control blood sample (Cdextran = 0) was prepared by
adding normal RBCs into a 1× PBS solution.
2.2. Fabrication of a Microfluidic Device and Experimental Procedure
As shown in Figure 1A, a master mold was fabricated using a cutting plotter (i.e., xurography
technique) [23–26]. Here, an adhesive sheet with a thickness of 100 μm was employed for 100 μm
depth. A master mold was designed by using a commercial software program (AutoCAD 2014,
Autodesk, San Rafael, CA, USA) [Figure 1A-a]. A cutter blade (CE6000-40, Graphtec, Irvine, CA,
USA) was used to cut a cover of the adhesive sheet [Figure 1A-b]. The cover was peeled off from
a liner [Figure 1A-c]. The master mold was finally prepared by attaching the liner on a glass slide
[Figure 1A-d]. PDMS (polydimethylsiloxane) was mixed at a ratio of 10:1 with a curing agent, and the
mixture was poured on the master mold positioned in a Petri dish. The air bubbles dissolved in the
PDMS were completely removed by operating a vacuum pump for 1 h. The PDMS was cured in a
convection oven at temperature of 75 ◦C for 1.5 h, and the PDMS block was peeled off from the master
mold. Two biopsy punches were used, and the inlet port and outlet port was displayed through holes
with diameters of 1.5 mm and 0.75 mm, respectively. Following the simultaneous treatment of oxygen
plasma (CUTE-MPR, Femto Science Co., Gyeonggi, Korea) on the PDMS block and on a glass substrate,
the microfluidic device was prepared by bonding the PDMS block to the glass substrate.
A microfluidic device was mounted on an optical microscope (IX53, Olympus, Tokyo, Japan)
equipped with a 4× objective lens (numerical aperture (NA) = 0.1). As shown in Figure 1B, a pipette
tip that was tightly fitted into inlet port after a pipette tip (50–1000 μL, Eppendorf, Germany) was cut
approximately 34 mm from the top surface. The outlet port was connected to a disposable syringe
with a polyethylene tube. The flow rate was set to 2 mL/h (i.e., Q = 2 mL/h) at the withdrawal
mode. Blood (0.2 mL) was dropped into the pipette tip with a pipette. In order to avoid non-specific
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binding of plasma protein, microfluidic channels and the pipette tip were filled with 1% bovine serum
albumin (BSA) diluted with 1× PBS solution (pH 7.4, GIBCO, Life Technologies, Gangnam-gu, Korea)
for 20 min. The BSA solution was removed from the microfluidic device by releasing the pinch
valve. Subsequently, 0.2 mL of blood was dropped into the pipette tip, and it was ready to measure
RBC aggregation under continuous hematocrit variations. As shown in Figure 1C-d, a high-speed
camera (FASTCAM MINI, Photron, San Jose, CA, USA) was employed to capture blood flows in the
microfluidic channels. The spatial resolution of the camera corresponded to 1280 × 1000 pixels. Each
pixel corresponds to 10 μm. A function generator (WF1944B, NF Corporation, Tokyo, Japan) triggered
the high-speed camera at an interval of 1 s to sequentially capture two microscopic images at a frame
rate of 1 kHz. All experiments were conducted at a room temperature of 25 ◦C.
Figure 1. Details of a master mold using an adhesive sheet and a conical pipette tip, and schematic
diagram of a proposed method for quantifying red blood cells (RBCs) aggregation and erythrocyte
sedimentation rate (ESR) in a pipette tip. (A) Fabrication procedure for preparing an adhesive sheet for
a master mold. (A-a) A pattern of master mold designed with commercial software. (A-b) A cutter
blade to cut a cover of the adhesive sheet. (A-c) The cover was peeled off from a liner. (A-d) The master
mold was finally prepared by attaching the liner on a glass slide. (B) A pipette tip tightly fitted
into a microfluidic device. The pipette tip was prepared by cutting 34 mm from the top surface.
(C) A schematic diagram of the proposed method including a pipette tip, a disposable microfluidic
device, a pinch value, and a syringe pump. (C-a) A microfluidic device is composed of an inlet
port, an outlet port, and parallel microfluidic channels (N = 4, width = 600 μm, depth = 100 μm,
and length = 8 mm). (C-b) A pipette tip fitted into inlet port is filled with 0.2 mL blood. The outlet
port is connected to a disposable syringe (1 mL) with a polyethylene tube (inner diameter = 250 μm,
length = 600 mm). A disposable syringe is installed into the syringe pump. Flow rate is set to 2 mL/h
(i.e., Q = 2 mL/h) at the withdrawal mode. (C-c) A pinch valve was installed in front of the disposable
syringe to control blood flow in parallel microfluidic channels. A pinch valve was manually opened for
10 s (Topen = 10 s) and closed for 290 s (Tclose = 290 s) during a single period (T = 300 s). (C-d) Image
acquisition system including microscope, high-speed camera, and external trigger. (C-e) A specific
region-of-interest (ROI) (80 pixel × 400 pixel) for each microfluidic channel was selected to determine
average velocity (<U>i, <U>ii, <U>iii and <U>iv) and average image intensity (<I>i, <I>ii, <I>iii and
<I>iv), which were calculated by conducting time-resolved micro-particle image velocimetry (PIV)
technique and digital image processing, respectively.
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2.3. The Proposed Method for Quantifying RBCs Aggregation and ESR over Time
A simple measurement technique of RBC aggregation under continuous ESR is proposed by
sucking blood from a pipette tip into parallel microfluidic channels, and quantifying image intensity
of blood over an interval of time. Several data of RBC aggregation are obtained throughout a single
experiment at an interval of specific time duration.
Figure 1C shows a schematic diagram of the proposed method including a disposable microfluidic
device, a pipette tip, a pinch valve, and a syringe pump. A microfluidic device is designed with an
inlet port, an outlet port, and parallel microfluidic channels (N = 4, width = 600 μm, depth = 100 μm,
and length = 8 mm) [Figure 1C-a]. A pipette tip (50–1000 μL, Eppendorf, Hamburg, Germany) is cut
approximately 34 mm from the top surface [Figure 1B], and the pipette tip is tightly fitted into an inlet
port (inner diameter = 1.5 mm). The outlet port is connected to a disposable syringe (1 mL) with a
polyethylene tube (inner diameter = 250 μm and length = 600 mm). After the disposable syringe is
installed into a syringe pump, the flow rate was set to 2 mL/h (Q = 2 mL/h) at the withdrawal mode.
Subsequently, 0.2 mL blood is dropped into the pipette tip with a pipette [Figure 1C-b]. The RBC
migrates towards the button position due to continuous ESR in the pipette tip, and thus the previous
method quantifies ESR by measuring the height of the RBC-depleted region [15,17]. In contrast
to previous ESR measurement, the proposed method is suggested to measure variations of RBC
aggregation under continuous ESR by evaluating the microscopic image-based intensity of blood flow
in microfluidic channels. Therefore, to evaluate variations in hematocrit due to continuous ESR in the
pipette tip, blood is supplied from the conical pipette tip to the microfluidic channels over an interval
of time. A pinch valve (Supa clip, Pankyo, Gyeonggi-do, Korea) was installed between the outlet
port and the disposable syringe to periodically ensure blood delivery into the microfluidic device.
A pinch valve is manually opened for 10 s (Topen = 10 s) and closed for 290 s (Tclose = 290 s) during
a single period (T = 300 s) [Figure 1C-c]. As shown in Figure 1C-e, a specific ROI (80 × 400 pixels)
is selected for each microfluidic channel to determine an average value of blood velocity for each
microfluidic channel (<U>i, <U>ii, <U>iii and <U>iv) and an average value of image intensity for each
microfluidic channel (<I>i, <I>ii, <I>iii and <I>iv) that are calculated by conducting time-resolved
micro-PIV technique and digital image processing, respectively.
As a preliminary study, blood with 30% hematocrit was prepared by adding normal RBCs
into a specific dextran solution (i.e., Cdextran = 15 mg/mL). Figure 2A shows temporal variations of
averaged image intensity (<I>) for individual microfluidic channel and averages blood velocity (<U>)
through four microfluidic channels. Here, to monitor temporal variations of blood flow depending
on the operation of the pinch value (i.e., open or close), velocity fields were obtained by conducting
time-resolved micro-PIV technique. After guaranteeing the operation of the pinch valve sufficiently,
we did not try to get velocity information. Sequential images for representing RBC-depleted regions
in a pipette tip were captured with elapses of time (t) ([a] t = 300 s, [b] t = 600 s, [c] t = 900 s, and [d]
t = 1200 s). With respect to an elapse of time, the RBC-depleted region tended to increase due to
continuous ESR in conical tip. Additionally, image intensity (<I>) tended to decrease due to an increase
in the hematocrit. As shown in Figure 2B, temporal variations of <I> for each microfluidic channel are
obtained for a single period (T = 300 s). Temporal variations of image intensity (<I>), which are called
a syllectogram, are used to calculate three representative factors (SA, SB, and SC) [19] as follows:
SA =
∫ t = ts
t = 0
(< I > − < I >min)dt (1)
SB =
∫ t = ts
t = 0
(< I >max − < I >)dt (2)
SC =
∫ t = ts
t = 0
< I >min dt (3)
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In Equations (1)–(3), <I>min and <I>max are denoted as <I>min = <I (t = 0)> and <I>max = <I (t = ts)>,
respectively. Furthermore, <I>min tended to decrease due to ESR in the pipette tip, and thus SC was
used to represent the dynamic behavior of ESR. According to most previous methods, a blood sample
was directly dropped into an inlet port of the microfluidic device. Since hematocrit of the blood
sample remained constant in a microfluidic channel, the previous methods did not require to consider
the effect of continuous ESR in the reservoir on the RBCs aggregation. In other words, the previous
method did not consider the effect of hematocrit variations on the syllectogram (i.e., SC = 0). In other
words, as shown in right panel of Figure 2B, RBC aggregation was quantified by calculating AI as
AI = SA/(SA + SB). However, in this study, the proposed method involved simultaneously measuring
RBC aggregation and ESR in conical pipette tip. The continuous ESR caused to increase hematocrit of
blood supplied into a microfluidic channel. According to temporal variations of <I>, <I>min decreased
due to increases in hematocrit. In order to quantify RBC aggregation due to ESR in the conical
pipette tip, it was necessary to simultaneously consider variations in <I> due to RBC aggregation
(i.e., SA) and <I>min due to ESR (i.e., SC). Thus, EAI is evaluated as EAI = SA/SC. For convenience,
ts was fixed as ts = 250 s. Sequential microscopic images for four microfluidic channels indicated
that RBC tended to gradually aggregate with respect to an elapse of time (t) ([a] t = 0, [b] t = 100 s,
[c] t = 200 s, and [d] t = 300 s). This preliminary result indicated that the proposed method measured
variations of RBC aggregation under continuous ESR by quantifying image intensity of blood in each
microfluidic channel.
Figure 2. Quantification of two indices (AI and EAI) for quantifying RBCs aggregation and ESR in a
conical pipette tip. (A) Temporal variations in <I> for each microfluidic channel and average velocity
(<U>) through four microfluidic channels. Sequential images for representing RBC-depleted regions
in a pipette tip with an elapse of time (t) ([A-a] t = 300 s, [A-b] t = 600 s, [A-c] t = 900 s, and [A-d]
t = 1200 s). (B) Temporal variations of <I> for each microfluidic channel over a single period. Sequential
microscopic images represent RBC aggregation for each microfluidic channel with an elapse of time (t)
([B-a] t = 0, [B-b] t = 100 s, [B-c] t = 200 s, and [B-d] t = 300 s). Two indices (AI and EAI) were defined
as AI = SA/(SA + SB) and EAI = SA/SC from a syllectogram obtained for 300 s.
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2.4. Quantifications of Image Intensity (<I>) and Blood Velocity (<U>)
In order to evaluate variations in image intensity of blood with an elapse of time, a specific
ROI (80 pixel × 400 pixel) was selected within each microfluidic channel as shown in Figure 1C-e.
Average pixel values over the ROI (<I>i, <I>ii, <I>iii, and <I>iv) were estimated by performing
digital image processing with a commercial software program (Matlab, Mathworks, Natick, MA,
USA). To evaluate temporal variations of blood flow, velocity fields were obtained by conducting
a time-resolved micro-PIV technique to evaluate temporal variations in blood flow. Specific ROIs
(80 pixel × 400 pixel) were selected for each microfluidic channel to obtain velocity fields of blood
flow. The size of the interrogation window corresponded to 16 × 16 pixels. The window overlap
corresponded to 50%. The obtained velocity fields were validated with a median filter. The average
velocities of blood flow for each microfluidic channel (<U>i, <U>ii, <U>iii, and <U>iv) were calculated
as an arithmetic average over the ROI. Finally, average blood velocity in the parallel microfluidic
channel (<U>) was calculated as <U> = (<U>i + <U>ii + <U>iii + <U>iv)/4.
3. Results and Discussion
3.1. Variation of Width in Microfluidic Channel Fabricated by Using an Adhesive Sheet for Master Mold
In this study, the use of a liner cut from an adhesive sheet to form the master mold was employed
to simplify the fabrication process, compared to MEMS fabrication. Variations of channel width were
measured by analyzing microscopic images obtained from high-speed camera. After then, digital
image processing was conducted to measure channel width of individual channel. Measurement for
each channel was repeated ten times (n = 10). As shown in Figure 3A, the corresponding channel width
(W) for each channel was measured as (a) W = 615 ± 12 μm for (i) channel, (b) W = 615 ± 23 μm for (ii)
channel, (c) W = 575 ± 18 μm for (iii) channel, and (d) W = 571 ± 33 μm for (iv) channel. In other words,
this simple technique could be employed to prepare microfluidic channel within 4% normal deviation
in channel width of individual channel. Compared with MEMS fabrication, this simple technique
was not feasible to fabricate a microfluidic channel with highly consistent dimensions. According
to the previous studies, this xurography technique had poor resolution for dimensions smaller than
500 μm. However, it provides several advantages including inexpensive cost (material and equipment)
and rapid fabrication without cleanroom [24,26]. Due to high advantages, it had been employed to
fabricate biomedical device for blood flow analysis [25,27]. However, in this study, dynamic blood flow
was required to disaggregate aggregated RBCs sufficiently. Since RBCs aggregation was quantified at
stationary blood flows by clamping polyethylene tube with a pinch valve, blood flow in each channel
does not have an influence on measurement of RBCs aggregation. Even though this technique has a
little deviations in channel width, an adhesive sheet could be simply used as a master mold to prepare
microfluidic device. On the other hand, to verify variations of each microfluidic device, channel width
was measured with five microfluidic devices. Averaged channel width for each device was used to
quantify device-to-device variation. Four channel widths of each device were arithmetically averaged
as W ave = [W(i) + W(ii) + W(iii) + W(iv)]/4. As shown in Figure 3B, averaged channel width (Wave)
remained consistent for five different devices. From these measurement results, the use of a liner cut
from an adhesive sheet contributes to simplifying the fabrication process, and to preparing PDMS
microfluidic channel reliably.
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Figure 3. Quantitative measurement of width variations of four microfluidic channels fabricated by
using an adhesive sheet for master mold. (A) Variations of channel width for four individual channels.
(B) Variations of averaged channel width for five different devices.
3.2. Quantitative Evaluation of the Effects of Pinch-Valve Operation and Syringe Pump Flow-Rate
In order to analyze the dynamic effect of a microfluidic system (polyethylene tube and a microfluidic
device) on the performance of the proposed method, image intensity (<I>) and blood velocity (<U>)
of blood flow in parallel microfluidic channels were quantified with high resolution. Two sequential
microscopic images were captured and recorded at an interval of 0.1 s. Hematocrit of blood was adjusted
to 30% by adding normal RBCs into autologous plasma. A flow rate was set to 2 mL/h with a syringe
pump. Figure 4A-a,A-b show temporal variations of image intensity (<I>) and average of blood velocity
(<U>) obtained for specific durations of 120 s and 25 s. When a pinch valve clamps or releases the
polyethylene tube, <I> and <U> showed transient behaviors with respect to time. The experimental
results indicated that blood flow stopped shortly within 0.2 s. After clamping the tube, image intensity
(<I>) tended to increase immediately. According to previous studies [17,28], blood flow decreased
gradually based on the compliance effect of the microfluidic system when a syringe pump was used to
control blood flow in a microfluidic channel in the delivery mode. In other words, when the syringe pump
was set to zero value of the flow rate (i.e., Q = 0), RBC aggregation did not occur due to transient blood
flow in the microfluidic channel. Thus, RBC aggregation was quantified by using temporal variations
in image intensity after an elapse of 20 s [28] or 60 s [17]. For this reason, a glass capillary tube [2] or
detour channel [14] was applied to minimize time delay due to the compliance effect of the microfluidic
system. However, in the proposed method, a syringe pump sets to constant flow rate as withdrawal
mode. The pinch valve clamped or released the polyethylene tube, and thus the blood flow stopped or
ran within a very short time. The experimental results indicated that RBC aggregation was measured
immediately after clamping the tube with a pinch valve (i.e., close mode). Additionally, the compliance
effect of fluidic system on RBC aggregation and ESR was negligible.
To verify the effect of syringe pump flow-rate on RBC aggregation (i.e., AI) and ESR (i.e., EAI),
temporal variations of image intensity (<I>) and velocity (<U>) were obtained by varying flow rate of
the syringe pump (Q) (Q = 0.5 mL/h, 1 mL/h, and 2 mL/h). Figure 4B-a shows temporal variations of
<I> with respect to flow rate of syringe pump (Q). Here, <I> denotes average values of image intensity
in four microfluidic channels. With increasing syringe pump flow-rate, <I> tends to decrease. For up
to 600 s, minimum value of <I> (i.e., <I>min) tends to decrease gradually because of continuous ESR in
the conical pipette tip. After 600 s, <I> remained constant without respect to syringe pump flow-rate.
In addition, amplitude of <I> (i.e., ΔI) was decreased over time. Figure 4B-b shows temporal variations of
<U> with respect to syringe pump flow-rate (Q). Here, <U> denotes averaged blood velocity through four
microfluidic channels, especially for 10 s per each period. By increasing flow rate, blood velocity (<U>)
tends to increase distinctively. In addition, at the higher syringe pump flow-rate of Q = 1~2 mL/h, blood
velocity was decreased gradually from t = 300 s to t = 900 s. Then (t > 900 s), blood velocity remained
constant over time. However, at the lower syringe pump flow-rate of Q = 0.5 mL/h, blood velocity
remained constant over time. Using temporal variations of <U> during a specific time duration of 1500 s,
temporal variations of two indices (AI and EAI) were obtained by varying flow rates. As shown in
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Figure 4B-c,B-d, AI as conventional RBC aggregation index remained constant without respect to flow rate
but not with respect to the initial condition (t = 0). However, due to continuous ESR in the conical pipette
tip, hematocrit of blood supplied from the conical tip into microfluidic channels was increased. Thus, EAI
was decreased gradually over time. In addition, syringe pump flow-rate does not contribute to varying
EAI. From these experimental demonstrations, it is found that syringe pump blood-flow rate does not
have a significant influence on measurement of AI and EAI. In other words, the syringe pump flow-rate
of Q = 0.5 mL/h is considered sufficient for removing and filling blood samples in each microfluidic
channel for each period. In this study, for convenience, the higher syringe pump flow-rate of Q = 2 mL/h
was selected to easily suck and remove blood samples from the bottom area of the pipette tip and change
blood samples in each microfluidic channel.
Figure 4. The quantitative evaluation of the effects of vital two factors including pinch-valve
operation and syringe pump flow-rate on the measurement of RBC aggregation and ESR. (A) Dynamic
characterization of image intensity (<I>) and blood velocity (<U>) based on operation of the pinch
valve (open, close). To evaluate transient response with a high resolution, <I> and <U> were obtained
at intervals of 0.1 s. Hematocrit of blood was adjusted to 30% by adding normal RBCs into the plasma
solution. At the constant flow rate of 2 mL/h with syringe pump, temporal variations of <I> and <U>
were obtained for specific duration of (A-a) 120 s and (A-b) 25 s. As a result, blood flow was stopped
immediately within 0.2 s after clamping a tube with a pinch (i.e., close). (B) The effect of syringe pump
flow-rate (Q) on the measurement of RBC aggregation (i.e., AI) and ESR (i.e., EAI). Temporal variations
of <I> and <U> were obtained by varying flow rate of syringe pump (Q) (Q = 0.5, 1, and 2 mL/h).
(B-a) Temporal variations of <I> with respect to blood flow rate. (B-b) Temporal variations of <U>
with respect to syringe pump flow-rate. (B-c) Temporal variations of AI with respect to syringe pump
flow-rate. (B-d) Temporal variations of EAI with respect to syringe pump flow-rate.
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3.3. Quantitative Evaluation of the Channel Number for Evaluating Variations of AI and EAI
To find out the effect of the channel number on measurement of RBCs aggregation and ESR,
the variations of RBC aggregation and ESR (i.e., AI and EAI) were evaluated with respect to number of
channel (n) (n = 1,2, 3, and 4). Figure S1 (Supplementary Materials) showed microscopic images for
microfluidic device with multiple numbers of channel (n) [(a) n = 1, (b) n = 2, (c) n = 3, and (d) n = 4].
Blood sample was prepared by adding normal RBCs into plasma. Hematocrit was fixed at 30%.
As shown in Figure 5A, temporal variations of <I> and <U> were simultaneously measured with
respect to channel number. As a result, <I> and <U> were decreased with increasing channel numbers.
When removing pinch valve (i.e., open mode) for 10 s, blood velocity tended to decrease with increasing
channel number. Furthermore, image intensity of stasis blood flow tended to decrease for rest time
of each period (~290 s). In other words, blood velocity for short duration time (~10 s) contributed to
changing image intensity of blood. Temporal variations of two indices (AI and EAI) were obtained by
analyzing temporal variations of image intensity for each duration of period. As shown in Figure 5B-a,
AI does not show significant difference with respect to channel number. To compare with scattering
of AI, coefficient of variation (COV) (~standard deviation/mean) was estimated as less than 0.05
from two channels to four channels. However, since minimum value of image intensity (<I>min) for
each period was inserted to calculate EAI, higher number of channels contributed to decreasing EAI.
As shown in Figure 5B-b, four channels showed lower values of EAI compared with the rest of channel
numbers. In addition, COV of EAI remained within 0.1 from two channels to four channels.
Figure 5. Quantitative evaluation of channel numbers for measuring scattering of two indices (AI
and EAI). (A) Temporal variations of <U> and <I> with respect to channel number (n) ((A-a) n = 1,
(A-b) n = 2, (A-c) n = 3, and (A-d) n = 4). (B) Temporal variations of AI and EAI with respect to channel
number. (B-a) Temporal variation of AI and, coefficient of variation (COV) with respect to channel
number. (B-b) Temporal variations of EAI and COV with respect to channel number.
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3.4. Quantitative Evaluation of the Effect of Hematocrit Variations
In order to evaluate the effect of hematocrit on the RBC aggregation under continuous ESR,
the four different hematocrits (Hct) (Hct = 20%, 30%, 40%, and 50%) were prepared by adding
normal RBCs into autologous plasma. RBC aggregation and ESR were quantified using AI and
EAI, respectively. Figure 6A shows temporal variations of <I> with respect to each microfluidic
channel and hematocrit level (Hct) ([a] Hct = 20%, [b] Hct = 30%, [c] Hct = 40%, and [d] Hct = 50%).
Image intensity (<I>) varied over time with respect to each microfluidic channel and hematocrit.
With respect to blood with 20% hematocrit, all RBCs were passed from a pipette tip to outlet port
after 1200 s, and thus, variations in image intensity for four microfluidic channels were obtained up
to 1200 s. With respect to blood with 30% hematocrit, variations of image intensity were obtained up
to 1500 s. However, the other two blood types (Hct = 40% and 50%) exhibited a lower value of ESR
in a pipette tip, and thus, RBCs continued to exist in the microfluidic channels. Variations in image
intensity were obtained up to 1800 s. Blood with lower hematocrit exhibited a higher value of SA and
SC when compared with blood with higher hematocrit. This result indicated that blood sample with
lower hematocrit exhibited higher values of ESR and RBC aggregation. Temporal variations of <I>
were used for four microfluidic channels to obtain temporal variations of AI and EAI with respect to
hematocrit. RBCs aggregation was quantified using temporal variations of image intensity from stasis
blood flow (t = 0). The effect of shear rate on RBCs aggregation measurement was negligible (i.e.,
.
γ = 0).
As shown in Figure 6A, since temporal variations of image intensity were obtained by analyzing
microscopic images captured at stasis blood flows, RBCs aggregation only contributed to varying
image intensity of blood sample in each microfluidic channel. As shown in Figure 6B-a, AI did not
display significant differences with respect to hematocrit (Hct) and measurement time (t). Additionally,
blood with lower hematocrit exhibited a higher value of AI when compared with blood with higher
hematocrit. Furthermore, AI remained constant over time. Conversely, temporal variations of EAI
were obtained with respect to hematocrit to include the effect of ESR. As shown in Figure 6B-b, EAI
shows a significant difference with respect to hematocrit when compared with AI. Therefore, blood
with 20% hematocrit exhibited a higher value of EAI when compared with other blood. Moreover,
blood with 40–50% hematocrit exhibited a similar value to EAI after 900 s. The result indicated that
EAI was more effective at evaluating the effect of hematocrit on the RBC aggregation when compared
with that of AI, because EAI included the effect of ESR in the pipette tip.
As quantitative comparison, the effect of hematocrit on ESR measurement was quantified by using
a modified conventional method [15,17]. Here, hematocrit of blood (Hct) were adjusted to Hct = 20%,
30%, 40%, and 50% by adding normal RBCs into autologous plasma. After installing four disposable
syringes vertically in base plate, blood with different hematocrit (~1 mL) was dropped into each
syringe with a pipette as shown in Figure 6C-a. At intervals of 30 s, consecutive images were captured
with a digital camera (D700, Nikon, Tokyo, Japan). The ESR was then quantified by measuring the
height of RBCs-depleted layer (i.e., H) over time. As shown in Figure 6C-b, temporal variations
of H were obtained by varying hematocrit. After then, to quantify relationship between proposed
method (i.e., EAI) and conventional method (i.e., H), simple regression formula for each method was
used as EAI = a1 + a2 exp (−t/λEAI) and H(t) = b1 + b2 exp(−t/λH), respectively. Here, λEAI and λH
denote corresponding time constants for proposed method and conventional method. By conducting
nonlinear regression analysis with a commercial software (Matlab, Mathworks, Natick, MA, USA),
variations of λEAI and λH were obtained with increasing hematocrit. As shown in Figure 6D-a, both
time constants tend to increase gradually with respect to hematocrit. In other words, ESR is saturated
within a short time for lower hematocrit, compared with higher hematocrit. In addition, EAI shows
very similar trend with respect to hematocrit. To find out relationship between two time constants
(λEAI and λH), linear regression analysis was conducted using EXCEL program (MicrosoftTM, Natick,
MA, USA). As shown in Figure 6D-b, coefficient of R2 shows sufficient high value of R2 = 0.9521. From
this result, both methods have significantly linear relation. Furthermore, it leads to conclusion that EAI
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as newly suggested index can be effectively employed to monitor variation of ESR through quantifying
image intensity of blood flowing in microfluidic channels.
Figure 6. Quantitative evaluation of the effect of hematocrit on the performance of the proposed
method. Specifically, RBC aggregation and ESR are quantified using two indices (AI and EAI).
Hematocrit (Hct) (Hct = 20%, 30%, 40%, and 50%) was adjusted by adding normal RBCs into autologous
plasma. (A) Temporal variations of <I> with respect to each microfluidic channel and hematocrit (Hct)
([A-a] Hct = 20%, [A-b] Hct = 30%, [A-c] Hct = 40%, and [A-d] Hct = 50%). (B) Temporal variations of
AI and EAI with respect to hematocrit. (B-a) Temporal variations of AI with respect to hematocrit.
(B-b) Temporal variations of EAI with respect to hematocrit. (C) ESR measurement using a disposable
syringe (~1 mL) as a conventional method. (C-a) Snapshot images for quantifying ESR method with
respect to hematocrit. Here, H represents height in RBCs-depleted layer. (C-b) Temporal variations of H
with respect to hematocrit. (D) Quantitative comparison between conventional method and proposed
method. (D-a) Variations of λEAI and λH with respect to hematocrit (Hct). (D-b) Linear relationship
between λEAI and λH.
3.5. Quantitative Evaluation of RBC Aggregation under Continuous for Homogeneous Aggregated RBCs
A performance demonstration involved applying the proposed method to measure RBC
aggregation under continuous ESR for homogeneous aggregated RBCs. In order to elevate
RBC aggregation for normal RBCs, three different concentrations of dextran solution (Cdextran)
(Cdextran = 5 mg/mL, 15 mg/mL, and 20 mg/mL) were prepared by adding dextran into 1× PBS
solution. Subsequently, hematocrit of the blood sample was adjusted to 30% by adding normal RBCs
into three different concentrations of the dextran solution. Additionally, a control blood sample
was prepared by adding normal RBCs into 1× PBS solution (Cdextran = 0) to exclude the effect of
RBC aggregation.
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Figure 7A shows temporal variations of <I> and <U> for two different bloods prepared by adding
normal RBCs into 20 mg/mL dextran solution and PBS solution, respectively. The tube opened shortly
at an interval of 300 s, and thus, an average of blood velocity (<U>) was measured as a periodic
pulse-like shape. Image intensity (<I>) tended to immediately increase over time when the pinch valve
clamps the tube (i.e., in the close mode). A blood sample with a higher concentration of the dextran
solution (Cdextran = 20 mg/mL) exhibited larger variations in image intensity (i.e., SA), when compared
with that of the control blood sample (Cdextran = 0). For two blood samples, a minimum value of <I>
(<I>min) exhibited a significant decrease at t = 300 s. Following this, <I>min remained constant with
an elapse of time. This result indicated that ESR occurs dominantly within 300 s. After 300 s, ESR
remained constant with time elapses.
Figure 7. Quantitative evaluations of RBC aggregation (i.e., AI) and ESR (i.e., EAI) with the proposed
method and the modified conventional ESR method. To elevate RBC aggregation and ESR, three
concentrations of dextran solution (Cdextran) (Cdextran = 5 mg/mL, 15 mg/mL, and 20 mg/mL) were
prepared by adding dextran into a PBS solution. Hematocrit is adjusted to 30% by adding normal RBCs
into three different concentrations of the dextran solution. (A) Temporal variations of <I> and <U> for
two different blood samples (Cdextran = 0, 20 mg/mL). (B) Temporal variations of AI with increasing
concentrations of the dextran solution. (C) Temporal variations of EAI with increasing concentrations
of the dextran solution. (D) Variations of AI and EAI with respect to the concentration of the dextran
solution. (E) Temporal variations of H with respect to specific concentrations of dextran solution. Here,
H denotes height of RBCs-depleted layer in a disposable syringe. (F) Linear relationship between
proposed method (i.e., EAI) and the modified conventional ESR method (i.e., λH).
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In order to quantify RBC aggregation under continuous ESR, two indices (AI and EAI) were
calculated using temporal variations of <I> for each microfluidic channel. As shown in Figure 7B,
the temporal variations of AI were obtained with respect to concentrations of the dextran solution.
The control blood sample (i.e., normal RBC in PBS suspension) showed a lower value of AI = 0.30 ± 0.01
when compared with aggregated blood sample (i.e., normal RBCs in plasma), as shown in Figure 6B-a.
Hence, the AI gives higher value of reference, since control blood sample was prepared to exclude RBC
aggregation. Thus, it was estimated that lower hematocrit (Hct = 30%) contributed to a higher value of
AI as a reference value. Additionally, the blood sample exhibited a higher value of AI with increases
in the concentration of the dextran solution. However, AI did not indicate significant differences for
blood samples, with concentrations of the dextran solution ranging from Cdextran = 15 mg/mL to
Cdextran = 20 mg/mL.
As shown in Figure 7C, temporal variation of EAI was calculated using temporal variations of
image intensity (<I>) with respect to concentrations of the dextran solution. As a result, EAI remained
constant after 2 cycles. Since each cycle is continued for five min., the proposed method requires at
least 10 min. The proposed method does remove necessity of repetitive test as significant advantage.
The control blood sample exhibited a significantly lower value of EAI (i.e., EAI = 0.04 ± 0.01) as a
reference value when compared with that of the AI. Overall variations in EAI are significantly higher
than those of AI within a specific dextran solution. Furthermore, EAI exhibited a significant difference
at specific dextran concentrations ranging from Cdextran = 15 mg/mL to Cdextran = 20 mg/mL.
Finally, as shown in Figure 7D, variations of AI and EAI were displayed with respect to a specific
dextran solution. The linear regression analysis indicated a high value of R2 (i.e., R2 = 0.9666), and thus,
EAI linearly varied within a specific concentration of dextran solution. However, AI varied gradually
below 15 mg/mL dextran solution. Furthermore, AI approached saturation above 15 mg/mL dextran
solution. According to most previous methods, a blood sample was directly dropped into an inlet port
of the microfluidic device. Since hematocrit of the blood sample remained constant in a microfluidic
channel, the previous methods did not require to consider the effect of continuous ESR in the reservoir
on the RBCs aggregation. In other words, the previous method did not consider the effect of hematocrit
variations on the syllectogram (i.e., SC = 0). Based on previous methods [2,3], the RBC aggregation
was quantified by calculating AI as AI = SA/(SA + SB). However, in this study, the proposed method
involved simultaneously measuring RBC aggregation and ESR in conical pipette tip. The continuous
ESR caused to increase hematocrit of blood supplied into a microfluidic channel. According to temporal
variations of <I>, minimum value of <I> (i.e., <I>min) decreased due to increases in hematocrit. In order
to quantify RBC aggregation due to ESR in the conical pipette tip, it was necessary to simultaneously
consider variations in <I> due to RBC aggregation (i.e., SA) and <I>min due to ESR (i.e., SC). Thus, EAI
is evaluated as EAI = SA/SC.
3.6. Quantitative Comparison between the Proposed Method and the Modified Conventional ESR Method
To compare with the experimental results obtained by the proposed method, blood was prepared
by adding normal RBCs into a specific concentration of dextran solution (Cdextran) (Cdextran = 0,
5 mg/mL, 15 mg/mL, and 20 mg/mL). Here, Cdextran = 0 denotes 1× PBS solution. Thereafter, 1 mL
blood was dropped into a disposable syringe (1 mL, BD Science, Singapore) as a modified conventional
method [15,17]. Figure 7E shows temporal variations of H by varying various concentrations of dextran
solution. As a result, dextran solution contributes to increasing H significantly, compared with control
blood. To quantify variations of ESR, simple regression expression was suggested as H(t) = b1 + b2 exp
(−t/λH). Then, time constant (i.e., λH) was obtained by conducting nonlinear regression analysis with
commercial software. Figure 7F represents the quantitative comparison between proposed method
(i.e., EAI) and the conventional method (i.e., λH). To verify the relationship between the proposed
method and conventional method, a linear regression analysis was conducted with EXCEL program
(MicrosoftTM, Natick, MA, USA). Since the coefficient of R2 has higher value of R2 = 0.8789, the EAI
obtained by the proposed method can give comparable value of ESR, compared with the conventional
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method. As shown in Figure 6B-b, EAI of normal blood (Hct = 30%) was varied from 0.16 to 0.22.
According to Figure 7D, EAI was increased linearly with increasing concentration of dextran solution.
Blood with lower concentration of dextran solution (Cdextran = 5 mg/mL) had EAI = 0.134 ± 0.014.
In other words, 5 mg/mL dextran solution played a similar ESR behavior, compared with plasma
solution. Blood prepared with higher concentration of dextran solution (Cdextran = 20 mg/mL) had
EAI = 0.286 ± 0.019. From this result, maximum concentration of dextran solution (20 mg/mL)
contributed to increasing EAI twice, compared with normal blood. According to previous study [22],
using streptozotocin-induced rats, variations of ESR were measured by varying duration of diabetes
(DDiabetes). Compared with control, ESR was increased over twice. From this results, EAI obtained by
the proposed method can be effectively used to detect variations of ESR or RBCs aggregation.
From this experimental demonstration, it is found that the suggested method is able to quantify
variations of RBC aggregation under continuous ESR. In other words, EAI is more effective when
compared with AI. Furthermore, the method provides multiple data of RBC aggregation and ESR
through a single experiment. The rheological property varied continuously, and thus it is very effective
at obtaining several data points without repetitive tests. Compared with the previous methods,
this proposed method had some merits including fabrication, multiple channels, and quantitative
comparison of ESR value. First, the use of a liner cut from an adhesive sheet to form the master mold
was newly suggested to simplify the fabrication process, compared to MEMS fabrication. Since RBC
aggregation is quantified under stasis blood flows or lower shear rates, it is not imperative that each
microfluidic channel should have uniform sizes for consistent blood flows. Thus, this method can
remove MEMS fabrications, which require high cost and technical expertise. Second, when RBC
aggregation varied over time, the repetitive test caused to increase scattering of aggregation index
largely. Thus, multiple measurement of RBC aggregation was required to avoid large scattering due
to repetitive test conducted for long time. At last, ESR relationship between modified conventional
method and proposed method was obtained by conducting regression analysis technique. As a result,
the EAI obtained by the proposed method gave comparable value of ESR, compared with the modified
conventional ESR method.
4. Conclusions
In this study, a simple measurement technique of RBC aggregation under continuous ESR was
demonstrated by sucking blood from a conical pipette tip into parallel microfluidic channels and
quantifying image intensity, especially throughout single experiment. Two indices (AI and EAI) were
suggested to quantify variations of RBC aggregation due to ESR in the conical pipette tip. First, when
clamping the fluidic tube with the pinch valve, blood flow in each microfluidic channel was stopped
shortly within 0.2 s. RBCs aggregation was measured immediately after clamping the tube with a
pinch valve (i.e., close mode). Additionally, the compliance effect of the fluidic system had a negligible
effect on transient blood flows. In addition, AI and EAI remained constant without respect to flow
rate (Q) (Q = 0.5 mL/h, 1 mL/h, and 2 mL/h). From this result, RBC aggregation and ESR were
measured immediately by clamping the tube with a pinch valve, at the constant flow rate of 2 mL/h.
Second, the proposed method was applied to measure the effect of hematocrit on the RBC aggregation
under continuous ESR. AI remained over time with respect to hematocrit. However, EAI showed
a significant difference with respect to hematocrit and measurement time. Compared with AI, EAI
was more effective for evaluating continuous ESR in the conical pipette. After that, to quantify the
relationship between the proposed method (i.e., EAI) and the modified conventional ESR method
(i.e., H) with respect to hematocrit level, time constants (λEAI, λH) were obtained by conducting
regression analysis with simple regression formula [i.e., EAI = a1 + a2 exp (−t/λEAI), H = b1 + b2 exp
(−t/λH)]. For two time constants (λEAI, λH) with respect to hematocrit, linear regression analysis
indicated that the coefficient of R2 showed a sufficient high value of R2 = 0.9521. Thus, EAI can be
effectively employed to measure ESR in the reservoir, compared with a modified conventional ESR
method. The proposed method was finally applied to evaluate RBC aggregation (AI) and ESR (EAI)
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for homogeneous aggregated RBCs. As a result, EAI and AI were gradually increased by varying
concentration of dextran solution ranging from Cdextran = 5 mg/mL to Cdextran = 20 mg/mL. To evaluate
the relationship between the proposed method and a modified conventional ESR method, EAI and
λH were obtained at specific concentrations of dextran solution. Since regression analysis showed
higher value of R2 = 0.8789, the EAI obtained by the proposed method gave comparable value of ESR,
compared with the modified conventional ESR method. These experimental demonstrations indicated
that the proposed method simultaneously measures RBC aggregation and ESR by using two indices
(AI and EAI). Moreover, the method provides multiple data of RBC aggregation and ESR through a
single experiment. Future tests will involve employing the proposed method to evaluate biophysical
properties of bloods collected from cardiovascular diseases.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-666X/9/7/318/s1:
Figure S1: Microscopic images for showing a microfluidic device with parallel microfluidic channel (n) [(a) n = 1,
(b) n = 2, (c) n = 3, and (d) n = 4].
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Abstract: A fabrication method is developed to produce a microfluidic device to test cell adhesion to
polymeric materials. The process is able to produce channels with walls of any spin coatable polymer.
The method is a modification of the existing poly-dimethylsiloxane soft lithography method and,
therefore, it is compatible with sealing methods and equipment of most microfluidic laboratories. The
molds are produced by xurography, simplifying the fabrication in laboratories without sophisticated
equipment for photolithography. The fabrication method is tested by determining the effective
differences in bacterial adhesion in five different materials. These materials have different surface
hydrophobicities and charges. The major drawback of the method is the location of the region of
interest in a lowered surface. It is demonstrated by bacterial adhesion experiments that this drawback
has a negligible effect on adhesion. The flow in the device was characterized by computational fluid
dynamics and it was shown that shear stress in the region of interest can be calculated by numerical
methods and by an analytical equation for rectangular channels. The device is therefore validated for
adhesion tests.
Keywords: cell adhesion; biomedical coatings; microfabrication; computational fluid
dynamics; microfluidics
1. Introduction
The term ‘biofilm’ was coined in 1981 [1] and refers to a community of microbial cells that is
attached to a surface and enclosed in a self-produced exopolymeric matrix mainly composed by
polysaccharide material [2]. Biofilm formation is due to the onset of adhesion of cells to a surface. The
development of biofilms in medical devices is a common problem, which can lead to hospitalization,
revision surgery due to microbiological implant colonization or mortality.
Recent reviews provide a source of evidence to the undesirable biofilm formation in medical
devices [3–9]. These biofilms pose a challenge to the health care community. Currently, to reduce
biofouling, there is a spurring development of smart polymers that are used for coating biomedical
implants, artificial organs, lab on chip surfaces, implantable drug delivery systems [10], giving way to
the development of next generation biomedical devices with reduced fouling.
Many types of measures were proposed to combat biofilms, like conventional usage of antibiotics
or surfaces designed to inhibit initial adhesion of cells, for the first stage of biofilm formation [11].
A clear understanding of the initial adhesion mechanisms can lead to the development of ideal
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biomaterials in which cells are unable to attach and growth of biofilms would be hindered [12].
Consequently, there arises a need to quantify and understand the initial adhesion phenomenon over
diverse materials.
Different types of biomaterials were used throughout the past 30 years, for different types
of biomedical applications. Ramakrishna, et al. [13] have given a brief introduction of different
biocompatible polymers used for different types of implants. For example, poly-l-lactide acid (PLLA) is
a biodegradable polymer, which degrades over time without harmful consequences to the body [14,15].
Different types of pins and screws, coated with PLLA, are used to fix the implants. Autografts, namely
suspensory fixation, hamstring fixation [16] are used as fixing agents for femoral implants to reduce
operation failures.
Recently, researchers started taking advantage of microfluidic devices for biofilm research [17–19]
due to several benefits:
• The different biological cells can be monitored in real time with microscopy
visualization techniques;
• Low-cost assays and reagents can be used in the microliter range helping in cost cutting;
• Leak-proof inlet and outlet connections can be made easily as the poly-dimethylsiloxane (PDMS)
microfluidic channels are deformable;
• The surface can be easily modified and the geometry can be designed according to the application;
• The flow is always laminar, even at a high shear stress range.
In the particular case of adhesion tests, tests can be conducted in a simpler and smaller setup.
The pumps required have lower power, the amount of fluid is smaller, and the setup is more flexible.
Multiple tests can be conducted in parallel in a single chip and new geometries are easy to produce.
Additionally, by using microfluidic devices, researchers can easily mimic the dynamical conditions
of biomedical settings. It has been shown that adhesion is influenced by the flow patterns near the
wall, the wall shear stress being the most important parameter used to characterize the flow influence
on adhesion. For this reason, microdevices to study the wall adhesion must have well characterized
hydrodynamic conditions. It is crucial that the wall shear stress is predictable given the flow rate
used in the experiments. Additionally, geometrical features of the device should not interfere with the
flow or with adhesion in the regions of interest. For this reason, straight channels are the preferred
configuration for dynamic adhesion tests. New cells need to be validated to assure they are adequate
for routine adhesion tests. Computational fluid dynamics (CFD) is usually used to characterize the
flow and calculate the wall shear stress.
To aid the vast developing applications based on microfluidics, there are many conventional
rapid prototyping techniques developed for microchannels fabrication. Duffy, et al. [20] demonstrated
a method to produce PDMS channels for microfluidic applications. First, the channel is designed
in Computer-Aided Design (CAD) software. The design is printed in a transparency and used as
a mask for making a positive relief master mold. The master mold is produced in SU-8 polymer
epoxy photoresist, step described in detail by Blanco, et al. [21] and Che-Hsin, et al. [22]. The
PDMS channels are then casted with this mold and baked to obtain irreversibly sealed channels.
Other conventional methods are commercially used for micromolding such as: micromilling [23],
micropowder blasting [24], hot embossing [25], laser ablation [26] and stereo lithography [27].
Xurography is a technique developed by Bartholomeusz, et al. [28] utilizing a simple cutter plotter.
The microchannels can be cut, according to the application, on vinyl films or other types of films.
Positive relief molds, of thicknesses ranging from 25 to 1000 μm, can be generated in the cutter plotter
and made ready for casting microchannels in less than 30 min. These molds can also be used as normal
molds to produce PDMS microchannels through soft lithographic technique [29].
The foremost advantages of xurography technique are the reduced capital cost and manufacture
time. The alternative to xurography is photolithography, a technique that needs expensive machines
and clean rooms. Design modifications using photolithography techniques require more than a day,
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with procedures with long pre and post bake steps. The main disadvantage of xurography is the low
resolution that precludes the production of microchannels with dimensions smaller than 200 μm.
Microfabrication techniques that increase the range of possible materials to be used in microfluidics
adhesion tests would contribute significantly to the research progress. The objective of adhesion tests is
to evaluate different materials in their original form, and therefore a fabrication procedure that changes
the material must be avoided. The new techniques must be compatible with existing equipment and
with microfabrication techniques, the PDMS soft lithography being the most used. In PDMS soft
lithography, irreversible PDMS-PDMS sealing has some important advantages: the bond between the
device and the cover is strong and there is no need to use plasma oxygen that would change the surface
properties being tested. With existing techniques, PDMS does not bond easily with any polymer unless
a surface treatment is applied that would change the surface properties of the polymer. The techniques
must also be inexpensive and with short development cycles.
In this work we introduce a technique to incorporate a small wall patch into a PDMS microchannel
produced from molds easily made in-house by xurography. The molds can be produced through any
other technique, but xurography has low costs and large accessibility. The wall patch can be made
of different polymers. The technique is useful to produce channels for adhesion tests, by adapting a
standard PDMS soft-lithography. The procedure is compatible with irreversible PDMS-PDMS sealing
and does not require plasma oxygen or any other surface treatment. Care was taken to validate the
device for adhesion tests performing adhesion experiments and flow numerical simulations. Since
one of the key factors influencing cell adhesion is the wall shear stress, the flow in the device was
characterized by computational fluid dynamics and the wall shear stress was calculated for the
conditions studied.
2. Materials and Methods
2.1. Mold Preparation
The molds of the microchannels were produced by xurography [28], a technique that uses a
cutter-plotter to produce molds by removing excess material from adhesive films. The design of the
models was made in CorelDRAW. Afterwards, the design was copied to GreatCut software, which
instructed an Expert24 GCC plotter (GCC, New Taipei City, Taiwan) to cut the microchannels.
Four different polymer films were tested to check compatibility with PDMS soft lithography [29].
Adhesive film obtained from Sadipal (Girona, Spain) showed to be the most suitable and was selected
for mold production. The thickness of the Sadipal adhesive films used was 100 μm and this was the
height of the microchannel.
2.2. PDMS Soft Lithography
Microchannels were made from poly-dimethylsiloxane (PDMS) using soft lithography
techniques [29]. The microchannels were prepared with a homogenous mixture of PDMS and
curing agent (Sylgard 184, Dow Corning, Midland, MI, USA) at a ratio of 5:1. A desiccator connected
to the vacuum pump was used to remove the air bubbles formed during the PDMS mixing process.
The PDMS mixture was poured over a mold and kept in the oven for 20 min at 80 ◦C. After curing,
the PDMS microchannel was peeled off from the mold. Holes of 1 mm in diameter were punched
through the PDMS replicas, at both ends of the channel, to provide inlet and outlet flow with the help of
a syringe tip. The PDMS microchannels were sealed with a PDMS coated thin slab (usually a glass slide,
see next section) and kept in the oven for approximately 12 h at 80 ◦C. The sealing method is based on
partial curing PDMS-PDMS bonding without plasma treatment described in the literature [30].
2.3. Insertion of Polymer Wall Patches in the Channels
To test the adhesion of cells in a given material, a patch of the material must be inserted in one of
the walls of the channel (usually the bottom wall). With this in mind, channels comprising 5 different
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wall materials were fabricated by modifying the sealing slides. In one case, polystyrene cover was
used as substrate to fabricate microchannels with polystyrene wall surfaces, while in the other 4 cases
different polymers were spincoated over the sealing glass slide to insert a patch of polymer in the wall
of the channel.
The coated glass slides, used to seal the channels, were prepared by a two-layer spin coating
technique (Figure 1) using a WS-650S-6NPP-Lite Laurell Technologies spin coater (North Wales, PA,
USA). Different volatile polymers and solvents were mixed in appropriate volume percentages (Table 1).
The polymer solution was spincoated over the substrate (Figure 1b). After the formation of a polymeric
film, by evaporation of the solvent, a scotch tape was pasted over the polymer surface (Figure 1c) and
the PDMS was spincoated for 50 s at 5000 rpm over both the polymer and the scotch tape (Figure 1d).
The scotch tape was carefully peeled off (Figure 1e) and the slide was baked for 5 min in the oven
at 80 ◦C. A lowered surface (3 × 3 mm2) was left on the slide. The level of the lowered surface was
determined from the experimental relation between thickness, coating speed and time [31,32] and
found to be approximately 10 μm. The PDMS slab with the channel imprinted on it was sealed over
the slide. The PDMS slab and the slide were aligned to ensure that the microchannel crossed the
lowered surface.
 
Figure 1. Fabrication procedure: (a) Substrate; (b) Polymer coating; (c) Scotch tape pasted over the
polymer layer; (d) poly-dimethylsiloxane (PDMS) coating; (e) Removal of the Scotch tape; (f) Sealing
with PDMS slab with the microchannel imprinted in it.
Table 1. Polymers and solvents used to prepare polymeric solutions.
Polymer Solvent Polymer Concentration (w/w)
Polyethylene oxide (PEO) Dichloromethane (DCM) 1.14%
Poly-l-lactide acid (PLLA) Dichloromethane (DCM) 5.00%
Polyamide (PA) Trichloroethanol 0.49%
Polydimethylsiloxane (PDMS) Curing agent (Sylgard 184) 10.0%
The procedure can also be used to test the adhesion to the substrate (e.g., polystyrene surfaces)
and in this case the first layer spin coating step (Figure 1b) is skipped. This alternative procedure can
be used to produce microchannels with other surfaces, such as glass, provided that a transparent thin
slab is available.
The method described above produces microchannels with PDMS surface along most of its
length and a small patch of a different material located in a lowered surface half-length from the
inlet (see Figure 2). The lowered surface is an unavoidable side effect of the method. To allow for
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PDMS-PDMS bonding, a layer of PDMS must be added above the polymer layer, with the exception
of a small region that is not covered with PDMS and corresponds to the lowered surface of polymer.
To test the effect of the lowered surface on bacterial cell adhesion, microchannels with PDMS walls
along the full length of the microchannel were produced following the double layer technique, in which
both layers are made of PDMS.
Figure 2. Microchannel representation and mesh details: (a) Microchannel, showing the lowered
surface in grey, the region of interest in black and domain limits; (b) Profile representing the level of the
upper and lower surfaces of the channel; (c) 3D representation of the numerical domain; (d) Lowered
surface detail; (e) Microchannel cross-section outside the lowered region; (f) Cross-section available to
the flow in the lowered surface region.
2.4. Bacteria and Culture Conditions
Escherichia coli JM109(DE3) was used, since this strain had already demonstrated a good adhesion
capacity [33]. A starter culture was prepared as described by Teodosio, et al. [34] and incubated
overnight. A volume of 60 mL from this culture was centrifuged (for 10 min at 3202× g) and the cells
were washed twice with citrate buffer 0.05 M [35], pH 5.0. The pellet was then resuspended and diluted
in the same buffer to obtain a cell concentration of 7.6 × 107 cell mL−1.
2.5. Cell Adhesion Test
Cell adhesion tests with E. coli were performed with different polymer channels. Three trials
were conducted for each material. The cell suspension was pumped using a syringe pump (Cetoni,
neMESYS syringe pump, Korbussen, Germany) through a tygon® tube to the microfluidic channel.
Adhesion was followed using a fluorescence inverted microscope (DMI 5000M, Leica Microsystems
GmbH, Wetzlar, Germany) with a 40× objective. Microscopic images were captured with a CCD
camera (Leica DFC350FX, Leica Microsystems GmbH, Wetzlar, Germany) with a time interval of 60 s.
The image sequence obtained is in tiff format as recorded by Leica Application Suite software. The
area of the region of interest was 312 × 233 μm2. Initial adhesion experiments lasted for 1800 s.
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2.6. Flow Conditions
The flow conditions studied are indicated in Table 2. With these conditions, the shear stress
range is from 0.01 Pa to 1 Pa, covering the majority of shear stresses that can be found in the human
body [36,37].
Table 2. Hydrodynamic conditions.
Flow Rate (μL/min) Mean Velocity (m/s) Reynolds Number
Nominal Wall Shear Stress
(Equation (6)) (Pa)
0.667 2.50× 10−4 0.06 0.01
1.35 5.00× 10−4 0.12 0.02
15 5.56× 10−3 1.30 0.2
65.1 2.41× 10−2 5.65 1
2.7. Image Analysis
All the 30 images were imported to Image J software [38]. A low noise region was selected in the
images using the crop tool. The images were converted from 8 bit to 32 bit to improve contrast. To set
the scale for processing, the pixel aspect ratio was set to one. Depending on the images, they can be
smoothed using the mean filter with 1 pixel as radius. Then, the background was subtracted with
rolling ball radius ranging from 1 to 18 pixels. A light background was obtained with the E. coli cells
bright and visible. The brightness and contrast were fine-tuned to get more accurate cell count. The
threshold was adjusted, for the stack of images, to generate a black and white image containing black
cells over a white background. Cells have a characteristic size range (from about 0.5 μm to 3 μm) and
particles and noise outside the size range were filtered out. Then the cells were automatically counted.
The image for t = 0 already shows some cells, since the first image is taken some minutes after the flow
starts. The number of cells for t = 0 was subtract from the total of cells counted.
By observation of the images obtained it was possible to distinguish cells from other particles
due the characteristic shape of E. coli and the progressive increase of the number of cells throughout
the experiments. The automatic counting method was compared with manual counting and this
comparison showed that the automatic counting was accurate.
2.8. Hydrophobicity Test
The surface hydrophobicity can be determined by the contact angle formed between a surface and
a polar and apolar liquid drop [39]. In this work, the contact angles were determined automatically by
the sessile drop method in a contact angle meter (OCA 15 Plus; Dataphysics, Filderstadt, Germany)
using water, formamide and α-bromonaphtalene (Sigma-Aldrich Corporation, St. Louis, MI, USA) as
reference liquids [40]. For each surface, at least 10 measurements with each liquid were performed at
25 ± 2 ◦C.
According to van Oss [39], the total surface energy (γTOT) of a pure substance is the sum of
the apolar Lifshitz-van der Waals components of the surface free energy (γLW) with the polar Lewis
acid-base component (γAB):
γTOT = γLW + γAB (1)
The polar AB component comprises the electron acceptor γ+ and electron donor γ− parameters,
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The surface energy components of a solid surface (s) are obtained by measuring the contact
angles (θ) with the three different liquids (l), with known surface tension components, followed by the
simultaneous resolution of three equations of the type:













The degree of surface hydrophobicity is expressed as the free energy of interaction (ΔG mJ·m−2)
between two entities of that surface immersed in a polar liquid (such as water (w) as a reference

























If the interaction between the two entities is stronger than the interaction of each entity with water,
ΔG < 0, the material is hydrophobic and if ΔG > 0, the material is hydrophilic.
Additionally, the surface charge of each polymer was characterized through the zeta potential.
Particle suspensions of each material [41] were prepared in order to measure the electrophoretic
mobility, using a Nano Zetasizer (Malvern Instruments, Malvern, Worcestershire, UK).
2.9. Numerical Simulations
The flow in the cell was simulated by numerical methods to clarify the stability and the predictability
of the flow patterns near the observation region. The microchannel used has a rectangular cross section
of 450 × 100 μm and a length of 15 mm. The channel is represented in Figure 2a. In Figure 2a it is
possible to observe the lowered surface represented in grey, the region of interest in black and the
limits of the numerical domain. The inlet and outlet have a diameter (Din) of 0.44 mm (represented in
Figure 2a). A profile along the channel, showing the level of the lower and upper walls, is represented
in Figure 2b.
A section of the microchannel, around the visualization region, was selected for simulation domain
(Figure 2c). This region includes the lowered surface, which results from the fabrication method, where
the region of interest is located. The length of the domain is 5 mm. The lowered surface has a length
of 3 mm and a width of 3 mm. The lowered surface level is approximately 10 μm. The cross section
available for flow in the lowered surface region is shown in Figure 2f. Outside the lowered region the
cross section available for the flow is rectangular (Figure 2e). A detail of the mesh used is shown in
Figure 2d.






where ρ and μ are the density and viscosity of the fluid, respectively, Q the flow rate, W the width of
the channel and H the depth of the channel.
Numerical values of the wall shear stress (WSS) are compared with data from the analytical










Nominal wall shear stress, used to distinguish the experiments, was calculated through
the analytical Equation (6). The real wall shear stress, as given by the numerical simulation,
is slightly different.
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where τ is the wall shear stress in the straight channel (outside the lowered surface) and Hls the depth
of the channel in the lowered surface section.
Numerical simulations were made with the commercial code Ansys Fluent CFD package (version
14.5) by solving Navier–Stokes equations. A model of the microchannel was built in Design Modeler
14.5 and was discretized into a grid of 278,000 cells by Meshing 14.5. The QUICK scheme [43] was used
for the discretization of the momentum equations and the PRESTO! scheme for the discretization of
the pressure terms. The velocity–pressure coupled equations were solved by the PISO algorithm [44].
The no slip boundary condition was considered for all the walls. Simulations were made in steady
state mode until convergence. The properties of water (density and viscosity) at 37 ◦C were used.
Corrected numerical results were calculated by applying Equation (7). The value of τ used was
the wall shear stress of a straight channel (without a lowered surface) previously obtained numerically.
3. Results
3.1. Hydrophobicity
The surface properties of the different materials fabricated are presented in Table 3. Results
showed that PLLA, PDMS, PA and PS are hydrophobic surfaces (ΔG < 0 mJ·m−2) whereas PEO is
hydrophilic (ΔG > 0 mJ·m−2). For illustration, water droplets are shown in Figure 3 for different
materials. Additionally, the zeta potential results showed that all the polymers’ surfaces have a
negative charge. The range of surface characteristics assures that the procedure can be used to study a
large range of surface parameters, a very important factor for bacterial adhesion studies, wherein it is
desirable to cover the characteristics of all available materials used in medical or industrial applications.
Table 3. Surface properties of different materials.







Figure 3. Water droplet over the surfaces of PDMS, PA, PS, poly-l-lactide acid (PLLA) and Polyethylene
oxide (PEO) illustrating the hydrophobicity of the materials.
3.2. Adhesion
Adhesion tests were performed for all 5 materials cited in Table 3. A subset of the results obtained
(for PS, PLLA and PDMS) is represented in Figure 4. The images show the surface after 1800 s assays
and the processed images. Cells are visible in all three surfaces studied and so the images can be
processed to obtain a clean image for cell counting. Adhesion data for the 1800 s of test are shown in
Figure 5. The data show that different materials have distinct adhesion behaviour. A higher bacterial
adhesion was observed on the PDMS surface during the 1800 s assay while a lower bacterial adhesion
was observed on the PS surface. Additionally, it was observed that bacterial adhesion increases linearly
with time. Additional results are shown for PA and PEO in Figures 6 and 7.
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Figure 4. Images for adhesion in different materials for t = 1800 s: PS, PLLA and PDMS. Top row
is before and bottom row after image processing. Results obtained for nominal wall shear stress of
0.02 Pa.
 
Figure 5. Number of adhered cells per cm2 for PS, PLLA and PDMS for nominal wall shear stress of
0.02 Pa.
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Figure 6. Images for adhesion in different materials for t = 1800 s: PA and PEO. Top row is before and
bottom row after image processing. Results obtained for nominal wall shear stress of 0.01 Pa.
 
Figure 7. Number of adhered cells per cm2 for PA and PEO for nominal wall shear stress of 0.01 Pa.
An experiment was performed to test if the unevenness of the channel can change significantly
the adhesion rate. To achieve this goal, experiments were performed in a PDMS channel produced by
the same fabrication method. First, a layer of PDMS was spincoated over a glass slide. Then, a scotch
tape was used to protect a small region, as described in the methods section. Then, a second layer of
PDMS was spincoated over the first one. The slide was then used to produce the channels. Figure 8
shows the bacterial cell density along the channel after 1800 s for three different shear stresses. As can
be seen in the figure, the presence of a lowered surface in the scotch tape location is not perceptible.
The variability of adhesion along the channel is much higher than any possible effect produced by the
lowered surface.
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Figure 8. Cell density after 1800 s of adhesion on PDMS for three different nominal wall shear stresses.
(a) WSS = 0.02 Pa; (b) WSS = 0.2 Pa; (c) WSS = 1 Pa.
3.3. Numerical Simulation
Wall shear stress (WSS) at the bottom wall and velocity fields at the midplan are represented in
Figures 9 and 10, respectively. These figures show a small velocity decrease in the region of the channel
crossing the lowered surface. Lateral regions (see Figure 2) of the lowered surface have an almost zero
velocity. The wall shear stress is also smaller in the part of the channel that crosses the lowered surface
region, where the region of interest is located.
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Figure 9. Wall shear stress (WSS) in the lowered surface region for a nominal wall shear stress of 1 Pa.
 
Figure 10. Velocity magnitude in the midplan in the lowered surface region for a nominal wall shear
stress of 1 Pa.
Figure 11 shows the wall shear stress along the centreline of the bottom wall of the channel.
The figure is for the higher nominal WSS studied (1 Pa), but results for the other wall shear stresses,
not shown here, are similar. Some edge effects are observable, mainly due to the influence of the
inlet and outlet boundary conditions. At the inlet, the edge effects are small, revealing that the flow
develops in a short length, and enters fully developed in the lowered surface region. In this lowered
region, the wall shear stress is smaller. A small transition region exists of about 300 μm.
The analytical Equation (6) underpredicts the numerical WSS data in the channel outside the
lowered region. This result is expected since the analytical equation is exact only for channels with an
infinite width. In the present case the ratio between the width and the height of the channel is 4.5,
which implies that the velocity is higher than what would be in a channel with infinite width.
The correction—Equation (7)—made on the analytical equation underpredicts the WSS in the
lowered surface, while the correction made to the numerical results predicts correctly the WSS in the
lowered surface.
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Figure 11. Wall shear stress along the centreline at the bottom surface in the lowered region for a
nominal wall shear stress of 1 Pa. Figure shows numerical predictions (symbols), predictions based
on analytical Equation (6) and predictions with corrections based on Equation (7). Local domain
coordinates are used to represent the distance from the domain inlet.
4. Discussion
A technique developed to create microchannels with polymeric patches for adhesion tests allows
the fabrication of patches with several different materials. Surface hydrophobicities of the materials
used in this work, range from −65.32 to 0.350 mJ m−2 and zeta potential from −11.0 to −29.8 mV. From
the bacterial adhesion results on five selected materials (PLLA, PDMS, PA, PEO and PS), it was verified
that these different materials led to different adhesion behaviours. According to the thermodynamic
theory, a higher bacterial adhesion would be expected on the most hydrophobic surface and a decrease
would be expected with decreasing hydrophobicity [45]. A lower bacterial adhesion was in fact
obtained in PS, the less hydrophobic surface. However, a higher number of adhered bacteria was
observed in PDMS and not in the most hydrophobic surface, PLLA and PEO, which is hydrophilic,
has a higher adhesion that PA, which is hydrophobic. Additionally, no correlation between bacterial
adhesion and surface charge was found. Although it was verified that bacterial adhesion was not
controlled by surface hydrophobicity or charge, other specific parameters of each surface, such as
chemical composition, may have affected bacterial adhesion. The effect of surface properties may also
be concealed by the flow conditions. The results presented in this paper are for WSS of 0.01–0.02 Pa
and low Reynolds number, for which cell sedimentation has relevant contribution to cell adhesion.
These results show that different materials, with different properties, were in fact placed in a specific
position in the microchannel and induce different bacterial adhesion.
One of the inherent weaknesses of the method is the fact that a region of the microchannel is
lowered, i.e., there is a small gap of about 10 μm in the edges of this region. The tests performed with
PDMS surfaces (Figure 8) for wall shear stresses between 0.02 Pa and 1 Pa show that the lowered surface
does not influence adhesion. Hydrodynamic consequences of this lowered surface were studied in
detail by CFD. The CFD study shows that the region has a smaller WSS. Nevertheless, the WSS in this
region is stable and calculable by Equation (7). Overall, the results obtained showed that the device
performs predictably in adhesion tests and can be adopted for general use in routine tests.
The accuracy of the channels obtained by the current procedure is limited by the accuracy of
the underlying microfabrication technique. In the current work the channels were fabricated by
xurography, which has an error of approximately 5% to produce channels of 450 μm width [46].
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5. Conclusions
A new low-cost device for adhesion tests in polymeric surfaces, which can be fabricated in a
laboratory with low resources, was developed and characterized. The most expensive equipment
used in the fabrication procedure is a spin coater. The fabrication method is suitable to produce
microchannels to test bacterial adhesion in different materials, provided that the material is available
as a transparent substrate or that the material is a spincoatable transparent polymer that can be casted
by solvent evaporation.
The section of the channel containing the region of interest is lowered. However, this lowered
surface has a predictable effect on wall shear stress and a negligible one on bacterial adhesion, as shown
by adhesion tests and CFD.
The device was validated to be used to perform bacterial adhesion tests under relevant shear
stresses. This work contributes to increase the options for experimenters to perform adhesion tests in
microfluidic devices, with advantages related to reactant consumption and parallelization.
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Abstract: Some cells cultured in vitro have multiple nuclei. Since cultured cells are used in various
fields of science, including tissue engineering, the nature of the multinucleated cells must be
determined. However, multinucleated cells are not frequently observed. In this study, a method
to efficiently obtain multinucleated cells was established and their morphological properties were
investigated. Initially, we established conditions to quickly and easily generate multinucleated cells by
seeding a Xenopus tadpole epithelium tissue-derived cell line (XTC-YF) on less and more hydrophilic
dishes, and incubating the cultures with medium supplemented with or without Y-27632—a ROCK
inhibitor—to reduce cell contractility. Notably, 88% of the cells cultured on a less hydrophilic dish
in medium supplemented with Y-27632 became multinucleate 48 h after seeding, whereas less than
5% of cells cultured under other conditions exhibited this morphology. Some cells showed an odd
number (three and five) of cell nuclei 72 h after seeding. Multinucleated cells displayed a significantly
smaller nuclear area, larger cell area, and smaller nuclear circularity. As changes in the morphology
of the cells correlated with their functions, the proposed method would help researchers understand
the functions of multinucleated cells.
Keywords: multinucleated cells; XTC-YF cells; morphological analysis; Y-27632; hydrophobic dish
1. Introduction
Most cell types normally have a single nucleus, whereas some types of cells contain multiple
nuclei. Nuclear division without cytokinesis occurs in some types of mammalian cells, including
megakaryocytes, which produce blood platelets, and some hepatocytes and heart muscle cells [1].
Cells of the monocyte/macrophage lineage can fuse and form large multinucleated giant cells that
have long been recognized as a histopathological hallmark of tuberculosis, schistosomiasis and other
granulomatous diseases [2]. Even mononuclear cells sometimes become multinucleated cells in
culture [3].
Some studies indicate concerns of multinucleated cells to pathophysiological events. When
endothelial cells obtained from sites of arteriosclerosis are cultured, they exhibit a multinucleated
morphology [4]. Multinucleated cells are frequently seen in malignant neoplasms [5]. Multinucleated
giant cells are found in epulis, during unusual patterns of chronic inflammation, and are responsible
for eliminating foreign bodies and cell debris by phagocytosis [6].
The mechanism by which the properties of mononuclear cells are altered to a multinucleated
morphology is not completely understood. Since researchers have attempted to use cells cultured
in vitro for tissue engineering [7], understanding of the properties of multinucleated cells is important
to produce risk-free tissues.
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The ultimate goal of the present study is to investigate the properties of multinucleated cells. For
the purpose, we initially established a method to efficiently obtain multinucleated cells because people
still struggle with harvesting multinucleated cells. The existence of multinucleated cells of NMFH-2
and NMFH-1 cells were 10.2% and 5.00%, respectively [5]. If experimental systems to collect many
multinucleated cells are established, various biochemical, molecular and immunological assays can
be made. Although a method designed to incubate multinucleated cells by exclusively selecting and
sub-culturing these cells has been reported, the procedure took 10 months [3]. Zang et al. observed
multinucleated cells after culture on a hydrophobic substrate in the absence of myosin [8]. In this
study, we tested the administration of Y-27632, a ROCK inhibitor that decreases myosin activity and
cell contractility, to efficiently obtain any type of cell without gene transfer. The cells were incubated
on a less hydrophilic dish and cultured with Y-27632. After establishing the method for generating
multinucleated cells, the nature of the multinucleated cells was evaluated based on the morphology
of the cells and cell nuclei. This experiment is based on reports that alterations in the nuclear size
and shape are associated with and diagnostic markers of human diseases, including cancer and other
pathologies [9,10].
2. Materials and Methods
2.1. Contact Angle of Dishes
Reportedly, multinuclear cells are more frequently observed after culture on a hydrophobic
surface [8]. Thus, we initially assessed the hydrophobicity of a dish. The contact angle θ of the dish
surface was measured to evaluate its hydrophobicity. A 5 μL water drop was placed on ϕ 35 mm
plastic dish (430165, CORNING, Corning, NY, USA) and ϕ 35 mm glass bottom dish from Fine Plus
International (FC27-10N, FPI, Kyoto, Japan) and Matsunami Glass Industry (D11140H, Matsunami,
Kishiwada, Japan). After imaging the droplet from the lateral side of the dish with a digital camera
(CX3, Ricoh Imaging, Tokyo, Japan), the radius r of the contact area and height h of the droplet
was measured using image analysis software (ImageJ 1.48v, National Institutes of Health, Bethesda,
MD, USA) as follows. First, ten points on the edge of the droplet were spotted manually and their
coordinates (xi, yi) (i = 1, 2, 3, . . . , 10) were measured. Then, a circle that fits the measured points was
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where A, B, and C are parameters of the circle. The equation of the circle is given by:
x2 + y2 + Ax + By + C = 0. (2)









The height of the droplet h was directly measured from lateral images of the droplet. The contact





using the half angle method [11].
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2.2. Cells
Xenopus laevis cells derived from tadpoles (XTC-YF, RCB0771, RIKEN BioResource Center,
Tsukuba, Japan) were used for ease of handling. The cells were cultured at 25 ◦C in culture medium
(Leibovitz’s L-15 Medium, Wako Pure Chemical Industries, Osaka, Japan) that had been diluted
two-fold with sterilized distilled water. The medium included 10% fetal bovine serum (S1820, Biowest,
Nuaillé, France) and a 1% antibiotic solution (P4333, Sigma-Aldrich, St. Louis, MO, USA).
2.3. Conditions Used to Prepare Multinucleated Cells
XTC-YF cells were seeded on the FPI and Matsunami glass bottom dishes to investigate
the conditions required to generate multinucleated cells. Y-27632 (257-00511, Wako Pure
Chemical Industries) was added to the culture medium at a concentration of 100 μM to suppress
myosin-induced contraction.
The cultured cells were fixed with 10% neutral buffered formalin for 10 min followed by washes
with phosphate-buffered saline (PBS(-)) to confirm the multinucleated phenotype. The cells were
immersed in 32 μM Hoechst 33342 (Molecular Probes, Thermo Fisher Scientific, Tokyo, Japan) for
20 min to fluorescently stain the cell nuclei and washed with PBS(-). Phase contrast images of the
cells and fluorescently stained cell nuclei were captured using an inverted fluorescence microscope
(IX-71, Olympus, Tokyo, Japan) equipped with an EM-CCD camera (iXon Ultra 888, Andor Technology,
Belfast, UK) through a 20× (UPLFLN20X, Olympus) or 40× (LUCPLFLN40X, Olympus) objective lens.
For image analysis, 680 μm × 680 μm images at 20× magnification and 340 μm × 340 μm images
at 40× magnification were captured. The image analysis software (ImageJ 1.48v) was used to create a
superimposition of the phase contrast and fluorescence images. The total numbers of cells, Nall, and
multinucleated cells, Nmulti, in the images were counted. The percentage of multinucleated cells Rmulti




× 100 [%]. (5)
2.4. Time-Lapse Imaging
Time-lapse images were captured to directly observe cell division. The XTC-YF cells were seeded
on the FPI glass bottom dish, as described in Section 2.3, and observed under an inverted microscope
(IX-73, Olympus) equipped with a CCD camera (DP73, Olympus). The phase contrast images of the
cells were captured through the 20× objective lens at 5 min intervals from 3 to 72 h after seeding.
2.5. Morphometry of the Cells and Cell Nuclei
The XTC-YF cells were seeded on FPI glass bottom dishes, and half of the cultures were treated
with 100 μM Y-27632. After a 48 h incubation, cells were fixed and stained as described in Section 2.3.
The phase contrast images and images of the fluorescently labeled nuclei were captured using the
setup described in Section 2.3. The images of the fluorescently labeled cell nuclei were binarized to
obtain nuclear outlines. The cell shapes were manually outlined in the phase contrast image. From
the outlines of the cells and nuclei, the cellular area Scell and nuclear area Snucleus were measured. In
the case of multinucleated cells, the areas of individual nuclei were measured. The cellular (αcell) and
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where Mcell and Mnucleus represent the major axis of the best fit ellipse of the cellular and nuclear
areas, respectively. A circularity value of 1 represents a perfect circle and a value of 0 indicates a
(segmented) line.
2.6. Statistical Analysis
The difference in contact angle between the dishes was determined using the Tukey method. The
differences in morphological data between mononuclear and multinucleated cells were determined
using unpaired t-tests. The data are presented as the means ± standard deviations (SD), and the
significance level was set to p = 0.05.
3. Results and Discussion
3.1. Contact Angle of Glass Bottom Dishes
Images of droplets on dishes are shown in Figure 1. The glass bottom dish manufactured by FPI
had a significantly larger contact angle (93 ± 2◦, n = 10; Figure 1a) than the glass bottom dish from
Matsunami Glass Industry (71 ± 4◦, n = 10; Figure 1b) and plastic dishes (66 ± 3◦, n = 10; Figure 1c). All
groups had a significant difference in the contact angle. Based on these results, the dish manufactured
by FPI is less hydrophilic than the dish manufactured by Matsunami Glass Industry and plastic dishes.
Thus, in the following experiments, we used the glass bottom dish manufactured by FPI as a less







(a) Glass bottom dish (FPI) (b) Glass bottom dish (Matsunami) (c) Plastic dish (Corning) 
Figure 1. Typical images of droplets plated on (a) glass bottom dishes manufactured by Fine Plus
International (FPI) and (b) Matsunami and (c) a plastic dish. Image contrast was enhanced for visibility.
Bars correspond to 2 mm calibrated at the surface of the dish.
3.2. Comparison of Multinucleated Cells Plated on Different Dishes
Figure 2 shows typical images of XTC-YF cells after the administration 100 μM Y-27632 at 48
h after seeding. Many multinucleated cells were observed after seeding on a less hydrophilic glass
bottom dish (manufactured by FPI) and an incubation in medium containing Y-27632 (Figure 2a). On
the other hand, when cells were seeded on a more hydrophilic dish (manufactured by Matsunami) or
seeded on a less hydrophilic dish but incubated in normal medium, few multinucleated cells were
observed (Figure 2b–d). Figure 3 plots the percentage of multinucleated XTC-YF cells (Rmulti) as
a function of time after seeding. On the less hydrophilic glass bottom dishes, the Rmulti gradually
increased, reaching 88% after 48 h. When the cells were seeded on the less hydrophilic dish without
Y-27632 or on a more hydrophilic dish, the Rmulti was ≤ 5%, even after 48 h. Therefore, the condition
required to produce multinucleated XTC-YF cells was incubation on a less hydrophilic dish in media
containing 100 μM Y-27632. These results were in good agreement with a previous report showing that
cells exhibited a multinucleated morphology after culture on a hydrophobic surface under conditions
that inhibited myosin shrinkage [8]. Since Y-27632 is a Rho-kinase inhibitor that suppresses cellular
contraction, the reagent is considered to inhibit cytokinesis.
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(a) Less hydrophilic, Y-27632(+) (b) Less hydrophilic, Y-27632(-) 
  
(c) More hydrophilic, Y-27632(+) (d) More hydrophilic, Y-27632(-) 
Figure 2. Typical images of XTC-YF cells seeded on (a,b) less hydrophilic (FPI) and (c,d) more
hydrophilic (Matsunami) glass bottom dishes. Cells were incubated with (a,c) normal medium
containing 100 μM Y-27632 and (b,d) normal medium alone. Multinucleate cells are shown in red and
their nuclei are shown in blue. Scale bars represent 100 μm.
Figure 3. The percentage of multinucleated cells (Rmulti, as defined in Equation (5)) of XTC-YF cells
after seeding on less (FPI) and more hydrophilic (Matsunami) dishes and culture in the presence or
absence of Y-27632. n, Number of cells.
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Multinucleated cells are produced at a high rate when the contractile force of myosin is inhibited
and after culture on a relatively less hydrophilic dish. Unlike the long-term culture method [3], the
present method yields multinucleated cells in the usual culture period. Additionally, unlike the gene
transfer method [8], the present method is designed to study multinucleated cells in situ since the
modification of gene expression is not required. The present method is thus beneficial for studying
effects of multinucleation on cellular functions.
The surface hydrophobicity can be controlled by coating octadecyltriethoxysilane or fluorine
resin-coating. The tuning of hydrophobicity for efficient production of multinuclear cells remain as
future tasks.
3.3. Changes in the Number of Nuclei during the Incubation
Time-lapse images were captured to confirm that the multinucleated cells were not generated by
fusion but instead through inefficient division. The time-lapse images of XTC-YF cells seeded on the
less hydrophilic dish and cultured with medium containing 100 μM Y-27632 are shown in Figure 4 and
Video S1. Over time, the projected area of the cells gradually increased (Figure 4b), and cells exhibiting
a mononuclear morphology at the time of adhesion developed multiple nuclei following a subsequent
cell division without cytokinesis (Figure 4c–e). Thus, the XTC-YF cells became multinucleated through
inefficient division. The time of the first cell division after seeding was 21.5 ± 11.5 h. Some multinuclear
cells divided again and the number of nuclei increased over time (Figure 4e–h). When multinucleated
cells divided, all nuclei divided at the same time (Figure 4f). However, multinucleate cells with two
nuclei sometimes divided into odd numbers of nuclei, such as three or five cell nuclei (Figure 4h). As
shown in Figure 4 and Video 1, cells underwent multipolar mitosis and two clusters of chromosomes
segregated into a single nucleus. This chromosomal mis-segregation is likely to produce aneuploid
progeny [12], which is a condition associated with cancer [13,14].
(a) (b) (c) (d) 
(e) (f) (g) (h) 
Figure 4. Typical time-lapse images of the XTC-YF cells incubated in medium containing 100 μM
Y-27632 and seeded on a less hydrophilic glass bottom dish. Bars in (h) = 30 μm and are applicable to
all images. The numbers in the upper left of the panels indicate the time after seeding.
Figure 5 shows the relationship between the elapsed time and the number of nuclei per cell.
Forty-eight hours after seeding, many cells contained two nuclei. As shown in Figure 4 and Video 1,
multinucleated cells further divided at later time points. This division increased the number of cells
with more than two nuclei and decreased the number of cells with two nuclei at 72 h after seeding.
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Figure 5. The number of nuclei in XTC-YF cells incubated with medium containing 100 μM Y-27632
and seeded on less hydrophilic glass bottom dishes.
3.4. Morphology of the Cells and Cell Nuclei of Multinucleated and Mononuclear Cells
Figure 6a shows the nuclear area (Snucleus) of multinucleated and mononuclear cells. The Snucleus
of the multinucleated cells was significantly smaller than mononuclear cells. As confirmed in Video 1,
chromosome division definitely occurred, and thus the smaller nuclei observed in multinuclear cells
indicated chromosomal condensation. Since the nuclear size positively correlates with nuclear import
rates and the concentrations of two transport factors, importin α and Ntf2 [15], the concentrations of
these factors might be reduced in multicellular cells compared with mononuclear cells. Importin α
and Ntf2 modulate the import of lamin B3 [15], a major component of the nuclear lamina that supports
the nuclear envelope and is involved in DNA replication [16], suggesting a possible difference in DNA
replication between multinucleated and mononuclear cells.
A cell nucleus divided, as confirmed in the time-lapse movie (Video S1). Thus, normal numbers
of chromosomes would be present in a single nucleus, even in the multinucleated cells. As shown
in the results presented in Figure 6a, the Snucleus of the multinucleated cells was much smaller than
mononuclear cells. Since the nuclear volume in cancer cells influences the proliferative activity [17],
multinucleated cells might display differences in cell proliferation.
Figure 6b shows the cellular area (Scell) of multinucleated and mononuclear cells. The Scell of
the multinucleated cells was significantly larger than mononuclear cells. In this study, Y-27632 was
administered to obtain multinucleated cells. Since Y-27632 interferes with myosin II activity and
reduces the tension of stress fibers, a cell treated with Y-27632 spreads and exhibits an increased
cellular area [18]. Thus, the significant increase in the cell area of multinucleated cells might be
due to the effect of Y-27632. Further experiments will be needed to determine whether Y-27632 or
multinucleation increased the cell area.
According to Wilson, the ratio of the area of the cell nucleus to the area of the cell is a constant
value [19]. If the ratio in multinucleated cells is defined for each nucleus within a cell, the ratio
observed for multinucleated cells at 48 h after seeding (2.4 ± 0.6%) was smaller than mononuclear
cells (5.9 ± 2.1%). However, multinuclear cells contain at least two nuclei. Thus, if the sum of the
nuclear area in a single multinucleated cell is considered, the ratio is comparable to the nuclear area
of mononuclear cells (5.0 ± 1.3%). In this sense, the ratio proposed by Wilson [19] is applicable to
multinuclear cells.
Figure 6c shows the nuclear circularity (αnucleus) of multinucleated and mononuclear cells.
The nuclear circularity of the multinucleated cells was significantly smaller than mononuclear cells.
The circularity of the nucleus tends to decrease in the presence of an abnormal number of chromosomes
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in cancer cells [20]. Thus, we speculated that the nuclei of multinucleated cells contain an abnormal
number of chromosomes.
Figure 6d shows the cellular circularity (αcell) of the multinucleated and mononuclear cells. There
were no significant differences in the cellular circularity between the multinucleated and mononuclear
cells, and the cellular circularity appeared to be lower in the multinuclear cells. The cells treated with
Y-27632 exhibited an increased degree of polarization and decreased circularity [21–24], or no change
in cellular circularity [25]. Since Y-27632 was administered to obtain multinucleated cells in this study,
the multinucleation of cells appears to decrease their circularity.
As shown in Figure 6, the morphology of the cell and cell nucleus of the multinucleated cells was
completely different from the mononuclear cells. Since defects in nuclear size and shape are associated
with and diagnostic markers of human disease, including cancer and other pathologies [9,10], further
investigations focusing on cellular functions and their mechanisms will be required.
  
(a) Nuclear area Snucleus 
 
(b) Cell area Scell 
 
(c) Circularity of the nucleus αnucleus 
 
(d) Circularity of the cell αcell 
Figure 6. Morphology of multinucleated and mononuclear XTC-YF cells 48 h after seeding on the
less hydrophilic glass bottom dish. Morphological data, such as (a) the nuclear area, (b) cell area, (c)
circularity of the nucleus, and (d) circularity of the cell, are shown. n, Number of nuclei; *, p < 0.05.
4. Conclusions
In summary, the present study established conditions to generate multinucleated XTC-YF cells,
by seeding the cells on a less hydrophilic dish in a medium containing Y-27632. The present method
quickly and easily produced multinucleated cells compared to pioneering methods [3,8]. Some cells
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divided to produce cells with an odd number of nuclei. The multinucleated cells had a significantly
smaller nuclear area, larger cell area, and smaller nuclear circularity. The present method could
contribute to improving our understanding of the nature of multinuclear cells.
Supplementary Materials: The following materials are available online at http://www.mdpi.com/2072-666X/
10/2/156/s1, Video S1: Time-lapse images of cell division.
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Abstract: Metastatic cancer cells are known to have a smaller cell stiffness than healthy cells because
the small stiffness is beneficial for passing through the extracellular matrix when the cancer cells
instigate a metastatic process. Here we developed a simple and handy microfluidic system to assess
metastatic capacity of the cancer cells from a mechanical point of view. A tapered microchannel was
devised through which a cell was compressed while passing. Two metastasis B16 melanoma variants
(B16-F1 and B16-F10) were examined. The shape recovery process of the cell from a compressed state
was evaluated with the Kelvin–Voigt model. The results demonstrated that the B16-F10 cells showed
a larger time constant of shape recovery than B16-F1 cells, although no significant difference in the
initial strain was observed between B16-F1 cells and B16-F10 cells. We further investigated effects of
catechin on the cell deformability and found that the deformability of B16-F10 cells was significantly
decreased and became equivalent to that of untreated B16-F1 cells. These results addressed the utility
of the present system to handily but roughly assess the metastatic capacity of cancer cells and to
investigate drug efficacy on the metastatic capacity.
Keywords: microfluidics; mechanophenotyping; cancer; metastatic potential
1. Introduction
Metastasis is the spread of cancer cells from the primary site of origin to other sites of the body.
When cancer cells metastasize, some cells known as circulating tumor cells (CTC), penetrate the
endothelium and the basement membrane and pass through a tiny gap in the extracellular matrix [1–3].
It is therefore thought that having smaller stiffness is beneficial for cancer cells to instigate the metastatic
process [4]. In support of this, only few studies show that cancer cells are stiffer, and a large majority
of experiments indicate that cancerous cells are softer than their benign counterparts and that cellular
rigidity decreases with the progression of the disease—as summarized in Aliber et al. [4]—although it
remains unclear whether such cell softening is a universal feature [5].
Various tests were conducted to mechanically characterize living cells including cancer cells [6–15].
Mechanical studies on cancer cells and related cancer biology are thoroughly reviewed in Darling
et al. [16], Aliber et al. [4], and Chaudhuri et al. [17]. Using atomic force microscopy, Cross et al. [8]
demonstrated that metastatic cancer cells taken from the pleural fluids of patients with suspected lung,
breast, and pancreas cancer have stiffness as much as 70% smaller than the benign cells. Remmerbach
et al. [11] measured the compliance of cells from cell lines and primary samples of healthy donors
and cancer patients using a microfluidic optical stretcher. They found that cancer cells were on
average 3.5 times more compliant than those of healthy donors. Swaminathan et al. [12] showed
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that cancer cells with the highest migratory and invasive potential are five times less stiff than
cells with the lowest potential. Furthermore, they reported that invasiveness decreased when cell
stiffness, by restoring expression of the metastasis suppressor TβRIII/betaglycan, increased. It was
also reported that the more motile and metastatic cancer cells were, the softer they were, indicating
that nanomechanical stiffness was inversely correlated with the migration potential of the cancer
cell [13,14]. These results suggest that the cell stiffness is a reliable quantitative indicator or a good
biomarker of migration and the invasive potential of cancer cells. However, the conventional methods
of mechanical tests such as atomic force microscopy, optical tweezers, and micropipette aspiration are
time-consuming, labor-intensive, and often require difficult manipulation and mastery skills although
they give relatively accurate data [18]. Additionally, each method has its own drawback. For instance,
atomic force microscopy requires a cell adhering to a basement. Micropipette aspiration involves
difficult manipulation and fine adjustment of pressure. In order to use the cell stiffness as a biomarker
of the metastatic potential of cancer cells in clinical practice, more viable methods are demanded.
Microfluidic devices have high throughputs in selecting cancer cells and assessing their metastatic
functions [19–24]. For example, Hou et al. [22] and Khoo et al. [23] established a spiral microfluidic
channel to separate CTCs from blood cells. Tse et al. [24] evaluated the mechanical properties of cells
sampled from malignant pleural effusions using a crossed microfluidic channel, proposed by Gossett
et al. [25]. These studies addressed a great potential of microfluidic techniques to handily characterize
the mechanical properties of cancer cells in clinical practice.
Epigallocatechin gallate (EGCG) is a major component of green tea. Taniguchi et al. [26] reported
that EGCG inhibited the spontaneous metastasis of B16-F10 cells and B16-BL6 cells to the lungs
of mice. EGCG binds to various proteins and both DNA and RNA molecules [27], it also inhibits
binding of ligands and tumor promoters to their receptors in the cell membrane, and the receptor
signaling pathway of epidermal growth factor (EGF) [28]. EGCG also works as an immune check
point inhibitor [29]. EGCG acts on the cell membrane of cancer cells, hardens the cell membrane [30],
and suppresses cancer cell migration and invasion [31]. EGCG blocks induction of carcinogenic factors
by hardening the cell membrane and inhibits metastasis of cancer cells [32]. Taking these facts together,
it is considered that hardening of cancer cells with EGCG could be another way of inhibiting metastasis
of cancer cells.
Better and more appropriate cancer therapies, including a choice of drugs (weak or strong)
with minimal side effects, could be applied if the metastatic potentials of the circulating tumor cells
were easier to evaluate in clinical practice. The aim of the present study is therefore to investigate
the mechanical properties of cancer cells, in particular highlighting internal cytoskeletal structures
and changes brought by EGCG treatment. A microflow channel of a simple design was used to
evaluate cell stiffness. Here we used two cell types that are known to have different metastatic
potential and investigated whether these cells can be differentiated from their viscoelastic properties.
The same assessment process was also applied to untreated and EGCG-treated cells to see whether
effectiveness of EGCG treatment can be detected using the same procedure as used in differentiating
the metastatic potential.
2. Materials and Methods
2.1. Cell Sample
Mouse melanoma cell lines B16-F1 and B16-F10 were used. B16-F1 was obtained by a one-time
selective procedure and B16-F10 by a ten-time selective procedure using Fidler’s method [33], meaning
that B16-F10 was a select group of cancer cells having greater invasive and metastatic capacity than
B16-F1. The characteristics of the cells were reported in Fidler [33], Poste et al. [34], and Nakamura et
al. [35]. The cells were cultured in DMEM (05919, Nissui, Tokyo, Japan) containing 10% fetal bovine
serum (172012, Sigma-Aldrich, St. Louis, MO, USA) in a humidified atmosphere of 5% of CO2 at 37 ◦C.
128
Micromachines 2019, 10, 207
Trypsin (25200-056, Gibco, Gaithersburg, MD, USA) was added to the cells that were
semi-confluent to detach them from dishes. After the cells were washed with phosphate buffered
saline (PBS(-)), cell samples with a concentration of 3–4 × 105 cells/ml were prepared.
2.2. Microflow Channel
Lee et al. [36] and Lima’s group [37,38] used hyperbolic-shaped contraction for the ability to
impose a constant strain rate along the centerline of the contraction, as well as to achieve high
extensional and shear flows. Although the hyperbolic-shaped contraction was efficient for causing cell
deformation, here we used a linearly tapered microflow channel, as shown in Figure 1a. The geometry
of the channel is similar to that in TruongVo et al. [39], who also used it to characterize breast cancer
cells. The channel has four ports: (a) Inlet for cell flow, (b) and (c) inlets for sheath flow, and (d) outlet.
In design, the main flow channel has a taper with an inlet width of 40 μm, an outlet width of 15 μm,




Figure 1. (a) Schematic drawing of the microflow channel—a, inlet port for cell flow; b and c, inlet
ports for sheath flow; and d, outlet. (b) A fabricated microfluidic device and (c) a magnified view of
the tip of the microflow channel.
The flow channel was fabricated according to standard photolithography and soft lithography
techniques. The negative photoresist pattern was fabricated on a silicon wafer (Matsuzaki, Tokyo,
Japan) with SU8- 3050 (Nippon Kayaku, Tokyo, Japan). PDMS prepolymer (Sylgard 184 silicone
elastomer kit, Toray Dow Corning, Tokyo, Japan) was poured onto the silicon wafer and baked at
80 ◦C for 1 h. Plasma treatment was used to chemically bond the PDMS mold to a glass slide with a
thickness of 0.12–0.17 mm (C050701, Matsunami, Bellingham, WA, USA). The fabricated microfluidic
device and the microscopic image of the tapered part are shown in Figure 1b,c, respectively. In the
final product, the width of the tip was 20 μm and the channel height was 32 μm.
2.3. Experimental Setup
Figure 2 provides a schematic illustration of the experimental setup. The experimental setup
mainly consists of an inverted microscope (IX-71, Olympus, Tokyo, Japan), a high-speed camera
(FASTCAM Mini AX200, Photron, Tokyo, Japan), syringe pumps (KDS-210, KD Scientic, Holliston,
MA, USA), and a flow channel. Cells were introduced to the flow channel by one of the syringe
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pumps. Along with cell flow, sheath flow was also introduced to direct cells to the center of the channel.
The total flow rate of the cell flow and sheath flows was set to 66 μL/min that gave approximately
1.5 m/s at the tip of the tapered channel. The ratio of the flowrate between cell flow and sheath flow
was 1:6. A cell shape at the tip of the taper and its downstream was recorded with a high-speed camera
at a frame rate of 100,000 fps via an objective lens of 60x (N.A. 0.7, LUCPlanFLN 60x, Olympus).
The cell height h(t)—defined as cell length in a direction perpendicular to the flow, exemplified in
Figure 3—was measured using image analysis software (ImageJ 1.48v, National Institutes of Health,
Bethesda, MD, USA).
Figure 2. Schematic illustration of the experimental setup. The microflow channel was placed under
the microscope and cell deformation was recorded with a high-speed camera.
 
Figure 3. A time series of snapshots of a cell showing how the cell was recovering its shape after it had
left the tip of the tapered channel (a). The time interval between consecutive snapshots (b–h) is 20 μs.
The scale bar in Figure 3a applies to all images.
2.4. Mechanical Characterization of a Cell
Cells leaving the tapered channel are released from compressive forces and gradually recover
to their original shape. Here, the compression strain ε(t) of a cell at time t after leaving the tapered





where h(t) is the cell height at time t, and h∞ is the cell height in the last frame where the cell is
sufficiently far from the tip of the tapered channel.
The recovery process of the cell diameter was expressed with a Kelvin–Voigt model that has
a purely viscous damper with a viscosity of μ and a purely elastic spring with a spring constant k
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connected in parallel. When a cell leaves the tapered channel, it is released from the compressive force.
Under this condition, the compressive strain of the cell, ε(t), is expressed with the following formula:






where τ is a time constant of shape recovery and equal to μ/k.
2.5. EGCG Treatment
EGCG is the main polyphenolic constituent of green tea [26]. Reportedly, EGCG inhibits tumor
promotion induced by teleocidin in a two-stage carcinogenesis experiment on mouse skin [40] and
duodenal carcinogenesis with N-ethyl-N’-nitro-IV-nitrosoguanidine [41]. It is also reported that EGCG
inhibits lung colonization of B16-F10 cells and spontaneous metastasis of B16-BL6 cells from the foot to
the lung [26]. Clinical trials have demonstrated that green tea catechins including EGCG are effective
for cancer prevention [42–45]. Here, EGCG was used to stiffen cells by following a protocol described
in Fujiki and Okuda [46]. An EGCG culture medium of 200 μM/L was prepared by diluting an
EGCG/PBS(-) solution of 25 mM/L in DMEM. Cells were cultured with the EGCG culture medium
for 4 h. After the culture, the cells were removed from dishes by treatment with trypsin, which was
followed by centrifuge and removal of the medium. Finally, EGCG-treated cells were suspended in
PBS(-) such that the cell concentration became 3–4 × 105 cells/mL.
2.6. Staining
The cell nucleus and actin filaments of B16-F1 and B16-F10 cells were stained. Staining was
conducted for both cells that were attached to dishes and cells that were floating. The latter group was
prepared by detaching the cells from the dishes with trypsin and leaving them for 30 min at room
temperature until the cells become stably spherical. In the following staining processes, the floating
cells were always centrifuged at a relative centrifugal force of 17.9 g for 5 min at washing and liquid
exchange. First, cells were fixed with 10% neutral buffered formalin for 10 min at room temperature
then washed with PBS(-). The cells were then permeated with 0.2% Triton X-100 in PBS(-) for 10 min
then washed. This was followed by blocking with 4% albumin from bovine serum (Wako)/PBS(-)
solution for 15 min then washing. For staining actin filaments, cells were treated with Alexa Fluor
488 phalloidin, diluted to 1:200 times with PBS(-) in a dark room for 30 min at room temperature.
For staining the cell nucleus, cells were treated with Hoechst 33342 diluted to 1:10,000 with 0.2%
BSA/PBS(-) solution in a dark room for 30 min at room temperature. Images were obtained using a
confocal laser scanning microscope (FV3000, Olympus) with a 60x oil immersion objective lens (N.A.
1.35, UPLSAPO60XO, Olympus). A laser (OBIS, Coherent, Santa Clara, CA, USA) with an excitation
wavelength of 488 nm and 405 nm was used to observe actin filaments and cell nuclei, respectively.
2.7. Statistical Method
Student’s unpaired t-test was used in all statistical analyses. A significance level of 0.05 was used.
3. Results
Figure 3 shows a series of snapshots of a B16-F10 cell flowing downstream from the tip of the
tapered channel. Note that the snapshots in Figure 3 were the ones obtained every two snapshots that
were recorded. The cell size at rest was 15.4 ± 1.6 μm for B16-F1 cells and 15.4 ± 1.4 μm for B16-F10
cells, and no statistical difference was found in cell size between them. As seen, the cell that was
compressed at the tip gradually recovered its shape to being spherical as it flowed further downstream.
A temporal variation of the compressive strain of the cell, ε(t), is shown in Figure 4 where Figure 4a–d
is for untreated B16-F1 cells, untreated B16-F10 cells, EGCG-treated B16-F1 cells, and EGCG-treated
B16-F10 cells, respectively. Note that the graphs in Figure 4 are a representative case of each cell and
treatment condition. All the figures demonstrate an exponential decrease in ε(t) as a function of time.
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Fitting Equation (2) to the data in Figure 4 clearly indicates that a change in the compressive strain
could be represented by the Kelvin–Voigt model.
 t t
t t
Figure 4. Time variations of the compressive strain of the cell. (a) Untreated B16-F1, (b) untreated
B16-F10, (c) epigallocatechin gallate (EGCG)-treated B16-F1, and (d) EGCG-treated B16-F10.
Figure 5 compares the initial compression strain, ε0, when a cell was at the tip of the taper.
The mean ± SD of ε0 was 0.15 ± 0.06 for untreated B16-F1 cells, 0.17 ± 0.09 for untreated B16-F10
cells, 0.15 ± 0.03 for EGCG-treated B16-F1 cells, and 0.18 ± 0.05 for EGCG-treated B16-F10 cells.
No statistical difference was found in ε0 between any combinations.
Figure 5. A comparison of the initial compressive strain, ε0. n: Number of cells.
A comparison of a time constant of the shape recovery τ is presented in Figure 6. The mean ±
SD of τ was 50 ± 15 μs for untreated B16-F1 cells, 70 ± 23 for untreated B16-F10 cells, 59 ± 22 μs for
EGCG-treated B16-F1 cells, and 60 ± 12 μs for EGCG-treated B16-F10 cells. A statistical difference in
τ was found in a pair of untreated B16-F1 cells vs. untreated B16-F10 cells (p < 0.05) and untreated
B16-F1 vs EGCG-treated B16-F1 cells (p < 0.05), while no statistical difference was noted in a pair of
untreated B16-F10 cells vs. EGCG-treated B16-F10 cells and EGCG-treated B16-F1 cells vs EGCG-treated
B16-F10 cells.
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Figure 6. A comparison of the time constant of shape recovery τ. n: Number of cells.
Figure 7 provides fluorescent images of cellular nuclei and the actin filaments of cells. Figure 7a,b
show the cells that remained adhered to dishes, and Figure 7c,d show the cells that were detached from
the dishes. Cell lines were B16-F1 for a and c, and B16-F10 for b and d. The detached cells appeared to
be spherical, while those adhering to dishes spread with extending processes. In looking at Figure 7a,b,
we found that when the cells adhere to dishes, B16-F1 cells had thicker actin filaments than B16-F10
cells, although both cell lines showed fibrous structure of actin filaments. To confirm this perceptual
finding, thickness of actin filaments was evaluated with the standard deviation of a Gaussian function
fitted to the intensity profile across stress fibers. This is because the spatial resolution of 0.083 μm/pixel
in the present images is not fine enough to measure the thickness of actin filaments with a certain
accuracy. The evaluation was conducted for three locations for each of the actin filaments arrowed in
Figure 7. The results demonstrated 2.15 ± 0.71 pixels for B16-F1 cells and 0.99 ± 0.14 pixels for B16-F10
cells (p < 0.05), supporting the perceptual finding of a difference in the thickness. For the cells that
were detached from the dishes, the fibrous structure disappeared and no remarkable difference in the
structure and amount of actin filaments was noticed between B16-F1 cells and B16-F10 cells.
Figure 7. Fluorescent images of actin filaments (green) and nuclei (blue). (a) Adhered B16-F1 cells,
(b) adhered B16-F10 cells, (c) floating B16-F1 cells, and (d) floating B16-F10 cells. Arrows in (a,b)
indicate actin filaments whose thickness was evaluated.
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4. Discussion
Microfluidic devices have been used in prior studies to find circulating tumor cells in blood.
Recently, Tse et al. [24] invented a microfluidic device of a crossed flow channel at the junction
where a cell was deformed by counter striking flows. They successfully classified cells based on
cell deformability and took the initiative in diagnosing malignant pleural effusions by microfluidics.
Raj et al. [47] fabricated a microfluidic device comprised of multiple parallel microconstrictions.
They introduced a theoretical model of cell flow and deformation in the channels and succeeded
in quantifying cell elasticity. The present study is situated in part as an extension of these studies.
As demonstrated in Figure 6, we found that a time constant of shape recovery could be a useful
index to rate the metastatic potentials of cancer cells. Moreover, the time constant could be useful to
assess drug-screening applications where biophysical changes occur in cells. The present microfluidic
system is totally label-free, which would relieve clinicians from the tangled procedure of labeling and
reduce their workload. The microfluidic system proposed here is simple, but its use is not limited to
screening of metastatic cells, it has the potential to be used in many areas of medicine other than cancer
diagnostics. Although some improvements such as quantification of cell viscoelasticity is necessary,
extensive applications of the present system will enable rapid mechanophenotyping of various cells.
Since a tapered portion of the channel was sufficiently long compared to cell size, viscous
deformation was assumed to have completed before a cell left the taper. In other words, in the current
system, it was considered that the effect of cell viscosity on cell deformation or shape at the tip of
the taper was considered to be small and the initial strain ε0 was determined mostly by cell elasticity.
As shown in Figure 5, the initial strain ε0 of B16-F1 cells was almost the same as that of B16-F10 cells,
leading to an assumption that there was no difference in cell elasticity between B16-F1 cells and B16-F10
cells. Moreover, as shown in Figure 6, B16-F10 cells had a significantly larger time constant τ than
B16-F1. As time constant τ is a ratio of the viscosity to the elasticity of a cell, μ/k, the assumption that
there was no difference in cell elasticity between B16-F1 cells and B16-F10 cells indicated that B10-F10
cells had larger cell viscosity than B10-F1 cells. In light of a biological viewpoint that more metastatic
and invasive cells should be softer to pass through a narrow gap in extracellular matrix, larger cell
viscosity could be unbeneficial for metastatic cells. The biological relevance of larger viscosity for more
metastatic cells remains inconclusive and should be clarified in future research.
The width of the flow channel at the exit of the tapered channel was 20 μm. This width might not
be small enough to cause large deformation to cells if we consider that the cell size was 15.4 μm in
diameter on average. In fact, as shown in Figure 5, we did not find a statistically significant difference
in cell stiffness between B16-F1 and B16-F10 cells in the present experimental condition. Two possible
reasons were considered. First, loaded cell deformation was not large enough to reflect a difference
in cell stiffness. Second, B16-F1 and B16-F10 cells have a comparable level of stiffness in the floating
state. Experiments with larger loading by using a device with smaller width will answer this question.
At the same time however, narrowing the channel increases the risk of clogging with cells or other
debris. Taking into account the practical applications of the proposed channel, clogging has to be
avoided. As shown in the present study, a statistically significant difference in the time constant was
noticed even with the current width. In this sense, though it was limited to the cell types examined
here, the width of 20 μm was considered to be sufficient.
The sheath flow was established in the present flow channel. The sheath flow is necessary as the
cell is much smaller than the taper tip and it is important to control cells at a particular position. In this
sense, the sheath flow was redundant in the current experiment because the channel width of the taper
tip was comparable with cell size.
Although cells flowed along the centerline of the flow channel at the tip, they may have had some
rotational motions when they were released into a large pool beyond the taper tip. Due to deformation,
cells would have not stayed in the centerline, although they moved downstream by inertia. As a
consequence, fluid shear was exerted on cells such that they exhibited rotational motions. Once cells
are out of the centerline, they experience a shear-induced lift force that drives them toward channel
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walls [48]. As deformed cells recover their shape, a time period of the rotation decreases [49], meaning
that cells rotate more quickly. However, we did not observe significant cell rotation when looking at
cell behaviors in the present experiment. This could be because the experiment’s duration was not
long enough to observe cell rotation. As shown in Figures 3 and 4, cell deformations were tracked for
only 200 μs in the present experiment. During that period of time, the cell traveled approximately
30 μm, which is 1.5 times as large as a cell size. The cell rotation would have introduced fluctuating
errors in cell height, thereby giving errors in the measurement of the time constant of shape recovery.
In fact, the time variation of cell height shown in Figure 4a showed fluctuating behaviors. Further
experiments are needed to assess the effect of cell rotations on the time constant of shape recovery.
Actin filaments are concerned with the structural strength, shape stability, and deformation
behaviors of cells [50–53]. As seen in Figure 7a,b, in adherent cells, B16-F1 cells appeared to have
thicker actin fibers than B16-F10 cells. This observation was consistent with Sadano et al. [54],
who found that actin fibers provide cells with mechanical integrity and structurally support the
plasma membrane. In this sense, B16-F1 cells that were rich in actin fibers should be stiffer than
B16-F10 cells. This speculation was congruent with Watanabe et al. [14], who demonstrated larger
elasticity in B16-F1 than B16-F10 using atomic force microscopy. In contrast, the present results
demonstrated no difference in cell elasticity between B16-F1 cells and B16-F10 cells. In fact, cell
deformation might not be large enough to reflect a difference in elasticity in the present experimental
condition. But, assuming that cells were sufficiently deformed, we attribute a discrepancy between
Watanabe et al. [14] and the present result to a difference in cell state—cells analyzed in this study
were detached from dishes and were suspended in PBS(-). In suspended cells, actins did not have
firm fiber structures. The cell detachment from a dish caused depolymerization of filamentous actins
(F-actin) into the monomeric globular form of actin (G-actin) as a part of cytoskeletal remodeling.
In fact, filamentous structures were not found in floating B16-F1 cells (Figure 7c) anymore, and no
remarkable difference was noticed in the structure and amount of actin filaments between B16-F1 cells
and B16-F10 cells. These observations indicated that the leveling in cell elasticity of B16-F1 cells and
B16-F10 cells was due to the loss of F-actin by cell detachment. Depolymerization of F-actin would
have resulted in an increase in the amount of G-actin. Dispersion of G-actin, or a solid particulate
phase in a liquid phase of cytoplasm might have resulted in changing the rheological properties of
cytoplasm. As shown in Figure 6, the viscosity of B16-F10 cells was larger than that of B16-F1 cells. This
would imply that an increase in G-actin provides cytoplasm with its pseudoplastic nature, by which
apparent viscosity decreased with increased stress. Future studies should warrant these speculations.
As shown in Figures 5 and 6, for B16-F1 cells, no changes in ε0 and shape recovery time constant
τ were observed, regardless of the catechin treatment. In contrast, the shape recovery time constant τ
of B16-F10 cells was significantly decreased by catechin treatment and was almost the same value as
that of B16-F1 cells, indicating that the catechin treatment promoted fast shape recovery of the B16-F10
cells. On the other hand, Figure 5 showed no change in ε0 of B16-F10 cells between catechin-treated
and untreated groups. Since a fluid force is continuously applied to the cells while passing through
the tapered part of the flow channel, ε0 is hardly influenced by the cell viscosity and is thought to be
solely determined by cell stiffness. If so, the decrease in the shape recovery time constant τ is thought
to be due to the decrease in cell viscosity μ by catechin treatment. Although the mechanism of how
catechin brings a change in the viscosity of cancer cells is unclear, these results suggest that it would
be possible to evaluate drug efficacy, at least in highly metastatic cancer cells, using the shape recovery
time constant τ.
Cells were potentially dead after they passed through microflow channels. A significant loss
of cancer cell viability can occur at shear stress levels above 10 Pa [55]. In the present experimental
condition, the maximum shear stress of a channel flow was roughly estimated to be 638 Pa under
the assumption of the Poiseuille flow. In the study by Zhou et al. [55], cell viability was 83% for the
maximum shear stress calculated to be 199 Pa. Their flow channels with smaller maximum shear
stress levels reduced cell viability, although a direct application of their results to our study is difficult
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as their channel is different from the present flow channel in design. However just for cancer cell
screening, cells were not necessarily viable after they passed through the flow channel. Cell viability
must be cared if filtration, concentration or sorting of cells are included in the scope of application.
Microfluidic techniques and devices offer rapid high throughput in cell mechanophenotyping
compared to conventional analytical techniques such as atomic force microscopy (AFM),
microaspiration, and optical tweezers [23,24,56–59]. In AFM, cell samples need to be indented one by
one with care, although it allows researchers to map the mechanical properties of a single cell and
provide information on cellular structures including cytoskeletal structure. One of the drawbacks
of AFM is that it is applicable only to cells that adhere to the base or dish, and thus the use of
AFM for floating cancer cells in circulation is not appropriate. Microaspiration and optical tweezers
are more conventional approaches for the mechanical characterization of cells. These techniques
provide both local and global mechanical properties of cells but are laborious and require partial
technical skill. In our experience, it takes more than an hour to measure a few cells. Microfluidic
techniques, including that used in the present study, reduce such laboratory workload. A comparison of
microfluidic techniques with AFM, microaspiration, and optical tweezers for measuring red blood cell
deformability is summarized in Bento et al. [18]. In microfluidic techniques, cells can be continuously
scanned once cell flow is supplied. Combined with imaging analysis, cell mechanophenotyping
can be automated. As the present system is not equipped with the automatic imaging analysis, cell
deformability was assessed manually after the experiment. Yet, indices of the cell deformability such
as the time constant were immediately obtained once a cell was identified in a series of recorded
images—after some assessments of image quality. Future improvement of imaging analysis will
achieve rapid mechanophenotyping of cancer cells.
Spring constant and viscosity coefficient cannot be determined independently with only the
present experiment data. Tajikawa et al. [60] and Kohri et al. [61] studied red blood cells using a similar
experimental setup, measured the Young’s modulus of red blood cells by a uniaxial tensile test in
a separate experiment and estimated the spring constant. This approach however, requires the cell
type to be known in advance, and it cannot be applied to this study where it is desired to identify an
unknown cell type and evaluate its metastatic potential. Recently, Raj et al. [62] developed a method
to estimate the Young’s modulus of the cell. A different approach to estimate the Young’s modulus
of floating cells is also given in TruongVo et al. [39], who used a flow channel similar to the present
design. If the spring constant k can be determined from the Young’s modulus of the cell using the
method of Raj et al. [62] and TruongVo et al. [39], the viscosity coefficient μ can then be estimated from
the shape recovery time constant τ and a more detailed analysis of the cell’s mechanical properties can
be made.
In the present experiment, the exposure time was 10 μs and the spatial resolution was 0.083
μm/pixel. Because of these conditions, some images were blurred and the boundary of cells was not
clear. In the present analysis, cell shape was manually determined. This may have resulted in errors in
measuring the cell height and in turn estimating the time constant of shape recovery. If a cell whose
diameter at rest is 15.4 μm is imaged and its diameter is measured as 14.8 μm, the compressive strain
for this case is approximately 0.039. If a cell diameter is measured two pixels larger, the diameter is
quantified as 14.966 μm and the compressive strain is calculated as 0.028. This yields approximately
10% error in the compressive strain. Careful tuning of the exposure time and the use of better spatial
resolution will improve the accuracy of the measurement such that an even tiny difference in the
mechanical properties between cells is appreciated.
5. Conclusions
The present study proposes a method to evaluate metastatic potential by evaluating the
viscoelastic properties of cancer cells on a tapered microchannel. The shape recovery time constant τ
became larger as cancer cells had higher metastatic potential. The results suggested that it would be
possible to evaluate the metastatic potential of cancer cells using the shape recovery time constant τ.
136
Micromachines 2019, 10, 207
The method is simple, but its use is not limited to screening of metastatic cells. It can be extensively
applied to various medical and biological areas other than cancer diagnostics, such as the assessment
of drug efficacy. Although further improvements are necessary, the present method will help with
rapid mechanophenotyping and screening of metastatic cancer cells in clinical practice.
Author Contributions: Conceptualization, M.N.; methodology, M.N. and D.O.; formal analysis, D.O.; resources,
M.N.; writing—original draft preparation, D.O. and M.N.; writing—review and editing, S.S. and M.N.; supervision,
M.N.; project administration, M.N.; funding acquisition, M.N.
Funding: This research was supported by the Nitto Foundation and a Grand-in-Aid for Scientific Research
18K12055 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Orr, F.W.; Wang, H.H.; Lafrenie, R.M.; Scherbarth, S.; Nance, D.M. Interactions between cancer cells and the
endothelium in metastasis. J. Pathol. 2000, 190, 310–329. [CrossRef]
2. Eger, A.; Mikulits, W. Models of epithelial–mesenchymal transition. Drug Dis. Today Dis. Models 2005, 2,
57–63. [CrossRef]
3. Chambers, A.F.; Groom, A.C.; MacDonald, I.C. Dissemination and growth of cancer cells in metastatic sites.
Nat. Rev. Cancer 2002, 2, 563–572. [CrossRef]
4. Alibert, C.; Goud, B.; Manneville, J.B. Are cancer cells really softer than normal cells? Biol. Cell 2017, 109,
167–189. [CrossRef]
5. Jonietz, E. Mechanics: The forces of cancer. Nature 2012, 491, S56–S57. [CrossRef]
6. Binnig, G.; Quate, C.F.; Gerber, C. Atomic force microscope. Phys. Rev. Lett. 1986, 56, 930–933. [CrossRef]
7. Hochmuth, R.M. Micropipette aspiration of living cells. J. Biomech. 2000, 33, 15–22. [CrossRef]
8. Cross, S.E.; Jin, Y.S.; Rao, J.Y.; Gimzewski, J.K. Nanomechanical analysis of cells from cancer patients. Nat.
Nanotechnol. 2007, 2, 780–783. [CrossRef] [PubMed]
9. Suresh, S. Nanomedicine: Elastic clues in cancer detection. Nat. Nanotechnol. 2007, 2, 748–749. [CrossRef]
10. Zhang, H.; Liu, K.; Soc, J.R. Optical tweezers for single cells. J. R. Soc. Interface 2008, 5, 671–690. [CrossRef]
[PubMed]
11. Remmerbach, T.W.; Wottawah, F.; Dietrich, J.; Lincoln, B.; Wittekind, C.; Guck, J. Oral cancer diagnosis by
mechanical phenotyping. Cancer Res. 2009, 69, 1728–1732. [CrossRef]
12. Swaminathan, V.; Mythereye, K.; O’Brien, E.T.; Berchuck, A.; Blobe, G.C.; Superfine, R. Mechanical stiffness
grades metastatic potential in patient tumor cells and in cancer cell line. Cancer Res. 2011, 71, 5075–5080.
[CrossRef] [PubMed]
13. Plodinec, M.; Loparic, M.; Monnier, C.A.; Obermann, E.C.; Zanetti-Dallenbach, R.; Oertle, P.; Hyotyla, J.T.;
Aebi, U.; Bentires-Alj, M.; Lim, R.Y.H.; et al. The nanomechanical signature of breast cancer. Nat. Nanotechnol.
2012, 7, 757–765. [CrossRef]
14. Watanabe, T.; Kuramochi, H.; Takahashi, A.; Imai, K.; Katsuta, N.; Nakayama, T.; Fujiki, H.; Suganuma, M.
Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in
(-)-epigallocatechin gallate-treated cells. J. Cancer Res. Clin. Oncol. 2012, 138, 859–866. [CrossRef]
15. Hayashi, K.; Iwata, M. Stiffness of cancer cells measured with an AFM indentation method. J. Mech. Behav.
Biomed. Mater. 2015, 49, 105–111. [CrossRef]
16. Darling, E.M.; Di Carlo, D. High-throughput assessment of cellular mechanical properties. Annu. Rev.
Biomed. Eng. 2015, 17, 35–62. [CrossRef]
17. Chaudhuri, P.K.; Low, B.C.; Lim, C.T. Mechanobiology of tumor growth. Chem. Rev. 2018, 118, 6499–6515.
[CrossRef] [PubMed]
18. Bento, D.; Rodrigues, R.O.; Faustino, V.; Pinho, D.; Fernandes, C.S.; Pereira, A.I.; Garcia, V.; Miranda, J.M.;
Lima, R. Deformation of red blood cells, air bubbles, and droplets in microfluidic devices: Flow visualizations
and measurements. Micromachines 2018, 9, 151. [CrossRef] [PubMed]
19. Tan, S.J.; Yobas, L.; Lee, G.Y.H.; Ong, C.N.; Lim, C.T. Microdevice for the isolation and enumeration of cancer
cells from blood. Biomed. Microdevices 2009, 11, 883–892. [CrossRef]
137
Micromachines 2019, 10, 207
20. Chen, J.; Li, J.; Sun, Y. Microfluidic approaches for cancer cell detection, characterization, and separation.
Lab Chip 2012, 12, 1753–1767. [CrossRef]
21. Ma, Y.H.V.; Middleton, K.; You, L.; Sun, Y. A review of microfluidic approaches for investigating cancer
extravasation during metastasis. Microsys. Nanoeng. 2018, 4, 17104. [CrossRef]
22. Hou, H.W.; Warkiani, M.E.; Khoo, B.L.; Li, Z.R.; Soo, R.A.; Tan, D.S.W.; Lim, W.T.; Han, J.; Bhagat, A.A.S.;
Lim, C.T. Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci. Rep. 2013, 3, 1259.
[CrossRef]
23. Khoo, B.L.; Warkiani, M.E.; Tan, D.S.W.; Bhagat, A.A.S.; Irwin, D.; Lau, D.P.; Lim, A.S.T.; Lim, K.H.;
Krisna, S.S.; Lim, W.T.; et al. Clinical validation of an ultra high-throughput spiral microfluidics for the
detection and enrichment of viable circulating tumor cells. PLoS ONE 2014, 9, e99409. [CrossRef]
24. Tse, H.T.; Gossett, D.R.; Moon, Y.S.; Masaeli, M.; Sohsman, M.; Ying, Y.; Mislick, K.; Adams, R.P.; Rao, J.; Di
Carlo, D. Quantitative diagnosis of malignant pleural effusions by single-cell mechanophenotyping. Sci.
Transl. Med. 2013, 5, 212ra163. [CrossRef]
25. Gossett, D.R.; Henry, T.K.; Lee, S.A.; Ying, Y.; Lindgrenc, A.G.; Yang, O.O.; Rao, J.; Clark, A.T.; Carlo, D.D.
Hydrodynamic stretching of single cells for large population mechanical phenotyping. Proc. Natl. Acad. Sci.
USA 2012, 109, 7630–7635. [CrossRef]
26. Taniguchi, S.; Fujiki, H.; Kobayashi, H.; Go, H.; Miyado, K.; Sadano, H.; Shimokawa, R. Effect of
(-)-epigallocatechin gallate; the main constituent of green tea; on lung metastasis with mouse B16 melanoma
cell lines. Cancer Lett. 1992, 65, 51–54. [CrossRef]
27. Kuzuhara, T.; Sei, Y.; Yamaguchi, K.; Suganuma, M.; Fujiki, H. DNA and RNA as new binding targets of
green tea catechins. J. Biol. Chem. 2006, 281, 17446–17456. [CrossRef]
28. Sah, J.F.; Balasubramanian, S.; Eckert, R.L.; Rorke, E.A. Epigallocatechin-3-gallate inhibits epidermal growth
factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem.
2004, 279, 12755–12762. [CrossRef] [PubMed]
29. Rawangkan, A.; Wongsirisin, P.; Namiki, K.; Iida, K.; Kobayashi, Y.; Shimizu, Y.; Fujiki, H.; Suganuma, M.
Green tea catechin is an alternative immune checkpoint inhibitor that inhibits PD-L1 expression and lung
tumor growth. Molecules 2018, 23, 2071. [CrossRef] [PubMed]
30. Tsuchiya, H.; Nagayama, M.; Tanaka, T.; Furusawa, M.; Kashimata, M.; Takeuchi, H. Membrane-rigidifying
effects of anti-cancer dietary factors. Biofactors 2002, 16, 45–56. [CrossRef] [PubMed]
31. Fang, C.Y.; Wu, C.C.; Hsu, H.Y.; Chuang, H.Y.; Huang, S.Y.; Tsai, C.H.; Chang, Y.; Tsao, G.S.W.; Chen, C.L.;
Chen, J.Y. EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion
molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.
Int. J. Mol. Sci. 2015, 16, 2530–2558. [CrossRef] [PubMed]
32. Takahashi, A.; Watanabe, T.; Mondal, A.; Suzuki, K.; Kururu-Kanno, M.; Li, Z.; Yamazaki, T.; Fujiki, H.;
Suganuma, M. Mechanism-based inhabitation of cancer metastasis with (-)-epigallocatechin gallate. Biochem.
Biophys. Res. Commun. 2014, 443, 1–6. [CrossRef] [PubMed]
33. Fidler, I.J. Selection of successive tumour lines for metastasis. Nat. New Biol. 1973, 242, 148–149. [CrossRef]
[PubMed]
34. Poste, G.; Doll, J.; Hart, I.R.; Fidler, I.J. In vitro selection of murine B16 melanoma variants with enhanced
tissue-invasive properties. Cancer Res. 1980, 40, 1636–1644. [PubMed]
35. Nakamura, K.; Yoshikawa, N.; Yamaguchi, Y.; Kagota, S.; Shinozuka, K.; Kunitomo, M. Characterization of
mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model. Life Sci.
2002, 70, 791–798. [CrossRef]
36. Lee, S.S.; Yim, Y.; Ahn, K.H.; Lee, S.J. Extensional flow-based assessment of red blood cell deformability
using hyperbolic converging microchannel. Biomed. Microdevices 2009, 11, 1021–1027. [CrossRef]
37. Yaginuma, T.; Oliveira, M.S.N.; Lima, R.; Ishikawa, T.; Yamaguchi, T. Human red blood cell behavior
under homogeneous extensional flow in a hyperbolic-shaped microchannel. Biomicrofluidics 2013, 7, 054110.
[CrossRef] [PubMed]
38. Rodrigues, R.O.; Lopes, R.; Pinho, D.; Pereira, A.I.; Garcia, V.; Gassmann, S.; Sousa, P.C.; Lima, R. In vitro
blood flow and cell-free layer in hyperbolic microchannels: Visualizations and measurements. BioChip J.
2016, 10, 9–15. [CrossRef]
138
Micromachines 2019, 10, 207
39. TruongVo, T.N.; Kennedy, R.M.; Chen, H.; Chen, A.; Berndt, A.; Agarwal, M.; Zhu, L.; Nakshatri, H.;
Wallace, J.; Na, S. Microfluidic channel for characterizing normal and breast cancer cells. J. Micromech.
Microeng. 2017, 27, 035017. [CrossRef]
40. Yoshizawa, S.; Horiuchi, T.; Fujiki, H.; Yoshida, T.; Okuda, T.; Sugimura, T. Antitumor promoter activity
of (-)-epigallocatechin gallate, the main constituent of “tannin” in green tea. Phytother. Res. 1987, 1, 44–47.
[CrossRef]
41. Fujita, Y.; Yamane, T.; Tanaka, M.; Kuwata, K.; Okuzumi, J.; Takahashi, T.; Fujiki, H.; Okuda, T. Inhibitory
effect of (-)-epigallocatechin gallate on carcinogenesis with IV-ethyl-IV’-nitro-N-nitrosoguanidine in mouse
duodenum. Jpn. J. Cancer Res. 1989, 80, 503–505. [CrossRef]
42. Bettuzzi, S.; Brausi, M.; Rizzi, F.; Castagnetti, G.; Peracchia, G.; Corti, A. Chemoprevention of human prostate
cancer by oral administration of green tea catechins in volunteers with highgrade prostate intraepithelial
neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Res. 2006, 66, 1234–1240.
[CrossRef]
43. Tsao, A.S.; Liu, D.; Martin, J.; Tang, X.M.; Lee, J.J.; El-Naggar, A.K.; Wistuba, I.; Culotta, K.S.; Mao, L.;
Gillenwater, A.; et al. Phase II randomized, placebocontrolled trial of green tea extract in patients with
high-risk oral premalignant lesions. Cancer Prev. Res. 2009, 2, 931–941. [CrossRef] [PubMed]
44. Singh, B.N.; Shankar, S.; Srivastava, R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms,
perspectives and clinical applications. Biochem. Pharmacol. 2011, 82, 1807–1821. [CrossRef] [PubMed]
45. Yang, C.S.; Wang, X. Green tea and cancer prevention. Nutr. Cancer 2010, 62, 931–937. [CrossRef]
46. Fujiki, H.; Okuda, T. (−)-Epigallocatechin gallate. Drugs Future 1992, 17, 462–464. [CrossRef]
47. Raj, A.; Dixit, M.; Doble, M.; Sen, A.K. A combined experimental and theoretical approach towards
mechanophenotyping of biological cells using a constricted microchannel. Lab Chip 2017, 17, 3704–3716.
[CrossRef]
48. Zhou, J.; Papautsky, I. Fundamentals of inertial focusing in microchannels. Lab Chip 2013, 13, 1121–1132.
[CrossRef]
49. Masaeli, M.; Sollier, E.; Amini, H.; Mao, W.; Camacho, K.; Doshi, N.; Mitragotri, S.; Alexeev, A.; Di Carlo, D.
Continuous inertial focusing and separation of particles by shape. Phys. Rev. X 2012, 2, 031017. [CrossRef]
50. Peeters, E.A.G.; Bouten, C.V.C.; Oomens, C.W.J.; Bader, D.L.; Snoeckx, L.H.E.H.; Baajiens, F.P.T. Anisotropic,
three-dimensional deformation of single attached cells under compression. Ann. Biomed. Eng. 2004, 32,
1443–1452. [CrossRef]
51. Hu, S.; Eberhard, L.; Chen, J.; Love, J.L.; Butler, J.P.; Fredberg, J.J.; Whitesides, G.M.; Wang, N. Mechanical
anisotropy of adherent cells probed by a three-dimensional magnetic twisting device. Am. J. Physiol. Cell
Physiol. 2004, 287, C1184–C1191. [CrossRef]
52. Kumar, S.; Mexwell, I.Z.; Heisterkamp, A.; Polte, T.R.; Lele, T.P.; Salanga, M.; Mazur, E.; Ingber, D.E.
Viscoelastic retraction of single living stress fibers and its imoact on cell shape, cytoskeletal organization,
and extracellular matrix mechanics. Biophys. J. 2006, 90, 3762–3773. [CrossRef] [PubMed]
53. Titushkin, I.; Cho, M. Modulation of cellular mechanics during osteongenic differentiation of human
mesenchymal stem cells. Biophys. J. 2007, 93, 3693–3702. [CrossRef] [PubMed]
54. Sadano, H.; Shimokawa-Kuroki, R.; Taniguchi, S. Intracellular localization and biochemical function of
variant β-Actin, which inhibits metastasis of B16 melanoma. Cancer Res. 1994, 85, 735–743. [CrossRef]
55. Zhou, J.; Giridhar, P.V.; Kasper, S.; Papautsky, I. Modulation of rotation-induced lift force for cell filtration in
a low aspect ratio microchannel. Biomicrofluidics 2014, 8, 044112. [CrossRef]
56. Liu, Z.; Huang, F.; Du, J.; Shu, W.; Feng, H.; Xu, X.; Cheng, Y. Rapid isolation of cancer cells using microfluidic
deterministic lateral displacement structure. Biomicrofluidics 2013, 7, 0011801. [CrossRef]
57. Du, G.; Fang, Q.; den Toonder, J.M.J. Microfluidics for cell-based high throughput screening platformsd—A
review. Anal. Chim. Acta 2016, 903, 36–50. [CrossRef]
58. Jiang, J.; Zhao, H.; Shu, W.; Tian, J.; Huang, Y.; Song, Y.; Wang, R.; Li, E.; Slamon, D.; Hou, D.; et al. An
integrated microfluidic device for rapid and high-sensitivity analysis of circulating tumor cells. Sci. Rep.
2017, 7, 42612. [CrossRef] [PubMed]
59. Nivedita, N.; Garg, N.; Lee, A.P.; Papautsky, I. A high throughput microfluidic platform for size-selective
enrichment of cell populations in tissue and blood samples. Analyst 2017, 142, 2558–2569. [CrossRef]
139
Micromachines 2019, 10, 207
60. Tajikawa, T. Quantitative evaluation of erythrocyte deformability by using micro-visualization
technique—Measurement of time constant of shape recovery process as a visco-elastic specification of
each blood cells. J. Vis. Soc. Jpn. 2014, 34, 16–21. (In Japanese)
61. Kohri, S.; Kato, Y.; Tajikawa, T.; Yamamoto, Y.; Bando, K. Measurement of erythrocyte deformability by
uniaxial stretching—Measurement of apparent Young’s modulus and time constant of shape recovering.
Trans. Jpn. Soc. Med. Biol. Eng. 2015, 53, 1–7. (In Japanese)
62. Raj, A.; Sen, A.K. Entry and passage behavior of biological cells in a constricted compliant microchannel.
R. Soc. Chem. 2018, 8, 20884–20893. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Measurement of Carcinoembryonic Antigen in
Clinical Serum Samples Using a Centrifugal
Microfluidic Device
Zhigang Gao 1,†, Zongzheng Chen 2,†, Jiu Deng 1, Xiaorui Li 1, Yueyang Qu 1, Lingling Xu 1,
Yong Luo 1,*, Yao Lu 3, Tingjiao Liu 4, Weijie Zhao 1,* and Bingcheng Lin 1,3
1 School of Pharmaceutical Science and Technology, Dalian University of Technology, Dalian 116024, China;
gzg1980@dlut.edu.cn (Z.G.); dengjiu@mail.dlut.edu.cn (J.D.); xrli@mail.dlut.edu.cn (X.L.);
yyqu@mail.dlut.edu.cn (Y.Q.); nongxuexueshi@gmail.com (L.X.); bclin@dicp.ac.cn (B.L.)
2 Integrated Chinese and Western Medicine Postdoctoral research station, Jinan University,
Guangzhou 510632, China; chenmond@foxmail.com
3 Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China; luyao@dicp.ac.cn
4 College of Stomatology, Dalian Medical University, Dalian 116024, China; tingjiao@dlmedu.edu.cn
* Correspondence: yluo@dlut.edu.cn (Y.L.); zyzhao@dlut.edu.cn (W.Z.);
Tel.: +86-0411-8498-6360 (Y.L.); +86-0411-8498-6195 (W.Z.)
† These authors have equally contributed to this work.
Received: 26 July 2018; Accepted: 10 September 2018; Published: 17 September 2018
Abstract: Carcinoembryonic antigen (CEA) is a broad-spectrum tumor marker used in clinical
applications. The primarily clinical method for measuring CEA is based on chemiluminescence
in serum during enzyme-linked immunosorbent assays (ELISA) in 96-well plates. However,
this multi-step process requires large and expensive instruments, and takes a long time. In this
study, a high-throughput centrifugal microfluidic device was developed for detecting CEA in serum
without the need for cumbersome washing steps normally used in immunoreactions. This centrifugal
microdevice contains 14 identical pencil-like units, and the CEA molecules are separated from the bulk
serum for subsequent immunofluorescence detection using density gradient centrifugation in each
unit simultaneously. To determine the optimal conditions for CEA detection in serum, the effects of
the density of the medium, rotation speed, and spin duration were investigated. The measured values
from 34 clinical serum samples using this high-throughput centrifugal microfluidic device showed
good agreement with the known values (average relative error = 9.22%). These results indicate that the
high-throughput centrifugal microfluidic device could provide an alternative approach for replacing
the classical method for CEA detection in clinical serum samples.
Keywords: centrifugal microfluidic device; CEA detection; density medium; fluorescent
chemiluminescence
1. Introduction
Carcinoembryonic antigen (CEA) is a polysaccharide-protein complex with a molecular weight
that ranges from 180 to 220 kD, and has 28 potential N-linked glycosylation sites. CEA is primarily
produced by the embryonic intestinal mucous membranes prior to birth. Thus, the concentration
of CEA is usually very low in the serum of a healthy adult. However, the serum concentration of
CEA can become elevated in the presence of several types of cancer, such as lung [1,2], breast [3,4],
colorectal [5,6], or gastric [7] cancers, as well as colon adenocarcinoma [8]. This means that CEA can be
considered a broad-spectrum biomarker for cancer diagnosis and prognosis.
A variety of immunoassay methods have been developed for detecting CEA in serum,
such as enzyme-linked immunosorbent assays (ELISA) [9], radioimmunoassays [10], fluorescence
Micromachines 2018, 9, 470; doi:10.3390/mi9090470 www.mdpi.com/journal/micromachines141
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immunoassays [11], chemiluminescence immunoassays [12] and amperometric immunoassays [13].
However, a common drawback of these testing methods is that multiple washing steps are required.
These repeated washing steps can give rise to increasing measuring errors, which decreases the
efficiency while requiring complex instrumentation. Recently, a wash-free one-step immunoassay [14]
was developed using a centrifugal microfluidic device, which has great potential for use in clinical
applications. This immunoassay method is based on the principle of centrifugal density gradient
equilibrium, which takes place inside a microfluidic device. Analytes with fluorescent labels were
separated from the bulk serum in one step, using the centrifugal force, through the dense medium
located in the microchannels. Afterwards, the fluorescence microbeads, which aggregated at the end
of microchannel, could be collected for quantitative analysis.
Following this strategy, Interleukin 6 was rapidly measured (within 15 min) in whole blood by
Ulrich et al. [14]. Chung-Yan Koh et al. accomplished the ultrasensitive detection of botulinum toxin
in a 2 μL unprocessed sample in 30 min from sample to answer [15]. These studies showed that it is
possible to develop a rapid, accurate, high-throughput centrifugal microfluidic chip for the detection
of CEA in serum.
In this study, chitosan, which is safe and has good biocompatibility, was used as the dense medium
in the centrifugal microfluidic. When combined with ELISA testing, the CEA could be separated
by the action of the centrifugal force produced by the rotation, and the concentration of CEA could
be detected using a semi-quantitative fluorescence method. This enables the rapid and convenient
detection of CEA in serum with high throughput.
2. Materials and Methods
2.1. Design and Manufacture of the Centrifugal Microfluidic Device
A polydimethylsiloxane (PDMS, Sylgard 184, DowDuPont Inc., Midland, MI, USA) glass
microfluidic device was designed, as shown in Figure 1A. The height, width, and length of the
individual microchannels were 150 μm, 4.2 mm and 1.5 cm, respectively. The diameter of the inlet
hole was 5 mm. The distance between the center of the chip and the inlet hole was 6.5 cm. With this
geometry, the micro-channels were patterned in PDMS using replica molding. The mold was prepared
by spin-coating a thin layer of negative photoresist (SU-8, MicroChem, Corp., Westborough, MA,
USA) onto a single side of a polished silicon wafer, which was patterned using UV exposure. Next,
the micro-channel layer was obtained by pouring PDMS with a 10:1 (w/w) base-to-crosslinker ratio
onto the mold to a thickness of approximately 3 mm. After curing the elastomer for 2 h at 80 ◦C,
the PDMS slab was peeled from the mold, and was then punched and hermetically bonded to a
coverslip by plasma oxidation.
Figure 1. Cont.
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Figure 1. Design of the centrifugal microfluidic device. (A) schematic representation of the sandwiched
immunocomplex formed by the binding of the target analyte; (B) schematic of the centrifugal
microfluidic platform immunoassay, depicting the multiplexed analysis of the serum; (C) operating
principle of the centrifugal microfluidic device.
2.2. Medium Density Screening
Based on the sedimentation process, a theoretical calculation pertaining to the relationship
between the density of a material and the centrifugal sedimentation has been proposed [16]. In the
case of particle transport in fluids, as in a sedimentation processes, the particles are subject to a viscous





where ρfluid and u are the density and velocity of the fluid relative to a particle, respectively, Aparticle
is the particle cross-sectional area, and Cd is the drag coefficient. In the laminar flow regime (Stoke’s
drag), the drag coefficient is proportional to the fluid viscosity μ and inversely proportional to its
velocity u relative to the particle, so that for a spherical particle with radius r, the drag force is
FS = 6πμru. (2)
Based on this, materials with intermediate densities, but various viscosities were tested.
The isolating effects of Percoll (Aladdin Inc., Los Angeles, CA, USA) at a concentration at 1.13 g/mL,
7% or 14% dextran (Aladdin Inc.), as well as 1% or 2% chitosan (Aladdin Inc.) were compared in this
study. To start, 1.4 g of dextran and 0.01 g Poloxamer (127 F) were dissolved in 9.8 mL hot water,
and then mixed with 0.2 mL 5% bovine serum albumin (BSA) solution and stored at 4 ◦C. Then, 2 g
chitosan powder was dissolved in a 0.1 M hydrochloric acid solution for 24 h using a centrifugal mixer.
Finally, the solution was used as the dense medium to be added to the centrifugal microfluidic channel.
2.3. Optimization of the Rotation Speed and Spin Time
After the channels of the microfluidic device were cleaned with Phosphate Buffered Saline (PBS),
10 μL of 1% BSA (Aladdin Inc.) were added, and the devices were stored in a refrigerator at 4 ◦C to
block the protein binding sites on the PDMS. Prior to adding 5 μL of 2% chitosan into the microfluidic
device, the channels were washed five times with PBS, and stored in a 4 ◦C refrigerator until just before
use. Then, 30 μL carboxyl-modified silica microspheres (Mozhidong Ldt., Beijing, China) were added
to a 500 μL centrifuge tube, diluted to 200 μL, and then packaged with 10 μL of the primary antibodies
(18.1 g/mL, Abcam, London, UK). After incubation on a table concentrator at room temperature for
2 h, and being stored at 4 ◦C in a refrigerator overnight, the beads with antibodies became stabilized.
Then, the bead–antibody complexes were washed three times with PBS (pH 7.4), and diluted to
200 μL. Then, 5 μL BSA at a concentration at 5% was added to the solution, which was incubated at
room temperature on a table concentrator for 2 h to block the remaining protein binding sites. Then,
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30 ng/mL CEA samples (Abcam), with labeled primary antibodies and fluorescence labeled secondary
antibodies, were successively added into microchannels with syringes or pipettes. The microfluidic
device was centrifuged at various angular velocities (1000, 1500, 2000, 2500, 3000, 3500 or 4000 rpm) or
at 2500 rpm for various spin durations (60, 90, 120, 150, 180 or 240 s). Afterwards, fluorescence images
were obtained using a fluorescence microscope (IX71, Olympus, Tokyo, Japan) that used a high-power
mercury lamp as the fluorescence light source and an exposure time of 3.5 s. After the fluorescence
images were obtained, the fluorescence intensity values, with the background subtracted, were read
by ImageJ software (version 2.1, National Institutes of Health, Bethesda, MD, USA). Then, statistical
analyses were performed based on the particular requirements.
2.4. Establishing a CEA Standard Curve
CEA antigen samples at various concentrations, with labeled primary antibodies and
fluorescence-labeled secondary antibodies, were successively added and incubated. Finally,
the microfluidic device was centrifuged for 150 s at 2500 rpm in a horizontal centrifuge. At the
same time, fluorescence images were obtained using a fluorescence microscope with exposure time
of 3.5 s. The fluorescence images were analyzed with ImageJ software to establish a standard curve
between the concentration of CEA and the corresponding fluorescence intensity.
2.5. Detection of CEA in Human Serum
BSA blocked bead–antibody complexes, and labeled primary antibodies and fluorescence-labeled
secondary antibodies were added to the centrifuge microfluidic device and incubated at room
temperature for 2 h. Then, clinical serum samples, which were collected and provided by the Affiliated
Hospital of Dalian Medical University from both healthy and cancer person, were added to the
centrifuge chip, and spun at 2500 rpm for 2.5 min. After obtaining the fluorescence images using the
fluorescence microscope and processing with the ImageJ software, the standard concentration curve
were used to obtain the experimental CEA concentrations.
2.6. Statistical Analysis
The SPSS 18.0. (IBM, New York, NY, USA) was used for mean value and standard deviation
calculation as well as significance testing.
3. Results
3.1. Design, Fabrication, and Verification of the Centrifugal Microfluidic Device
Figure 1 shows the centrifugal microfluidic platform for detecting CEA using a
sedimentation-based immunoassay. The sample was mixed with a detection cocktail consisting of
silica microbeads (1 μm diameter), which were coated with specific antibodies for the target of interest,
in this case, CEA. The detection antibodies were labeled with a fluorescent tag, which binds to the
capture beads in the presence of the corresponding antigen (Figure 1A). After the serum samples were
mixed with the antibody-conjugated capture beads and fluorescent detection antibodies in solution,
they were added to a preloaded dense medium. The beads were pushed to the bottom of the channel
to form pellets by the centrifugal force. Eventually, the target analytes separated from the rest of the
sample (Figure 1B). The entire process of CEA detection could be completed in one step, as shown in
Figure 1C. The samples were added at the entrance of the centrifugal microfluidic platform, which was
split into 14 radially arranged pencil-like microchannels. Then, the target analyte could be detected
using a sedimentation-based immunoassay. This simple, one-step centrifugal microfluidic platform
provides high analytical accuracy and repeatability, which cannot be achieved by processes that require
multiple steps.
To validate the effectiveness of the chemiluminescence immunoassay used in this device,
CEA standard samples were measured using a double-antibody sandwich ELISA with the conventional
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method and the centrifugal microfluidic device. The proposed method was shown to be equivalent to
the conventional method based on the linearity of the response (see supplementary material in the
supporting information).
3.2. Medium Screening and Structure Optimization of the Microfluidic Device
Based on Equation (2), we screened various media to determine the optimal density and viscosity,
as one of the critical aspects in this study. Percoll, dextran (7% or 14%), and chitosan (1% or 2%)
were tested as dense media, as shown in Figure 2. It was suggested that the microbeads could not be
separated in a Percoll solution at a concentration of 1.13 g/mL (Figure 2A). However, if the sample
is whole blood with a density of 1.09 to 1.11 g/mL of red blood cells, Percoll can separate red blood
cells from plasma. Although dextran can separate the microbeads from solution as a clinical plasma
substitute, the separating effect is not as good as with the chitosan solution (Figure 2B,C). Because
the concentration of the dense medium solution is 1%, the modified antigen antibody beads can
become separated at the end of the microchannel. Furthermore, the rest of the solution will have been
mixed with the medium because this is beyond the abilities of the separation process (Figure 2D,E).
In addition, if the concentration of the dense medium is 2%, the modified antigen antibody beads
can pass through the medium to reach the bottom of the channel. Therefore, a chitosan solution with
a concentration of 2% was selected as the dense medium in the centrifugal microfluidic device to
separate the microbeads modified by antigen antibodies in solution.
 
 
Figure 2. Effect of the dense medium on isolation efficiency in the centrifugal microfluidic platform.
Separating effects of (A) Percoll, dextran ((B) 7% or (C) 14%), and chitosan ((D) 1% or (E) 2%) as dense
media and (F) their histogram comparison.
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3.3. Effects of Rotation Speed and Spin Duration on the Detection of CEA
The effects of rotation speed and spin duration were also considered in this study. In the
centrifugal microfluidic device with chitosan as the dense medium, the effects of various angular
velocities on the isolation power of CEA standard samples (25 ng/mL) were investigated.
In Figure 3A, the fluorescence intensity of aggregated microbeads increased as the rotation speed
increased from 1000 to 2500 rpm. However, even if the rotation speed was set to greater than 2500 rpm,
the fluorescence intensity of the aggregated microbeads did not increase, and instead plateaued at
a constant value. This indicates that spinning at 2500 rpm caused all the microbeads in the bulk
serum to migrate to the end of the microchannel. Thus, 2500 rpm was used as the rotation speed for
CEA detection.
Figure 3. Effects of rotation speed and spin duration on carcinoembryonic antigen (CEA) isolation.
(A) the effect of rotation speed on CEA isolation; (B) the effect of spin duration on CEA isolation.
Similarly, the effects of various spin durations of the centrifugal microfluidic device using chitosan
as the dense medium on the isolation of CEA in a standard sample (25 ng/mL) were investigated at
2500 rpm. As shown in Figure 3B, in the first two minutes, the microbeads were gradually separated
to the end of the microchannel, and the fluorescence intensity increased over time. After two minutes,
the microbeads in the sample were almost completely in the detection area, and the fluorescence
intensity was constant thereafter. To have a margin of safety, 2.5 min was selected as the centrifugal
spin duration.
3.4. CEA Detection in Human Serum Samples
CEA standard samples with various concentrations were measured using this device, and the
relationship between CEA concentration (x) and the fluorescence intensity (y) was established with a
standard curve (y = 1647.3x + 5432.9). It is suggested that the analytical sensitivity of the standard curve
is 1673.4. Based on Figure 4, the repeatability at each concentration was good (n = 4), and the curve
was linear within the CEA concentration range of 0.7–22.5 ng/mL (R2 = 0.993). Thus, these equations
can be used as a standard curve for sample detection, including human serum samples.
CEA in clinical human serum samples with known concentrations were measured using the
centrifugal microfluidic device, and comparisons between the known and measured concentrations
are shown in Table 1 and Figure 4. It can be seen from the table that the sample testing errors from 90%
of the samples are less than 20%, and the average relative error was only 9.22%. This indicates that the
detection results obtained by this device were reliable. In addition, as shown in Figure 5A, in these
tests, excluding the poor repeatability of certain outlier samples, the repeatability of the remaining
samples was good for CEA concentrations in the range of 0.5 ng/mL to 27 ng/mL. In addition, it was
determined from Figure 5B that, when the carcinoembryonic antigen concentration was less than
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2.0 ng/mL, the detection concentration was consistent with the known concentration, and when the
concentration of the serum sample was higher than 10 ng/mL, there were some slight differences
between the actual and measured concentrations.
 
Figure 4. Relationship between fluorescence intensity of aggregated microbeads and CEA concentration
in the serum.
Table 1. Results from 32 clinical serum samples.
No. Known Value (ng/mL) Measured Value (ng/mL), n = 3 Relative Error
1 12.94 12.82 ± 0.33 0.96%
2 3.69 3.82 ± 0.26 3.52%
3 0.71 0.58 ± 0.52 18.59%
4 2.4 2.43 ± 0.21 1.45%
5 5.76 6.10 ± 0.30 5.87%
6 2.75 2.94 ± 0.15 7%
7 0.91 1.03 ± 0.29 13.14%
8 2.55 3.31 ± 0.10 29.96%
9 2.01 2.04 ± 0.07 1.55%
10 2.02 2.23 ± 0.85 10.50%
11 2.52 2.47 ± 0.22 1.99%
12 8.01 7.46 ± 0.29 6.86%
13 14.07 13.59 ± 0.69 3.43%
14 24.16 24.54 ± 0.93 1.59%
15 9.12 9.48 ± 0.39 3.99%
16 26.54 25.69 ± 3.57 3.19%
17 3.35 3.29 ± 0.28 1.66%
18 2.98 3.27 ± 0.48 9.61%
19 1.34 1.57 ± 0.10 17.39%
20 9.63 9.48 ± 0.44 1.59%
21 2.04 2.08 ± 0.19 1.94%
22 4.58 4.60 ± 0.31 0.36%
23 0.91 0.93 ± 0.11 1.91%
24 0.53 0.55±0.15 4.67%
25 2.72 3.05 ± 0.37 12.31%
26 1.71 1.63 ± 0.46 4.48%
27 0.25 0.30 ± 0.08 21.68%
28 2.24 2.83 ± 0.57 26.23%
29 1.38 1.29 ± 0.18 6.55%
30 2.17 2.73 ± 0.51 25.8%
31 0.66 0.52 ± 0.36 21.22%
32 1.81 2.24 ± 0.97 24.02%
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Figure 5. CEA detection in clinical human serum samples. (A) the repeatability of actual samples;
(B) comparison of known and measured concentrations.
The CEA detection results using the centrifugal microfluidic device and the hospital instruments
were compared. As shown in Table 2, when excluding samples 7, 18 and 26, the p-value of samples
were above 0.05. This suggests that there were no significant differences between the detection method
of the centrifugal microfluidic device and the hospital’s method.
Table 2. p-values between paired samples.
Samples p-Value Samples p-Value Samples p-Value
1 0.299 12 0.655 23 0.514
2 0.752 13 0.728 24 0.953
3 0.497 14 0.114 25 0.112
4 0.655 15 0.13 26 0.032
5 0.474 16 0.761 27 0.162
6 0.748 17 0.662 28 0.545
7 0.016 18 0.001 29 0.394
8 0.389 19 0.164 30 0.255
9 0.762 20 0.084 31 0.471
10 0.437 21 0.32 32 0.668
11 0.453 22 0.71 – –
4. Discussion
A centrifugal microfluidic chip was constructed for detecting CEA in clinical serum samples.
The device is based on a sandwiched immunoassay with biocompatible chitosan as the dense medium.
It is driven by centrifugal force to implement rapid, high-throughput detection of serum CEA and
other biomarkers. This centrifugal microfluidic chip does not require any washing steps, and can
simplify the experimental procedure with increased accuracy and efficiency, compared with traditional
immunoassays. Thus, this centrifugal microfluidic device can be expected to be used for CEA
determination in hospitals.
The dense medium used in this microfluidic device was 2% chitosan to eliminate the need for the
complicated washing steps of the traditional detection method. This device was able to separate the
analyte from the solution in a one-step centrifugal process. Therefore, the samples could be detected
directly and easily. In addition, the 14 individual pencil channels acted as parallel systems on the
centrifugal microfluidic chip, with a relative standard deviation (RSD) value of just 4.95%.
The rotation speed and spin duration were optimized for the microfluidic device. It was
determined that 2500 rpm for 150 s was able to completely move the analytes of the samples to the
detection area. Thus, this microfluidic device can improve upon the current clinical detection methods.
Finally, the CEA detection results obtained from this centrifugal microfluidic device were
compared and verified with clinical values. Thirty clinical serum samples were measured based on the
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standard curve established between the CEA concentration and fluorescence intensity. The detection
error in 90% of the samples was less than 20% (Table 1), and the repeatability of the samples was good
over the range of concentrations of 0.5 ng/mL to 27 ng/mL. Although a few samples showed low
reproducibility, this might have been because the CEA was not uniformly distributed in the serum,
and the volume of samples added to microfluidic device was microscale, thus making the contents to
be measured in each sample unstable.
In conclusion, this study describes a centrifugal microfluidic device that was developed for
detecting CEA. This method uses density gradient centrifugation and is free of washing steps, and is
thus more accurate than traditional ELISA methods. It also can achieve high-throughput detection,
with the potential to be used in central labs.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-666X/9/9/470/s1,
Figure S1: Chip channel parallelism measurement, Figure S2: Standard curve for determination of protein
content, Figure S3: The comparation of fluorescence concentration curve between conventional ELISA method
and centrifugal microfluidic device. (A) conventional ELISA method; (B) centrifugal microfluidic device.
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Abstract: We present a flow cytometer on a microfluidic chip that integrates an inline lens-free
holographic microscope. High-speed cell analysis necessitates that cells flow through the microfluidic
channel at a high velocity, but the image sensor of the in-line holographic microscope needs a long
exposure time. Therefore, to solve this problem, this paper proposes an S-type micro-channel and
a pulse injection method. To increase the speed and accuracy of the hologram reconstruction, we
improve the iterative initial constraint method and propose a background removal method. The focus
images and cell concentrations can be accurately calculated by the developed method. Using whole
blood cells to test the cell counting precision, we find that the cell counting error of the proposed
method is less than 2%. This result shows that the on-chip flow cytometer has high precision.
Due to its low price and small size, this flow cytometer is suitable for environments far away from
laboratories, such as underdeveloped areas and outdoors, and it is especially suitable for point-of-care
testing (POCT).
Keywords: cell analysis; lens-less; microfluidic chip; twin-image removal; POCT
1. Introduction
Cell analysis using an optical microscope or a flow cytometer is an important technique in biology
and medicine [1]. Optical microscopes can obtain focus images of cells for biomedical applications,
and flow cytometers can collect the signature of a large number of cells in liquid specimens with high
analysis speed. However, these instruments are unsuitable for outdoor and undeveloped areas because
of their high price and large size. Currently, there is a need for a small and inexpensive cell analysis
device that combines the properties of the above two devices.
Over the past decade, lens-less imaging has been considered a good way to reduce the volume
and cost of cell analysis tools. Seung Ah Lee and Guoan Zheng designed opto-fluidic microscopes
using a complementary metal oxide semiconductor (CMOS) image sensor (CIS) and a microfluidic
channel [2–7]. To weaken the shadow-imaging diffraction, the distance between the cells and the
surface of the image sensor must be shorter than 2 μm. These researchers mounted a micro-channel
on a CIS by removing the protective glass and Bayer filter. To improve the spatial resolution of cell
images obtained with a 4× object lens, they used a multi-frame, super-resolution algorithm based the
sub-pixel movement of cells flowing through the micro-channel. At the same time, Aydogan Ozcan
and Serhan O. Isikman designed numerous lens-free on-chip microscopes based on incoherent digital
holography [8–25]. The lens-free on-chip microscopes capture digital diffractive images of cells by
using an in-line holographic structure. The diffractive images were used to reconstruct clear images
of the cells using angular spectrum theory [26], and the resultant clear cell images are comparable
to those obtained by a 10× object lens with a numerical aperture of ~0.1–0.2. Later, Se-Hwan Paek
and Sungkyu Seo proposed a new method to classify different types of cells using digital diffractive
images [27–30]. Mei Yan and Hao Yu conducted a blood cell analysis with a single-frame super
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resolution [31]. The concept of a lens-less microscopy technique is a novel idea for the miniaturization
of flow cytometry, but the accuracy and speed of cell counting in such a method are challenges.
At present, most devices based on a lens-less platform use only one frame to count cells, and this leads
to inaccurate cell counting [27]. It is not easy to distinguish between cells and dust using a static image,
which has a great influence on the ability to count with high precision.
In this manuscript, we propose an on-chip flow cytometer system based on lens-less imaging
and a microfluidic control technique to improve the speed of cell analysis. The system causes cells
to flow through a micro-channel in a polydimethylsiloxane (PDMS) microfluidic chip above a CIS.
A near-coherent light source is mounted above the microfluidic chip (~5 cm), and diffraction shadow
images of cells generated by the near-coherent light source are then captured by the CIS. To obtain clear
images of cells, a phase iterative reconstruction algorithm is used for image diffraction [32]. In addition,
the system can obtain a very accurate image without cells absented for background removal. After the
background is removed, images of each segmented cell can be acquired from the whole image more
precisely. Therefore, we can more accurately extract features from each cell image and quickly classify
and count cells.
Because of the low intensity of near-coherent light caused by a pinhole, the exposure time of
the image sensor in the system is longer than 400 ms. Therefore, there is stronger motion blur while
the cells are quickly flowing in the micro-channel. To solve this problem, this manuscript proposes
a method in which the cells in the micro-channel are imaged simultaneously in a large field of view
(FOV) instead of with a flow cytometer method in which the cells pass through the testing area at high
speed. In other words, the method takes advantage of the larger FOV of the CIS to reduce the cell
flow velocity. To utilize the large FOV of the CIS, we design an “S” channel shape. As a result, we can
ensure that the CIS captures the maximum possible number of cells in a frame. In addition, the cells in
current frame flow out of the micro-channel completely before the next exposure of the CIS. Thus, all
the cells in each frame are new cells, and the cells in each individual frame can be evaluated to increase
the number of tested cells. Regarding cost, the CIS is commonly used in industrial cameras and mobile
phones, so the price is very low (below $10). The microfluidic chip comprises a PDMS channel and
a piece of thin glass (0.18 mm), making it very cheap and easy to replace. Overall, this manuscript
proposes an on-chip cytometer that can test blood cells, bacteria, and other micro-particles in liquids.
Because of the low price and small volume, the system is especially suitable for places far away from
the laboratory and undeveloped areas and for family health tests.
2. Materials and Methods
2.1. System Setup
The flow cytometer utilized a lens-less imaging technique based on an in-line holography structure,
and the overall structure is shown in Figure 1.
 
Figure 1. The structure of an on-chip flow cell counting system: (a) The general structure of the system;
(b) the micro-channel on the image sensor (CIS) surface in the red box in (a).
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As shown in Figure 1, the flow cytometer comprised a greyscale CIS (Aptina MT9P031, Micron
Technology, Pennsylvania, ID, USA), a PDMS microfluidic chip and a blue light-emitting diode (LED)
light source (central wavelength of ~465 nm). The pixel size of the CIS was 2.2 μm, the effective pixel
size was 2592 H × 1944 V (5.7 mm × 4.2 mm), and the imaging area reached ~24.4 mm2. To obtain
holographic diffraction patterns on the surface of the CIS, the blue light LED was located 5 cm above
the surface of the image sensor. In addition, there was a plate with a pinhole (diameter of 0.1 mm) at
the front of the LED to obtain a coherent light source. To utilize the large FOV of the CIS, an S-type
micro-channel was designed that could easily determine the volume of liquid samples and count the
maximum possible number of cells in a frame. Moreover, the concentration of cells in a specimen
could be calculated accurately, similar to a classic cell counting chamber. We used a PDMS channel
and a piece of thin glass bonded together to obtain a microfluidic chip to capture the holograms of
cells (the diffractive shadow images of cell) and fix the microfluidic chip on the surface of the CIS.
We briefly introduce the fabricated process of the microfluidic below.
The photoresist (SU-8 2015, Microchem, Westborough, MA, USA) and a silicon wafer (4 inches
in diameter) were used to fabricate positive model. The 3 mL of photoresist was dropped in the
centrality of a wafer, and the photoresist film was 30 μm in thickness after using the spin coater at
1500 r/min for 15 s. Then, the silicon wafer was pre-baked for 15 min at 95 ◦C. The pre-designed
channel photolithography plate was used for exposure on the lithography machine for 125 s. Next, the
exposed wafer was after-baked for 3 min at 95 ◦C, and developed for 3 min. Then, we poured 30 g of
liquid PDMS on the positive film, and put it in baking box for 40 min at 95 ◦C to solidify. The solidified
PDMS layer and a piece of thin glass were bonded by vacuum plasma technique. Finally, the PDMS
layer was drilled the holes of the inlet and outlet to finish the microfluidic chip.
However, since a microfluidic chip was used, a cell sample could be continuously detected,
similar to a flow cytometer, as shown in Figure 2.
  
Figure 2. The proposed flow cytometer: (a) The flow cytometer system; (b) the holograms of the
microfluidic chip captured by the system. Box 2 is an amplificatory image of box 1, and box 3 is
a diffractive reconstruction image of box 2. Box 4 is the image of box 3 with the background removed,
where the red circles mark the cells.
Next, we prepared an experimental platform to obtain the features and parameters of the proposed
system. In addition, we found that the exposure time of the image sensor in this system was greater
than 400 ms. Unfortunately, motion blur is caused by the movement of cells in the sample when the
image sensor is operating during the exposure time. Therefore, we considered that instead of the cells
flowing through the detection area at high speed, a large number of cells passed through the exposure
region at one time. In other words, the system utilized the large FOV of the CIS to obtain a large
number of images of cells from each frame. To avoid the motion blur caused by cell flowing, we used
a method of periodically controlling the flow velocity of the specimen. There was only one inlet and
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one outlet in the micro-channel, ensuring that the flow of all the tested cells out of the micro-channel
and that of the new cells flow into the micro-channel took a short time. To obtain a sufficient processing
time for the image processing algorithm, the new cells were injected into the micro-channel during the
image processing period. Subsequently, all the tested cells flowed out the micro-channel, and then
the flow of the cells stopped and the cell images were captured by the image sensor. With several
repetitions, the device was able to collect the maximum possible number of cell signatures to improve
the accuracy of the analysis.
2.2. Sample Preparation
The flow cytometer is suitable for samples with a large number of cells, such as blood. Therefore,
we performed an experiment with whole blood. The concentration range of red blood cells (RBCs) in
whole blood is from ~4 × 1012/L to 5.5 × 1012/L. To ensure the reconstruction of the wavefront in the
in-line holography system, we had to reduce the concentration of cells in the whole blood. According
to the experiments, we found that 1:400 was a suitable volume dilution to count blood cells. When
RBCs were tested, the dilution ratio was 1:400, corresponding to 10 μL of whole blood diluted with
4 mL of phosphate buffer saline (PBS, 0.0067 M PO4), and the resulting solution was pumped into the
microfluidic chip for testing.
The concentration of white blood cells (WBCs) in whole blood is 4 × 109/L–10 × 109/L, and the
ratio of WBCs to RBCs is close to 1:1000. When WBCs were tested, 200 μL of a whole blood sample
was diluted with 400 μL of RBC lysis buffer and this was then injected into the micro-channel after
one minute of delay. The study was approved by the School of Automation and Information Ethics
Committee, Xi’an University of Technology.
2.3. Reconstruction of Lens-Less Holographic Images
The lens-less imaging technique utilizes an in-line holographic structure proposed by Gabor [33] to
reconstruct the image of the cell plane. The lens-less holographic imaging system is mainly composed
of a blue LED light source, a pinhole plate, a microfluidic chip and a CIS, as shown in Figure 3.
Figure 3. Graphic sketch of an in-line holographic microscope: (a) the structure of the lens-less
holographic imaging system; (b) the procedure for capturing the lens-less hologram by the CIS.
Because of the infinitesimal size of blood cells (~2–15 μm), the shadows of the blood cells on the
surface of the CIS are diffraction images. Due to the influence of diffraction phenomenon, the shorter
the wavelength of light source is, the higher the spatial resolution of the microscopic image becomes.
In the most commonly used LED of single frequency light sources, a blue light source has the shortest
wavelength. So we chose a blue LED as the light source. For convenience, we assumed that the cell
plane was the object plane and that the surface of CIS was the image plane. The distance from the
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pinhole to the object plane was d1, and the distance from the object plane to the image plane was d
(d1 >> d). According to the angular spectrum theory of diffraction, we can reconstruct an image of
the object plane by recording the image plane. We assumed that the transmittance of the sample was
O(x, y) and that the complex amplitude of the wavefront through the object plane was as below:
Ud(x, y) = 1 − O(x, y) (1)
Here, the image plane is assumed as the plane of z = 0, and the object plane is assumed as the
plane of z = d. According to the Rayleigh–Sommerfeld diffraction theory, the transfer function of light







1 − (λε)2 − (λη)2
]
0, otherwise




Here, ε and η denote the coordinates of a frequency domain and have been transformed by x and
y into a spatial domain. λ is the wavelength of the light source. According to the transfer function,
we can obtain the complex amplitude of the image plane:
U0(x, y) = H+d [1 − O(x, y)] (3)
where H+d and H
−
d represent the optical forward and backward propagation operators, which carry out
a fast Fourier transform and an inverse fast Fourier transform, respectively, belonging to a convolution
operator. d denotes the distance of the light propagation; in other words, it is the distance between the
object plane and the image plane. + and − denote forward propagation and backward propagation
along the z-axis, respectively. The light intensity in the holographic plane recorded by the image sensor
is the square of the amplitude of the light wave, and the light intensity is as below:
I0(x, y) = |U0(x, y)|2 (4)
In Equation (4), U0(x,y) is the complex amplitude of the actual light wave in the image plane, but
the image sensor can receive only the light intensity, I0, and the phase is discarded. Normally, image
sensor acquisition of the holographic plane light intensity is a linear process, so the light intensity
information collected by image sensor can be expressed as:
Is(x, y) = α + βI0(x, y) (5)
The amplitude of the light wave in the object plane can be obtained by the reconstruction of the
distance image at the back of the image plane:
Ur(x, y) = H+d [Is(x, y)] (6)
With Equations (1)–(6), we obtain Equation (7):
Ur(x, y) = D − O∗(x, y)− H+2d[O(x, y)] + H+d
{∣∣H+d [O(x, y)]∣∣2} (7)
In Equation (7), the first term is the direct current (DC) component; the second term is the focus
image; the third term is the holographic image, which is the focus image backward propagated
a distance of 2d; and the fourth term is the intermodulation. The second and third terms constitute the
twin image, which still appears after the forward transfer reconstruction of the diffraction plane and is
difficult to separate. In fact, the twin-image phenomenon, which is caused by the absence of a light
phase, is a major problem in the in-line holographic system. In addition, we used micro-bead images
obtained with a 10× objective lens to simulate the twin-image problem (Figure 4).
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Figure 4. The twin-image problem: (a) a 7 μm micro-bead image was used to simulate the
reconstruction of lens-less holographic images. (b) By simulating the holographic imaging with
Equations (1)–(4), we retained the amplitude of the complex number and discarded the phase to
simulate the recording procedure of a CIS. (c) We used Equation (6) to reconstruct the focus image of
object plane, but it was polluted by the twin-image phenomenon.
According to Gabriel Koren’s research [32], we can use only one diffractive to reconstruct a focus
image of the object plane and suppress the twin-image phenomenon. In our proposed algorithm, only
a holographic diffraction image and a cell-absent background image were needed to reconstruct the
phase and obtain a focus image of the object plane. The general steps were as follows:
Step 1: Using the square root of the light intensity and the initial value of the phase (generally 0),
reversely transfer the diffractive pattern of the image plane back to the object plane by the transfer
function to obtain the focus image. However, the initial estimation of the object plane seriously suffers
from the twin-image phenomenon. Thus, it is necessary to use the following steps to suppress the
twin images. The main operation of the reconstruction process is similar to the frequency domain
filter in digital image processing. The transfer function of the filter is shown by Equation (2), and the
reconstruction algorithm of the object plane is shown below:







Step 2: The region information of the object is extracted from the preliminary estimated object
image, which is used for the object plane constraint. Classic image segmentation algorithms, such as
the gradient boundary extraction algorithm and the threshold segmentation algorithm can be used to
find the object plane constraint. Because of the low signal-to-noise ratio (SNR) of the image extracted by
the CIS, the threshold segmentation algorithm is more reliable. The threshold is 0.34 in this manuscript;
in other words, the grey value of cell regions on the object plane is usually less than 0.34.
Step 3: The cell region is the C region, and the background is the non-C region. Through an iterative
algorithm, the cell regions are close to the real image, and the twin-image phenomenon will be
weakened on the object plane. The algorithm is
U(i+1)r (x, y) =
{
m × D(x, y), x, y /∈ C
Uir(x, y), x, y ∈ C
(9)
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Step 4: The new complex amplitude of the image is obtained by the forward transfer operation.
The phase of the newly calculated complex amplitude is retained, and the amplitude is replaced by the
original known image plane amplitude. This process is called the image plane constraint:
Ui0(x, y) =
∣∣∣U10(x, y)∣∣∣× exp(j × ϕi0(x, y)) (11)
The iteration can be completed by repeating the third and fourth steps and can converge after
5–6 iterations. To obtain the missing phase, the algorithm iterates between two planes (object plane
and image plane) through the amplitude and makes the iteration convergent using the object plane
constraint (Equation (9)) and the image plane constraint (Equation (11)). However, the algorithm
converges rapidly in the initial several iterations, and then the convergence is almost stagnant.
Furthermore, there is a large error in the estimation of the initial phase when the distance between
the object plane and the image plane has a deviation in an actual system. Therefore, the classic phase
recovery algorithm is necessary to improve an actual system. The manuscript proposes an initial phase














In general, there is no linear relationship between the amplitude and phase in a complex number.
However, the phase changes of near-coherent light passing through a cell are related to the cell
transmittance, and the cell transmittance is also expressed in amplitude. Therefore, there is a weak
correlation between amplitude and phase. Using this property, we can estimate the initial phase of the
iteration by transmittance. Through the initial phase constraint, the iterative convergent speed is faster,
the reconstruction precision is higher, and the anti-jamming ability is stronger.
To test the performance of the algorithm, we used a dyed leucocyte captured by a 20× object lens
microscope to perform a simulation. Using Equations (1)–(5) to establish a diffractive degradation
model, we obtained the diffractive pattern of the leucocytes. To replicate our flow cytometer, we chose
the same parameters as the actual system for simulation. The central wavelength of the light source
was 465 nm, the distance between the object plane and the image plane was 0.875 mm, and the pixel
size was 2.2 μm. The iterative algorithm without the initial phase constraint was compared to the
iterative algorithm with the initial phase constraint, and the result is shown in Figure 5.
To test the performance of the two methods, we calculated the root-mean-square error (RMSE)
for the reconstructed image of the object plane and original image. Finally, the proposed algorithm











(∣∣Uir(x, y)∣∣− |Ud(x, y)|)2 (13)
According to the distance between the object plane and image plane, we conducted two groups
of comparative experiments. The first was without deviation, and the second was with 20% deviation.
The RMSEs of the two method were calculated by Matlab (Version: 2016b, MathWorks, Endogenous,
MA, USA) and are shown in Figure 6.
In Figure 6, the ‘phase constraint’ is our proposed method, and the ‘non-phase constraint’ is the
classic method. The proposed method has a faster convergence rate and a lower error rate, making
it more conducive to counting and analyzing cells. As shown in Figures 5 and 6, by comparing the
two groups with the two methods, we found that the iteration method with initial phase constraints
had a faster iteration speed. In the case of a 20% distance deviation, the proposed method was able to
restore the cell image, whereas the original method could not restore the image effectively, which has
a great influence on the actual system. Moreover, when all the parameters were accurate, the proposed
method converged faster, and the RMSE of image reconstruction was smaller. The results in Figure 6
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show that our proposed method can greatly reduce the time consumption of the image processing
algorithm and provide a guarantee for the real-time implementation of the system.
 
Figure 5. The result of our proposed method and classic method without a phase constraint. (a) The
image captured by a 20× object lens microscope; (b) the diffractive image on the image plane;
(c) the image reconstructed by Gabriel Koren’s method with 0% deviation in distance; (d) the image
reconstructed by Gabriel Koren’s method with 20% deviation in distance; (e) the image reconstructed
by our modified method with 0% deviation in distance; (f) the image reconstructed by our modified
method with 20% deviation in distance.
Figure 6. The root-mean-square error (RMSE) of our proposed method and the classic method without
a phase constraint.
Finally, we used a frame image of whole blood cells captured by the lens-less flow cytometer to
test the computation time. We used Matlab to reconstruct the holographic image, and the hardware
was graphics workstation (Xeon E5-2600, 16 GB DIMM DDR4, Intel, Santa Clara, CA, USA). The time
consumed for one iteration was about 2 s with the classic method of phase iterative reconstruction, and
the proposed method took ~0.1 s longer than the classic method. However, the method we proposed
only needed 5 iterations, and the classic method needed 10 times to achieve the same reconstruction
effect. Therefore, the time consumed by the propose method was ~12.82 s, and that of the classic one
was ~24.42 s. In other words, it means that the proposed method reduced the computational time by
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~48%. In general, the two algorithms have almost the same computational complexity. Our algorithm
only adds one phase constraint to the first image reconstruction, but its time computation is ~0.19 s.
2.4. Blood Cell Analysis Method
In the on-chip flow cytometer, the blood cells flow in the micro-channel above the image sensor,
and their holographic diffraction image is transmitted onto the sensor surface by the near-coherent
light source. To reduce the cost and volume of the device, an ordinary blue LED with a limited
light intensity was used. The light on the plane of the cells is further weakened because the light is
illuminated through a pinhole. Therefore, the exposure time of the image sensor needs to be longer
than 400 ms to capture a bright enough hologram. If the blood cells move during the exposure time of
the CIS, there is a motion blur, as shown in Figure 7a. To solve this problem, we used a pulse injection
method, which is shown in Figure 7b.
 
Figure 7. The pulse flow control mode: (a) The flow of cells stops in the micro-channel during the CIS
exposure time to capture a holographic image of the cells. (b) When the system is processing images of
cells captured in the last exposure, the tested cells flow out of the micro-channel, and the new cells flow
into the micro-channel.
In Figure 7, t1 is the exposure time, and t2 is the injection time. This process can be controlled by
a micro-pump. Due to the high precision of micro-pump control, the injection time and stationary time
of the blood cells can be fixed. Therefore, the algorithm can be processed according to fixed parameters.
After an experiment, accurate cell image collection and injection of new samples in micro-pump mode
can be ensured.
In addition, instead of the micro-pump method, a hand-push model can be used to reduce the
cost and volume of the device. In the hand-push model, the motion state of the cells in the microfluidic
chip can be detected by the image processing algorithm. The system acquisition accuracy can generally
be guaranteed with t1 > 5 s and t2 > 20 s. The state of cell motion in the microfluidic chip is detected by
the RMSE between two frames.
In addition, there are two important problems, which relate to cell overlap. The first is the cell
overlap in the holographic image. As mentioned earlier, the raw image captured by the lens-less
platform is a holographic image, so the size of a diffractive image of the cell is ~4 times bigger than that
of a focus image. The inevitable cell image overlap was solved by the phase iterative reconstruction
algorithm. The other problem relates to the position of cell overlap and the 3D structure of the
micro-channel leads to the shadow image overlap. The problem is difficult to solve by digital image
processing algorithms. Therefore, we used a diluted cell sample to solve the problem. According to
the experiment, the 1:400 dilution ratio is an acceptable ratio for the blood cells, and cell overlap is
almost impossible at 1:1000 dilution. Considering the speed of counting, we chose a 1:400 dilution.
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The microfluidic chip was mounted above the CIS so that we could easily obtain the background
image without cells. In addition, we then injected a fluid sample of cells into the micro-channel to
record the holograms and reconstruct the focus images of the cells. The location and size of the cells
were determined by threshold segmentation with images with background interference removed.
According to our experiment, the flow velocity was 100 μL/min. Because of the infinitesimal volume
of the micro-channel (0.246 μL), the digital injection pump was able to replace all cells in the channel
less than 1s. However, it took ~15 s to 20 s for the cells in the fluid to become static. Fortunately, were
able to use this time to process the cell image. Since the pixel number of the CIS was about 5.04 million,
the computer took ~16 s to process the full resolution image.
The on-chip flow cytometry capability of this method, together with its ease of use, may offer
a highly precise and lower cost alternative to existing whole blood analysis tools, urine analysis tools
and plankton analysis tools, especially for point-of-care biological and medical tests.
3. Results and Discussion
To test the performance of our proposed system, we performed an experiment with whole blood
cells. In the results section, we show the results of focus image reconstruction for cell counting in our
proposed system.
Figure 8 shows that the images of the cells were captured by removing the background in the
reconstructed image and that the quantity and size of the sample were determined by the image
threshold segmentation algorithm. The system obtained an accurate background image, effectively
removed the background effect, accurately acquired the location of the sample, and greatly improved
the counting accuracy. Finally, the cell concentration was calculated based on the number of cells
and the volume of the micro-channel. The micro-channel was 30 μm in height, 150 μm in width,
and ~54.6 mm in length; thus, it was easy to calculate its volume as ~0.246 μL and projective area as
8.19 mm2.
 
Figure 8. The reconstruction of the focus cell images flow path. To better observe the effect of
holographic image reconstruction, which is a small segment of the whole image, all scale bars indicate
100 μm.
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Then, we used different concentrations of the whole blood samples to test the linearity and the
accuracy of the proposed method. We diluted seven groups of different concentrations of blood cells
with a dilution ratio to perform an experiment. The results of this experiment are indicated in Figure 9.
Figure 9. The result of linearity of different concentrations.
Ultimately, we used whole blood cells to count RBCs and WBCs in order to verify the effectiveness
of the cell counting procedure. According to the above preparation method, diluted whole blood cells
and lysed whole blood cells were divided twice. In addition, we needed to substract the concentration
of WBCs from the concentration of whole blood cells to get the concentration of RBCs. Then, the test
results of the proposed system were compared with those of an automatic blood cell analyser (BC-5180,
Mindray, Shenzhen, China), and the results are shown in Table 1.
Table 1. The result of different sample concentrations.
Sample No. Tools
White Blood Cells (WBCs)
Concentration
Error




Our system 6.83 × 109/L
1.4%
5.22 × 1012/L
2.4%BC-5180 6.93 × 109/L 5.35 × 1012/L
2
Our system 4.80 × 109/L
1.2%
5.28 × 1012/L
1.5%BC-5180 4.86 × 109/L 5.36 × 1012/L
3
Our system 6.33 × 109/L
0.6%
4.64 × 1012/L
1.9%BC-5180 6.29 × 109/L 4.73 × 1012/L
4
Our system 5.10 × 109/L
2.3%
4.61 × 1012/L
1.5%BC-5180 5.22 × 109/L 4.68 × 1012/L
5
Our system 6.78 × 109/L
2.6%
4.87 × 1012/L
2.7%BC-5180 6.96 × 109/L 4.74 × 1012/L
Table 1 shows that the average fractional errors of RBC and WBC counting were 2% and 1.6%,
respectively. In other words, the relative error between the proposed system and the whole blood cell
counter was less than 2%. This accuracy indicates the potential for applying the proposed system to the
early detection of some liquid samples, such as blood tests, urine tests, semen tests, and microbiological
tests. In areas where the use of large-scale, high-precision instruments is inconvenient, such as the
outdoors, the battlefield, and underdeveloped areas, the tool proposed here can enable early and
real-time detection.
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4. Conclusions
The current paper improved the twin-image recovery algorithm in a coaxial holography system
and increased the convergence speed of the iterative algorithm. In addition, this paper proposed
a flow cytometer based on lens-less holographic microscopy that improved the counting accuracy to
2.3%. The on-chip flow cytometer based on a pulse injection method can continuously count cells and
continuously collect a large number of cell images for subsequent cell analysis. Ultimately, this on-chip
flow cytometer is very suitable for use in underdeveloped areas and areas far away from the laboratory
because of its low price and tiny size and is in full compliance with the current development trend of
point-of-care testing (POCT).
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